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A new family of nucleotides has been designed, synthesised and evaluated for DNA 
sequencing by synthesis. Each of the nucleotide analogues had a free 3'-OH group 
and a fluorophore attached to the base through a small peptide linkage that was 
designed to stop multiple base additions. Analysis by HPLC and MALDI-TOF 
proved the modified nucleotides were incorporated into a growing DNA strand by a 
DNA polymerase and that the peptide linker was cleaved with high efficiency after 
incubation of the extended primer with a protease. 
Enzymatically cleavable nucleotides were successfully applied to chip-based 
sequencing by synthesis cycles. The fluorescent emission revealed the identity of 
the incorporated nucleotide and the removal of the fluorophore by a protease 
ensured the detection of the next base in the following cycle. 
Additionally, a practical microwave-mediated solid-phase protocol has been 
developed for the synthesis of cyanine dyes spanning the visible and the near 
infrared spectrum to allow the preparation of a series of fluorescent nucleotides for 
the design of a four-colour DNA sequencing technology. 
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Abbreviations 
A adenine, adenosine, alanine 
A Angstrom 
Ac acetyl 
ADP adenosine diphosphate 
Ahx 6-amino hexanoic acid 
Ala alanine 
Am-dCTP aminopropargyl deoxycitidine triphosphate 
Am-dUTP aminopropargyl deoxyuridine triphosphate 
AMP adenosine monophosphate 
APS adenosine phosphosulfate 
aq aqueous 
ATP adenosine triphosphate 
BEAMing beads, emulsion, amplification, magnetics 
Bn benzyl 
BODIPY boron difluoride dipyrromethene 




C cytosine, cytidine 
°C degrees Celsius 
CAE capillary array electrophoresis 
calcd calculated 
CCD charge-coupled device 
cDNA complementary deoxyribonucleic acid 
CE capillary electrophoresis 
cm centimetre 
CPG Controlled Pore Glass 
CRT cyclic reversible termination 
Cy cyclohexyl, cyanine 
d doublet, days 
dATP deoxyadenosine triphosphate 
DCM dichloromethane 
dCTP deoxycytidine triphosphate 
ddATP dideoxyadenosine triphosphate 
ddCTP dideoxycytidine triphosphate 
ddGTP dideoxyguanosine triphosphate 
ddNTP dideoxynucleoside triphosphate 
ddTFP dideoxythymidine triphosphate 





DLP digital micromirror device 
DMAP 4-(dimethylamino)-pyridine 
DMF dimethylformamide 
DMSO dimethyl sulfoxide 
DMT dimethoxytrityl 
DNA deoxyribonucleic acid 
dNTP deoxynucleoside triphosphate 
DSC disuccinimidyl carbonate 
dsDNA double-stranded DNA 
dTTP deoxythymidine triphosphate 
DVB divinyl benzene 
EDC 1 -ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
ELSD evaporative light scattering detector 
eq equivalent 
ES electrospray mass spectrometry 
ET energy transfer 
Et ethyl 
FACS fluorescence activated cell sorting 
FAM carboxyfluorescein 
FISSEQ fluorescent in situ sequencing 
FITC fluorescein isothiocyanate 
Fmoc 9-fluorenylmethoxycarbonyl 
FRET Förster resonance energy-transfer 
FTIR Fourier transform infrared spectroscopy 
g grams 
G guanine, guanosine 
h hours 
HGP human genome project 
HOBt 1 -hydroxybenzotriazole 
HPA 3-hydroxypicolinic acid 




J coupling constant 
L litres 
m 	 multiplet, metres 
M moles per litre 
mlz 	 mass to charge ratio 
MALDI-MS 	Matrix-assisted laser desorption ionisation mass spectrometry 
MAS 	maskless array synthesiser 






mp melting point 
MPSS massively parallel signature sequencing 
MS mass spectrometry 
MW molecular weight 
n.d. not determined 
nla not available or not applicable 
NBP nitrobenzyl pyridine 
NDP nucleoside diphosphate 
NHS N-hydroxy succinimide 
MR near infrared 
NMP nucleoside monophosphate 
NMR nuclear magnetic resonance 
NTP nucleoside triphosphate 
PBS phosphate buffered saline 
PCR Polymerase Chain Reaction 
PEG polyethyleneglycol 
PGP personal genome project 
Ph phenyl 
PP1 pyrophosphate 
ppm parts per million 
Pr propyl 
PS polystyrene 
PS-PEG polystyrene-polyethyleneglycol copolymer 
q quartet 
RI 10 rhodamine 110 
R6G rhodamine 6G 
Rf 	 retention factor (movement of compound/solvent front) 
Rho rhodamine 
RNA 	 ribonucleic acid 
ROX carboxy-X-rhodamine 
RP-HPLC 	reverse-phase high performance liquid chromatography 
rt room temperature 
s singlet, seconds 
SBH sequencing by hybridisation 
SBS sequencing by synthesis 
SDS sodium dodecyl sulfate 
SEM standard error of the mean 
SM starting material 
SMRT single-molecule real-time 
SN2 bimolecular nucleophilic substitution 
vi 
SNA single nucleotide addition 
SNP single nucleotide polymorphism 
SOLiD sequencing by oligonucleotide ligation and detection 
SPSC sodium phosphate saline citrate 
SSC saline-sodium citrate 
ssDNA single-stranded DNA 
t triplet 
T thymine, thymidine 
TAMRA tetramethylcarboxyrhodamine 
TBAI tetrabutylammonium iodide 
'Bu tert-butyl 
TCA trichloroacetic acid 
TEA triethylamine 
TEAA triethylammonium acetate 
TEAB triethylammonium bicarbonate 
Tfa trifluoroacetate 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
tic thin layer chromatography 
tR elution time of compound on HPLC 
TxR texas red 
U uracil, uridine, unit 
UV ultraviolet 
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1 	INTRODUCTION 
1.1 	Beyond the Human Genome Project (HGP) 
The human genome contains more than 3 billion base pairs and 20,000-25,000 
genes; with only 1.5% of the DNA contained in the genome encoding for proteins. 
Deciphering the DNA sequences of genes is critical for understanding the function 
of each human gene and the genetic bases of susceptibility to diseases. This was the 
primary goal of the Human Genome Project (HGP) an international research project 
headed by James Watson at the U.S. National Institute of Health)' 2 A parallel 
sequencing project was led by Venter, former president and founder of Celera 
Genomics. The first working drafts of the human genome, generated by the publicly 
sponsored Human Genome Project and by Celera Genomics, using two different 
sequencing technologies, were both released in February 2001.1,3  The complete 
draft of the human genome was released in 2003. 
A deeper understanding of the genome, made possible by the HGP, is having a 
strong impact on many different areas across life sciences such as molecular 
medicine, energy production, evolution and forensic. By having a detailed map of 
all the genes it is possible to investigate the causes of diseases, develop more rapid 
diagnostic tests and study how genes affect the way individuals respond to drugs. 
Sequencing of pathogenic microbes and drug resistant strains can give important 
insights into drug resistance and aid designing more effective drugs. 
The realisation of this goal requires the development of fast and cheap technologies 
which enable scientists to analyse DNA in a massively parallel manner. In the last 
three decades, advances in DNA sequencing technology have already allowed an 
impressive reduction of the sequencing cost: from $ 300 million in 2003 (first draft 
of the human genome) to $ 60 000 (March 2008) and the cost of sequencing an 
entire human genome is expected to drop further to $ 5000 by 2009. 
Established DNA sequencing technologies face many limitations in terms of speed 
and costs. Therefore, a "race" to develop faster and cheaper DNA sequencing 
technologies started, with the aim of reducing the cost of sequencing a human 
genome to $ 1000.6 
1 
In this chapter the structure of DNA will be first briefly reviewed to understand the 
chemistry behind sequencing technologies. The history of DNA sequencing 
technologies will be then presented, with an emphasis on the most common 
established techniques and recent developments. The chapter will conclude with a 
statement of aims for the present thesis. 
1.2 	Deoxyribonucleic Acid (DNA) 
Deoxyribonucleic acid (DNA) is a biopolymer, which holds the genetic information 
necessary for living organisms to function. This information is encoded in the 
sequence of the building blocks (nucleotides) that form DNA .7 
1.2.1 Nucleotides 
A nucleotide consists of three components covalently bound together: a pentose 
sugar, a nucleobase and one to three phosphate groups (Figure 1.1). The carbon 
atoms of the sugar ring are numbered 1' through 5' to distinguish them from the 
atoms of the base. 
The base is attached to the Cl' position of the sugar to form what is referred to as 
nucleoside. When one, two or three phosphate groups are attached to the 5' carbon 
of the sugar, the nucleoside is referred to as nucleotide. Nucleotides containing the 
sugar deoxyribose (like the ones forming DNA) are called deoxynucleotides and 
they lack of the 2' hydroxyl group which is normally present in the nucleotides 
forming RNAs. When the sugar lacks both hydroxyl groups at the 2' and 3' 
position, the nucleotide is referred to as dideoxynucleotide. The latter has found 
application in the dideoxy-chain termination DNA sequencing method developed 
by Sanger in 1977.8 
There are four different types of bases in the nucleotides forming DNA: adenine 
(A), guanine (G), cytosine (C) and thymine (T). The first two nucleobases are 
purines and are numbered 1 through 9. The last two nucleobases are pyrimidines 
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Figure 1.1 Structure of a DNA nucleotide. 
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Figure 1.2 Nucleobases in DNA 
1.2.2 Primary structure of DNA 
The DNA backbone consists of nucleotides covalently linked through 
phosphodiester bonds between the 3' hydroxyl group on the sugar ring of one 
nucleotide and the phosphate group attached at the 5' position of the adjacent 
nucleotide. These phosphodiester bonds lead to the formation of the so called 
"sugar-phosphate backbone" from which the bases project and stack atop each 
other. 
The DNA strand has two distinctive ends referred to as the 5' and the 3' ends, with 
the 5' end being the one with a terminal phosphate group and the 3' end being the 
one with a terminal hydroxyl group (Figure 1.3). DNA is synthesised by 
polymerases in a 5' to 3' direction by adding nucleotides to the 3' end (hydroxyl 












Figure 1.3 Primary structure of DNA 
In living organisms, DNA is typically present as a double helix of two antiparallel 
polynucleotides chains held together by hydrogen bonds between the bases. 
1.2.3 Secondary structure of DNA 
The structure of DNA was published in 1953 by Watson and Crick based on the X-
ray diffraction data obtained from Wilkins and Franklin. 9 
In the double helix, in which a base forms hydrogen bonds with a specific base on 
the opposite strand, A and T form two hydrogen bonds while C and G form three 
hydrogen bonds (Figure 1.4). The stability of DNA is determined by the GC content 
and by the length of the double helix. Long DNA molecules with a high GC content 
have stronger interactions between the two strands because of the higher number of 
hydrogen bonds and stacking interactions between the aromatic bases. ° 
This arrangement of nucleotides in the double helix is the basis for base-pair 
complementarity and is essential when DNA is copied. In the next section a brief 
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Figure 1.4 DNA base pairs 
1.2.4 DNA replication 
Replication of DNA occurs during cell division cycles and starts at specific sites of 
the chromosomes, called origins of replication. The DNA strands are unwound by 
enzymes called helicases and the resulting single-stranded DNA stabilised by the 
binding of single strand binding proteins to allow access to DNA polymerase. DNA 
is then synthesised by a polymerase, an enzyme able to bind and move along a 
single DNA strand using it as a template to extend the 3' end of a primer by adding 
nucleotides. The primer extended during replication is a RNA primer (synthesised 
by the enzyme primase using a DNA strand as a template). The energy necessary 
for the polymerisation is provided by the removal of two of the phosphate groups 
attached to the sugar of the incorporated nucleotide. The other phosphate is 
involved in the formation of a phosphodiester bond. DNA polymerases have proof-
reading activity, they correct mistakes in newly synthesised DNA by excising the 
incorrect base pair. After base excision, the polymerase can insert the correct 
nucleotide and the replication can continue. At the end of the replication process, 
two exact copies of the original DNA molecule obtained are divided between the 
two daughter cells.7 
DNA replication can be carried out in vitro using isolated DNA polymerases and 
synthetic DNA primers complementary to a known sequence in the DNA template. 
1.3 
	
Sanger DNA Sequencing 
The sequencing method that enabled scientists to realise the Human Genome 
Project was the Chain Termination method introduced by Sanger in 19778 
1.3.1 Chain Termination method 
The chain termination DNA sequencing method is based on the process of DNA 
replication and involves the synthesis of new strands of DNA complementary to a 
DNA strand of unknown sequence that acts as template for the incorporation, by a 
DNA polymerase, of nucleotides to the 3' end of a defined DNA primer (Figure 
1.6). Firstly, the DNA to be sequenced is fragmented and cloned. After extraction, 
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Figure 1.5 Structure of a deoxynucleotide (dCTP) and a dideoxynucleotide (ddCTP). 
Either the primer or the dideoxynucleotides are labelled with different fluorophores 
in order to be detected.1H3  As all four deoxynucleotides are present, chain 
elongation proceeds until dideoxynuclotides are incorporated. These molecules 
terminate chain elongation as they lack the 3' hydroxyl group and therefore they 
cannot form a phosphodiester bond with another nucleotide (Figure 1.5). In dye-
primer sequencing, four sequencing reactions are carried out in parallel. Each 
reaction mix contains a dye-labelled primer, four dNTPs and one particular ddNTP. 
In dye-terminator sequencing (currently used in Sanger-based DNA sequencers), 
the sequencing reaction is carried out using four dNTPs, unlabelled primers and 
on 
four labelled ddNTPs. The result is the formation of many DNA fragments of 
different lengths and colours emitting light at different wavelengths. All fragments 
are separated, by capillary electrophoresis 14  in an automated DNA sequencer, 
according to their size and the identity of the final base of each fragment revealed 
by the color detected by the laser at the bottom of the gel. By overlapping, it is 
possible to determine the sequence of nucleotides in each fragment and 
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Figure 1.6 Chain termination DNA sequencing using fluorescent ddNTPs: a) polymerase reaction 
with a mixture of dNTPs and labelled ddNTPs; b) labelled fragments generated during polymerase 
reaction and terminated after incorporation of a labelled ddNTP; c) separation of all fragments by 
capillary electrophoresis; d) detection of fluorescence signals. 
1.3.2 Advances in Sanger sequencing 
Since its introduction in 1977, the Sanger method has undergone many major 
innovations which have been essential for the completion of the HGP. Advances in 
enzymology, 15,16 fluorescent dyes, 1 7-19  fluorescence detection, 12  capillary 
electrophoresis, 14  DNA purification, cloning methods, 20  informatics and robotics 
contributed to an increase in the read-length, the accuracy and throughput of the 
Sanger method. Most laboratories have routine access to this technology and 
sequence DNA with a read-length of up to -4000 bp. 5 
7 
	
1.3.2.1 	Capillary Electrophoresis 
Capillary electrophoresis (CE) has gained popularity since its introduction in the 
1990's in automated DNA sequencers for the separations of DNA fragments instead 
of the large vertical slab gels, used in the original Sanger method. 14'2I 
A CE instrument comprises two electrolyte chambers linked by a capillary gel (-
50-100 jtm in diameter) to separate DNA chains under the application of an electric 
field and an in-line detector positioned at the capillary outlet to detect the 
fluorescent signals. This format allows rapid heat dissipation and enables faster 
separations than in slab gels. In addition it is highly compact and therefore requires 
low reagent volumes (nanoliter range) while reducing dramatically the cost of 
sequencing ($ 0.50 per kilobase). 
In 1997, another important innovation contributed to speed up the realisation of the 
HGP: the introduction of capillary array electrophoresis (CAE) in DNA 
sequencers. 22-25  CAE is a multiplexed array of 96 or 384 capillaries arranged on a 
miniature chip. 26 '27 The DNA fragments are introduced into the array and then 
separated in parallel inside the capillaries. As the fragments pass in the capillaries, 
they are irradiated all at once and detected with laser-induced fluorescence. Modern 
sequencers using CAE, contain 384 or more capillaries and are able to process up to 
1000 bp long reads with a production throughput of 2.5 megabases per day. 5,28  The 
Sanger method coupled to microchip-based electrophoretic technologies is by far 
the most competive platform for sequencing, in relation to read length and accuracy 
(99.999%); however, it is limited in terms of throughput. 
1.3.2.2 	Fluorescent Dyes & Detection 
In the original chain termination method introduced by Sanger, DNA fragments 
were tagged using radiolabelled primers made radioactive through incorporation of 
a phosphorus (32P) or sulphur isotope (35 S), and then loaded in four lanes of a high-
resolution polyacrylamide gel for separation. The reaction products were then 
detected by autoradiography. 8 
In 1986, the introduction of fluorescent dyes eliminated the need for manipulation 
of hazardous radioactive compounds and enabled DNA sequencing with higher 
sensitivity and in a single lane (instead of 4). 12  Since then, fluorophores with higher 
sensitivity and better spectral discrimination have been developed for the labelling 
of nucleotides together with enzymes able to incorporate them efficiently in DNA. 18 
An ideal set of dyes for DNA sequencing should include fluorophores with a strong 
absorbance at a common excitation wavelength and strong emission at four 
different wavelengths. However four-colour sequencing systems have shown some 
drawbacks as the fluorophores spectra often overlap and the excitation of four 
fluorophores from a common laser source has proven to be inefficient. 29,30  This 
problem has been partially resolved by using multiple lasers 31  or Förster resonance 
energy- transfer (FRET) dyes for the labelling of primers or ddNTPs.' 7 '32 '33 FRET 
takes place when a donor chromophore in its excited state transfers its excitation 
energy to an acceptor chromophore by a long-range dipole-dipole coupling 
mechanism. The efficiency of FRET depends on the distance between donor and 
acceptor (usually less than 10 nm) and on the degree of overlap between the 
emission spectra of the donor and the absorption spectra of the acceptor. 34 In 1995, 
Ju et al. described the synthesis of universal ET (energy transfer) primers having 
fluorescein as a donor dye and RI 10, R6G, TAMRA, ROX as acceptor dyes 
(Figure 1.7). 17,32  This set of ET primers has shown good spectral separation of 
emission wavelengths and good signal strength. Currently, FRET-based dyes are 
widely used in DNA sequencing for the labelling of primers (such as DYEnarnic TM 
ET primers from GE Healthcare) and nucleotide-terminators (DYEnamic ET 
terminators from GE Healthcare and Big Dye terminators from Applied 
Biosystems). 29 
Despite the advantage of using FRET-based dyes, the emission intensities of the 
corresponding labelled nucleotides cannot compete with those of single dye 
molecules. 30 Therefore, to address such limitations a number of strategies have been 
proposed to improve fluorescence detection, such as fluorescence life-time 35  and 
radio frequency modulation. 36  A promising technology for DNA sequencing, 
recently proposed, is called pulsed multiline excitation (PME). 3° This new 
technology has been applied to capillary electrophoresis for DNA sequencing and is 
based on the use of sequential laser pulses for the excitation of labelled DNA 
fragments being separated by CE (capillary electrophoresis). The advantage of this 
technique is that the emission signals are stronger as the absorption maxima of the 
dyes match the excitation sources and the temporal separation of the laser pulses 
eliminate any spectral overlap between fluorophores. Furthermore, stronger signal 
intensities are obtained as no dispersing elements (e.g. prisms) are needed for 
colour separation. 
This technique has a great potential for DNA sequencing as it enables the use of 
lower concentrations of material (because of its high sensitivity) and the 
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Figure 1.7 ET primers for DNA sequencing 
1.3.2.3 	Thermostable Enzymes & Polymerase Chain Extension 
Another important advance in DNA sequencing has been the introduction of 
thermostable DNA polymerases and their use in polymerase chain extension (PCR) 
reactions. 37 
PCR is a technique developed by Mullis in 1983 based on the use of thermostable 
DNA polymerases (such as Taq polymerase, isolated from Thermus aquaticus)38 for 
the amplification of DNA. 39  During PCR cycles, double stranded DNA is 
alternately heated to a high temperature (-90 °C) and cooled down in order to 
separate the two strands by denaturation which then enables the DNA polymerase 
to use them as templates for the synthesis of new complementary DNA strands. 
With PCR it is possible to amplify one or few copies of DNA to generate millions 
of copies, allowing thus the analysis of very small amounts of DNA. 
1.4 	New High Throughput DNA Sequencing technologies 
With the completion of the HGP, more than 150 billion bp of sequence information 
was produced . 29 The availability of this large amount of data paved the way to a 
new era, the so called "post-genomic era" that sees as main objective a deep 
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understanding and exploration of the complete human genome for application in 
pharmacogenomics, disease-gene linkage, gene function studies and finally clinical 
medicine. Additionally, de novo sequencing and re-sequencing of genomes are 
required for application in comparative genomics, evolution and epidemiology. 
There is also a strong need for the identification of all the genetic variations that are 
related to disease susceptibility and phenotypic diversity. The most common DNA 
sequence variation is known as Single Nucleotide Polymorphism (SNP) and occurs 
when a single nucleotide vanes among members of a species, affecting their 
response to diseases, pathogens, drugs, chemicals, etc.40 
In response to the need for ultra high throughput DNA sequencing methods, 
numerous strategies and technologies have been proposed, to reduce the cost of 
sequencing and to increase the throughput (Table 1.1). They include nanopore 
sequencing, 4 ' sequencing by hybridisation 42  and sequencing by synthesis 
technologies .43 
Most of these techonologies use new ultra-sensitive detection methods (e.g in single 
molecule DNA sequencing), microfluidic technologies and miniaturised arrays, 
which contributed to lower the costs and increase the quality of data generated by 
these new technologies. 
These techniques and the most recent DNA sequencing technologies are discussed 
below. 
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Table 1.1 New generations of DNA sequencing technologies. Table adapted from ref.544 
Roche-454 - - - $60 $500000 250 bp 
Emulsion PCR 
SBS (reversible 
Illumina- terminators) $2 $430000 36 bp Solexa 
Bridge PCR 
Helicos SBS-single molecule $1 $1 350 000 30 bp 
SBS (Ligase-octamers 
Applied with two-base 
encoding) $2 $591 000 35 bp  Biosystems 
Emulsion PCR 
SBS (Ligase-nonamers) 
Dover $1 $155000 13 bp 
Emulsion PCR 
Pacific Real time SBS-single - Under >1000 bp 
Biosciences molecule development 
Visigen Real time single Under >1000 bp molecule - development 
Intelligent Bio- SBS (reversible Under 
ystems terminators) - development 
* expected 
1.5 	Array-based Cyclic Sequencing Technologies 
The need for ultra-high-throughput DNA sequencing technologies encouraged 
researcher to develop non-electrophoretic-platforms in order to carry out genome 
analysis in an automated and highly parallel manner. 
Array-based sequencing technologies consist of repeated cycles of sequencing 
performed on an array of spatially separated DNA molecules. The array features are 
either ordered (DNA microarrays) or randomly dispersed (bead arrays). Each cycle 
consist in interrogating one or a few bases in parallel for a large number of 
oligonucleotides (thousands to billions). 45 
1.5.1 Solid Phase Arrays for DNA Sequencing 
Currently, solid-phase array sequencing devices are used for the production of high 
density DNA platforms for DNA sequencing applications as they enable scientists 
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to obtain a large amount of data, using small amount of reagents and miniaturised 
systems. Typically, DNA probes or targets are immobilised either onto planar 
surfaces made of glass/polymers (e.g Illumina sequencing technology) 46 or onto 
arrays of beads located in the microwells of a glass or fiber optic slide (e.g 454 Life 
Science Picoliter Sequencing System). 47,48 
1.5.1.1 Bead Arrays 
Bead arrays have found applications as highly parallel platforms for DNA cloning 
in a number of modem DNA sequencing technologies. 47 '49'50 Clonal beads are 
discrete colonies of PCR amplicons (PCR-amplified DNA) immobilised onto solid 
surfaces, such as beads ordered on a patterned planar surface. Polonies can be 
obtained by solid-phase PCR in polyacrylamide gels, 5 ' BEAMing (beads, emulsion, 
amplification, magnetics)-based cloning, 52  or Megaclone technology. 49,1'  All these 
methods developed for DNA amplification have been used in combination with 
different sequencing technologies (sequencing by synthesis and sequencing by 
ligation). 
BEAMing PCR (so-called emulsion PCR) is a clonal amplification technique that 
has been adopted for DNA sequencing platforms, such as 454, Polonator and 
SOLiD, to amplify sequencing features (these technologies are described in detail 
in the section 1.5.3).52  In this technique, magnetic beads coated with streptavidin 
are bound to oligonucleotides modified at their 5' position with biotin (Figure 1.8). 
An aqueous mixture containing oligonucleotide-bead complexes, DNA templates, 
nucleotides and DNA polymerase, is stirred with an emulsifier/oil mix to create a 
microemulsion. The emulsion is generated such that each droplet or "compartment" 
contains a bead. The emulsion is then aliquoted into the wells of a 96-well PCR 
plate and thermal cycled to amplify the DNA templates. In each droplet, where 
there are a bead and a DNA template, the bead-bound oligonucleotide acts as a 
primer during the amplification process. After breaking the emulsion, the DNA 
strands are denatured and the beads captured into the wells of a picotiter plate (e.g 
454 sequencing technology) or immobilised on a planar surface to produce high 
density "random" bead arrays (SOLiD and Polonator). Because each bead can have 
up to I million copies of each DNA template, the signal-to-noise ratio of enzymatic 
assays (e.g sequencing by synthesis cycles) carried out on these beads is very high. 
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Another important advantage of this technique is the ability to simultaneously 











Figure 1.8 Emulsion PCR: A) DNA fragments and microbeads; B) emulsion PCR (water-in-oil 
emulsion); C) clonal beads. 
The megaclone technology has been adopted in Massively Parallel Signature 
Sequencing (MPSS). 49 In this approach, DNA templates are conjugated by ligation 
to 32-mer tags and amplified by PCR to generate thousands of copies of each DNA-
tag "hybrid". Each DNA molecule has a unique tag, complementary to anti-tags 
sequences attached to microbeads. When amplified DNA and microbeads are 
mixed, the PCR products are captured by the magnetic beads bearing 
oligonucleotide sequences complementary to the tag in order to have -100 000 
identical DNA molecules covalently attached to each bead. One million microbeads 
are then loaded in a specially designed flow cell to form a packed monolayer of 
beads and used as platform for DNA sequencing by ligation (section 1.5.3.1). 
Bead-array-based technologies have also been developed by Illumina for 
application in DNA genotyping. 48 The arrays are constructed by self assembly of 3 
gm silica beads in the microwells of fiber optic chips or silica slides and can reach a 
density of 40 000 array elements per square millimetre. Hundreds of thousands of 
oligonucleotides are attached to each bead of the array acting as universal capture 
sequences in multiplexed genotyping assays. Because the arrays are assembled 
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ramdomly, each bead and sequence is identified using a decoding system based on 
sequential hybridisations to fluorescently labelled oligonucleotides complementary 
to the capture sequences. 54 
1.5.2 	Sequencing by Hybridisation 
DNA sequencing by hybridisation consists in using an array of short 
oligonucleotide probes complementary to different regions of an unkown DNA 
fragment to reconstruct its sequence from the hybridisation pattern. 55-57  Two 
different approaches have been reported. One approach consists of immobilising the 
DNA to be sequenced onto a surface (membrane or glass chip) and hybridising it to 
small labelled probes. An alternative strategy consists of hybridising genomic DNA 
to arrays of immobilised oligonucleotide probes. The binding of one 
oligonucleotide probe to its complementary strand is sensitive to a single mismatch. 
Therefore the occurrence of a sequence of nucleotides in a DNA target can be 
interrogated by using small probes that differ by only one base (A, C, T, G) (Figure 
1.9). Only one of the four probes matches fully the target sequence giving the 
strongest hybridisation signal. In this way, by reading the target sequence with a 
full set of overlapping probes, it is possible to determine each position in the target. 
Each region of the array is assigned to a set of probes, complementary to a specific 
region of the genome to resequence. The hybridisation pattern obtained from the set 
of overlapping probes is then used to reconstruct the sequence of the original DNA 
target using mathematical algorithms. 
An impressive amount of sequence information can be obtained with this method 
(>109 bases). Therefore sequencing by hybridisation has found application in 
massive genome resequencing for the investigation of single-nucleotide 
polymorphisms. It has been also applied to de novo sequencing; however this 
application still remains a challenge because of the low read-length (limited by the 
probe length) and the complexity of the method. 55 
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BASE 1 TATGT] 
T A T G C 
T A T G G 
A T G T A 
A T G T G 
BASE  A T G T C 
A T G T T 
T G T C A 
T G T C T ~  
BASE 3 ITGTCGI 
T G T C C 
SEQUENCE: I C I A T G T C G 
Figure 1.9 Sequence assembly using overlapping oligonucleotide probes in sequencing by 
hybridisation. Each base in the target is interrogated with a set of four probes (which differ by one 
base). The probe sequence in the highlighted box is the one that matches the target sequence, and 
giving the strongest fluorescence signal during hybridisation. 
A new high-throughput sequencing-by-hybridisation technology, called 'Shotgun 
SBH" has been proposed by Pilhak in 2008.' This technique overcomes some of 
the problems of the classic sequencing by hybridisation method, proposing the use 
of highly parallel sequencing platforms (10 millions sequencing features per square 
centimetre) containing a library of DNA target colonies (200 bp) obtained by 
rolling circle amplification.  60  Resequencing is carried out using small universal 
probes compatible with any genome. Firstly, genomic DNA is fragmented and 
converted in circular molecules containing a 50-mer universal linker used to 
hybridise the target DNA to primers immobilised on a surface. The target DNA is 
amplified by rolling circle PCR generating sub-micrometer structures which can be 
easily detected using sequence-specific fluorescent probes. A set of 582 fluorescent 
pentamers (containing locked nucleic acid monomers to increase the melting 
temperatures) is then sequentially added to hybridise the array of DNA target on the 
glass slide. At the end of the process, the full spectrum of overlapping DNA 
fragments is compared to the genome of reference to find genetic variations. The 
autors reported that, using this approach, 97.3 % of single mutations could be 
detected in a test genome. This high throughput platform is a cost-effective, 
Ef1 
accurate and highly parallel technique for resequencing applications, when a 
reference genome already exists. 
1.5.3 Sequencing by Synthesis 
Despite differences in sequencing biochemistry, the work flow of the so-called 
"second generation DNA sequencing technologies" (454, Polonator, SOLiD, 
Illumina Genome Analyzer, etc.) consist of three main steps: 
DNA fragmentation and modification (e.g. in vitro ligation of sequence 
adaptors) 
DNA amplification 
array sequencing (e.g. extension of primers by polymerases or ligases and 
imaging) 
These second-generation cyclic array sequencing technologies are all based on the 
principle of sequencing by synthesis, although primer extension can be performed 
either by a ligase (Polonator and SOLiD) or by a polymerase (454, Illumina). 
1.5.3.1 	Sequencing by Ligation 
Multiplex Polony Sequencing 
The method, developed by Church, is based on the amplification of DNA molecules 
on paramagnetic beads using emulsion PCR 52 and on the principle of four-colour 
sequencing by ligation. 50 Two platforms, SOLiD and Polonator, are based on this 
system. in the SOLiD platform, commercialised by Applied Biosystems, a two-base 
encoding system is used in sequencing-by-ligation cycles. In this approach, the 
beads bearing amplified DNA are immobilised on a planar surface to generate a 
high density random array. DNA sequences immobilised onto the beads are 
hybridised to an "anchor" primer that is ligated enzymatically to a population of 
degenerate octamers labelled with fluorescent dyes such that the identity of two 
positions (e.g the first two bases) of the octamers, which are complementary to the 
query positions, correspond to the identity of one particular fluorophore (Figure 
1.10). After those particular positions have been identified by four-colour imaging, 
the octamer is chemically cleaved to remove the fluorophore and the primer ligated 
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to another octamer to query other two positions. After the primer has been extended 
by ligation, the complex anchor primer-octamer is stripped by denaturation and the 
cycle restarts using a different mixture of octamers, with different positions 
encoded by the fluorophore, (or another primer that is set back one or few positions 
from the ligation site) to interrogate other positions. Sequencing data are acquired 
using a "colour space" mapping system to identify the colour and the position of 
each bead and consequently the two adjacent bases in the ligated octamer, which 
were encoded by the colour. 
ABI's SOLiD system was introduced on the market in 2007. It has a read-length of 
25-35 bp and generates 2-4 Gb per run of DNA sequencing data. The Polonator was 
launched in 2008 and is currently the most competitive technology in terms of 
instrument price (Table 1.1). However, the Polonator system is limited by the 
44 current read-length (13 bp). 5"'6 ' 
PrFUUniversal sequencing primer 	Ligase 	U U U U U 	 U 
ç illLnuium P1 adapter 
Universal sequencing primer 
(Jfflll 
P1 adapter 	Template sequence 
Figure 1.10 Microbeads generated by emulsion PCR and used in the sequencing method developed 
by Applied Biosystems (SOLiD). Figure adapted from ref. 6 ' 
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Massive Parallel Signature Sequencing 
Massive Parallel Signature Sequencing (MPSS), developed by Brenner, is a 
technology based on the Megaclone technique for the preparation of DNA samples 
and on cycles of ligation for DNA sequencing. 49  In this method, two million 
megaclone beads are loaded through the inlet of a flow cell and packed in a planar 
array so that each bead can be identified individually during sequencing. Like the 
sequencing method described in the previous section, this approach is based on 
sequencing by ligation. However, at the end of each cycle, the ligated sequences are 
cleaved using restriction endonucleases rather than being stripped by denaturation. 
In this approach, a short adapter containing the recognition sequence for a 
restriction endonuclease, is ligated to the end of each cDNA on the beads (Figure 
1. 11). When the restriction enzyme is added to the beads, it binds to the recognition 
sequence and it cuts another region of the DNA molecule leaving a four base pair 
overhang. In a ligation cycle, encoded adaptors are used to identify these four 
bases, one at a time. A set of 1024 encoded adaptors is ligated to the cDNA on the 
beads such that each microbead has an equal number of four different adaptors, 
each encoding a different position of the four-base overhang. 
MM  OJCDNA bead 1 
Ligation 
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Digestion with BBv I 
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p. : .. 
cDNA bead 
Figure 1.11 Sequencing reactions for MPSS. Adapted from ref. 49 
The encoded adapters are designed to contain a recognition region for the 
restriction enzyme (in order to repeate the cycle) and a sequence complementary to 
fluorescently labelled "decoder" probes used to sequentially identify the desired 
four-base sequence with an accuracy of 99.9%. 
This method has found application mainly in genotyping and gene expression 
analysis because of the short read-length (20 bp). De novo sequencing application 
would require an increase in the read-length of the method. 55 
1.5.3.2 	454 Pyrosequencing 
454 Sequencing technology is a highly parallel sequencing method commercialised 
by 454 LifeScience Corporation. This technology uses the BEAMing-based cloning 
technique (described in the section 1.5.1.1) for the preparation of DNA samples and 
the pyrosequencing approach to generate sequence data. 47 
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C) DNA + dNTP 	- DNA+1 + PP 1 
Polymerase 
PP 1 +APS — ATP 
Sulfurylase 
ATP + Lucifenn 	Oxyluciferin + photon 
b) 	 Luciferase 
Luciferase 
bead 
Figure 1.12 454 Sequencing technology: a) microbead carrying double stranded DNA; b) bead 
loaded in the well of a PicoliterPlate; c) Synthesis of ATP from the pyrophosphate released during 
extension and oxidation of luciferin by the enzyme luciferase to generate light. 
Following amplification of DNA by emulsion PCR, DNA-carrying microbeads are 
loaded on a plate made of 1.6 x 106  wells, which can be thought as picolitre-scale 
sequencing reactors (Figure 1.12). The enzymes required for pyrosequencing (ATP-
sulfurylase and luciferase) are immobilised on smaller beads. 
The sequencing reactions are carried out by delivering the reagents (buffers and 
nucleotides) into the flow chamber where the PicoTiterPlate is positioned. The four 
nucleotides are added sequentially over the slide. When a nucleotide is incorporated 
by a DNA polymerase, the pyrophosphate released is converted to ATP by a ATP-
sulfurylase, providing energy to the enzyme luciferase to oxidise the substrate 
luciferin and to generate light (Figure 1.12). The light generated during each 
incorporation step, is then recorded by the CCD (charge-coupled device) camera of 
the instrument in order to detect the DNA sequences in which that particular 
nucleotide has been incorporated. 
The key advantage of the 454 system over modem technologies is in its read length 
(200-300 bp), throughput and accuracy. However the cost of sequencing is much 
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higher than that of other platforms (SOLiD and Solexa). The 454 technology is 
currently the method of choice for the analysis of long reads (e.g. de novo 
assembly). 5 
1.5.3.3 	Fluorescent in situ sequencing 
Another massively parallel sequencing-by-synthesis approach is fluorescent in situ 
sequencing (FISSEQ) developed in Church's lab and licensed to Agencourt 
Bioscience. 5 ' In this approach DNA molecules are amplified on microbeads 
embedded in the polymer matrix of a slide. DNA fragments are sequenced by serial 
additions of a single fluorescent nucleotide (Figure 1.13) that is incorporated in 
DNA strands by a DNA polymerase. After each incorporation step, the slide is 
imaged using CCD optics and the fluorophore is removed either by photocleavage, 
or chemically from each incorporated nucleotide to allow the next sequencing 
cycle. The advantage of this approach is that it is inexpensive and has a low error 
rate (<1/3.3 million bases). It can be used for resequencing and de novo sequencing. 
This approach, like pyrosequencing, is based on the principle of Single Nucleotide 
Addition (SNA). 43 Therefore the major limitation is the analysis of homopolymeric 
sequences, in which the same base is repeated many times (e.g. AAAA). Because 
the 3'-OH of the nucleotides used in SNA is not protected, multiple incorporations 
occur when four nucleotides are added together. To avoid this, in SNA, nucleotides 
are added sequentially, one a time. However, when a sequence contains repeats, the 
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Figure 1.13 Structure of Cy5-SS-dCTP 
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To overcome this limitation, nucleotides protected at their 3' position have been 
designed for DNA sequencing by cyclic reversible termination. 
1.5.3.4 
	
Cyclic Reversible Termination 
Cyclic Reversible Termination is a DNA sequencing method based on cycles of 
primer extension, imaging and cleavage of a fluorescent reporter group, on a solid 
surface. 29,43 
In 2007 Illumina launched on the market a DNA sequencer based on this approach. 
Illumina genetic analysis technology is based on solid-phase DNA amplification 
methods62 and on the use of reversible terminators (section 1.5.4) .46,61,61 in this 
approach, DNA strands are attached onto a planar surface and amplified in order to 
create a high-density array made of 50 million colonies of DNA molecules (each 
colony is made of 1000 copies of DNA) (Figure 1.14). 
- a 
e 
Figure 1.14 Bridge PCR technique used for the amplification of DNA: a) genomic DNA is 
fragmented and ligated to adaptors at both ends (in orange and blue) and then attached to a planar 
surface; b) and c) unlabelled nucleotides are used to amplify each sequence; d) and e) double 
stranded DNA is denatured and clusters (or colonies) of DNA sequences are formed on the surface. 
Adaptef from ref. 5 
Polymerase reaction is carried out in the presence of four labelled reversible 
terminator nucleotides with the 3' position blocked to avoid multiple incorporations 
(Figure 1.16). After imaging the slide to identify the incorporated nucleotides, the 
fluorophore and the protecting group are removed chemically to allow the next 















Figure 1.15 Cyclic Reversible Termination DNA sequencing on a solid surface 
This technologies has a shorter sequence read-length (-35 bp) than capillary-based 
methods (>700 bp). Therefore, to date it has been applied mainly to the analysis of 
genetic variations and re-sequencing rather than whole genome de novo 
sequencing. 55 However, the low sequencing cost ($ 2 per megabase) and throughput 
(up to 90 million bases analysed in one run) make this technology one of the most 
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competitive DNA sequencing platforms. In addition, the use of reversible 
terminators allows for the analysis of homopolymeric repeats that are difficult to 
analyse with other methods (e.g. the pyrosequencing technology developed by 454 
Life Science). 5 '43 '45 Another advantage of cyclic reversible termination methods 
over single nucleotide addition methods is the possibility of using four different 
nucleotides simultaneously rather than four separate steps and thus reducing the 
number of cycles required for sequence analysis. 
Because the read-length of cyclic reversible termination technologies is determined 
by the efficiency of incorporation and deprotection steps, many research groups 
have focused on the optimisation of the chemistry of reversible terminators. 
Recent advances in the chemistry of reversible terminators are described in the 
section 1.5.4. 
1.5.4 Reversible Terminators 
The first example of a reversible terminator was reported by Metzker in 1994. 64 
Since then, a number of fluorescently labelled reversible terminators with cleavable 
linkers have been developed by academic groups and biotech companies for 
application in DNA sequencing by synthesis. 43 
Typically, a reversible terminator consists of a nucleotide with a small group 
capping the 3'-OH and a cleavable group linking the fluorophore to the base 
(generally at the 5 position of pyrimidines and at the 7 position of purines) (Figure 
1.16). 
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Figure 1.16 Structure of a reversible terminator with a protecting group in 3'-position and a 
cleavable linker connecting the fluorophore (orange star) to the base. 
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During a polymerase reaction, the reversible terminator is incorporated into the 
growing DNA strand causing temporary termination of the DNA synthesis. After 
identification of the incorporated nucleotide (e.g. by optical imaging), the reporter 
and the capping groups are removed and another polymerase reaction is allowed to 
proceed with another nucleotide analogue. 
Ideal reversible teminators should be recognised by a DNA polymerase, efficiently 
incorporated into DNA and rapidly cleaved to release the fluorophore. It is also 
important that the cleavage is complete to avoid residual fluorescent signals in the 
extended primer that would interfere with the next incorporation and detection 
steps. Cleavage of the linker and deprotection should be carried out in mild 
conditions compatible with the stability of DNA. Cleavable groups used to date for 
the synthesis of reversible terminators include disulfide bonds, allyl groups, 
azidomethyl groups and photo-cleavable 2-nitro-benzyl linkers (sections 1.5.4.1 and 
I Several small cleavable groups have been described for the protection 
of the 3' hydroxyl group. Metzker reported that nucleotides protected at the 3' 
position with groups containing ester linkages (acetyl or benzoyl) were not 
incorporated by any polymerase. On the contrary, small protecting groups 
containing ether linkages (e.g. allyl, methyl, nitrobenzyl, tetrahydropyranyl) have 
proved to be well tolerated by some DNA po1ymemses. 64 
Another class of reversible terminators, described by Burgess, includes nucleotides 
labelled with fluorescent molecules attached to the 3' position through a cleavable 
linker. The advantage of using these nucleotides is the fact that the fluorescent 
cleavable reporter group is used to block the 3' position and therefore only one 
deprotection step is required after incorporation. 65 However, this second type of 
nucleotide has been less exploited by researchers as polymerases do not tolerate 
modifications at the 3' position with bulky groups. 66,67 
The reversible terminators described in the literature include chemically cleavable 
and photocleavable linkers. The properties of these two classes of reversible 
terminators are discussed in the sections 1.5.4.1 and 1.5.4.2. 
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1.5.4.1 Chemically Cleavable Reversible Terminators 
In 2003 Church et al. proposed the use of a disulphide group as a chemically 
cleavable linker for reversibly dye-labelled nucleotides for application in 
fluorescent in situ sequencing on polymerase colonies (FISSEQ) (Figure 1. 13). 51 
The nucleotides were incorporated by a DNA polymerase in DNA strands 
immobilised on a surface; after imaging the slide, the linker was cleaved using a 
buffer solution containing 3-mercaptoethanol. 26-34 consecutive cycles of 
sequencing by synthesis were performed on a solid surface. Like the 
pyrosequencing method, fluorescent in situ sequencing is limited in the analysis of 
repeated bases (e.g. AAAA) as the hydroxyl group in the 3' position is not blocked. 
In addition, the nucleotides must be added sequentially to avoid multiple 
incorporations. In 2008 Turcatti et al. showed that reversible terminators bearing a 
disulfide linker could be used in 10 consecutives cycles of SBS. They also reported 
that, with an appropriate choice of the fluorophore, these nucleotide analogues 
could terminate the extension without the need for a blocking group at the 3' 
position. 66  
Linkers containing disulfide bridges have the advantage of being cleaved in 
relatively mild conditions, using a thiol or a water soluble trialkylphosphine. The 
main limitation of this cleavable group is the fact that it can be reversed or 
destabilised in particular reaction conditions. 68-70 
An alternative chemically cleavable linker has been reported by Ju et al. at the 
Columbia Genome Center. A full set of four fluorescent 3'-O-allyl-dNTPs-allyl-
fluorophore has been synthesized by protecting the 3'-OH with an allyl group and 
linking the fluorophore to the base through an allyl moiety (Figure 1.17). The allyl 
group and the fluorophore were removed in one step in 30 s by Pd-catalysed 
deallylation. 7 ' These nucleotides were efficiently incorporated by a DNA 
polymerase in 20 consecutive cycles of SBS on a microarray chip. 
Currently, this chemistry is being used in the sequencing platform of Intelligent 
Biosystems, a company co-founded by Ju and Gordon. They claim that this 
technology will reduce the cost of sequencing to $ 5000 by 2009 and to $ 1000 








Figure 1.19 Structure of the nucleotide reversible terminator 3'-O-N 3-dCTP 
The Genome Analyzer, commercialised by Illumina (see section 1.5.3.4), uses 
reversible terminators 3'-O-azidomethyl 2' deoxynucleoside triphosphates, each 
labelled with a different removable fluorophore (with a disulfide bridge). To 
improve the incorporation of these substrates, the DNA polymerase 9°Nm was 
modified .46 
An alternative method for removing the fluorescent signal after incorporation of the 
labelled nucleotide into a DNA strand has been proposed by Quake et al. 73 This 
method consists in quenching the fluorescence of the fluorophore so that a new 
signal can be detected after incorporation of the next nucleotide. The main 
limitation to the application of this method is the fact that the photobleached 
fluorophore remains within the DNA template and therefore interferes with the next 
cycles of extension. 
1.5.4.2 	Photocleavable Reversible Terminators 
Photocleavable groups have been used as an alternative to chemically cleavable 
linkers for the synthesis of reversible terminators. The advantage is in the 
possibility of carrying out the cleavage in milder conditions and without the need 
for chemicals or for additional purifications. The nitrobenzyl group is cleaved 
within lOs by irradiation with light (>300 nm) after the identity of the incorporated 
nucleotide has been determined by fluorescence imaging. 
The use of a photocleavable moiety for the synthesis of reversible terminators has 
been reported by many research groups. 43  Ruparel et al. have described in 2005 the 
synthesis and application of 3 '-O-allyl-dNTPs labelled with fluorophores connected 
to the bases through a nitrobenzyl linker (Figure 1 These reversible 
terminators required two deprotection steps in order to cleave the fluorophore by 
irradiation at 340 rim to deprotect the 3' hydroxyl group by Pd-catalysed 
deallylation. 
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Figure 1.20 Structure of the photocleavable reversible terminator 3 '-O-allyl-dCTP-PC-Bodipy 
1.5.5 Single Molecule DNA Sequencing 
All DNA sequencing methods, described in the previous sections, require 
amplification of DNA to achieve the required signal during sequence analysis. To 
reduce the cost of sequencing and avoid bias (due to sequences that amplify poorly) 
and errors introduced during the amplification process, single-molecule DNA 
sequencing (SMS) technologies have been developed by a number of companies 
such as Helicos, Pacific Biosciences, Visigen and Genovoxx. 29 '43 '55 '75 
These new DNA sequencing platforms, so-called "third-generation DNA 
sequencing technologies" include sequencing by synthesis methods, nanopore 
sequencing, real-time electrical detection 29,76  and transmission electron microscopy 
(TEM) of DNA synthesis. 75 
In this section, SMS methods which are already commercially available (True 
Single-Molecule Sequencing, by Helicos) or that are expected to be available in the 
next few years (e.g. SMRT sequencing by Pacific Biosciences and FRET-based 
SMS by Visigen ) are discussed. 
1.5.5.1 	Real-Time Single Molecule Monitoring of DIVA Synthesis 
The true single molecule sequencing (tSMS) technology developed by Quake and 
commercialised by Helicos Biosciences, relies on the cyclic interrogation of DNA 
sequences (bearing poly-(dA) "tails") hybridised to universal primers (with poly-
(H) sequences) immobilised on a planar surface. 73 ' 77 DNA analysis is performed 
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by adding fluorescent nucleotides (one a time) and a DNA polymerase to the array. 
The position of each template on the array is determined by fluorescence imaging. 
After primer extension, the array is imaged and then the fluorophore cleaved to 
allow next extension. 
This technology enables the analysis of billions of sequences per run (lh), 
providing a huge amount of data and sequence informations. However, this 
sequencing platform is still very expensive and limited in terms of read-length. 
Other technologies (e.g. SMRT), which are currently under development, seem 
more promising in terms of speed, cost and potential to analyse longer reads . 75 
Furthermore, like the pyrosequencing approach, the method developed by Helicos 
uses nucleotides that are not protected in the 3' position, therefore analysis of 
homopolymeric sequences is less accurate. 
One of the most exciting and promising DNA sequencing technologies is the 
single-molecule real time sequencing (SMRT) technology, developed by Webb and 
Craighead at Cornell University and by Pacific Biosciences. 7879 This technology is 
based on two proprietary innovations: the use of fluorescent nucleotides labelled on 
the y phosphate group and zero-mode waveguide chips. The nucleotide analogues 
used in this technology are labelled on the phosphate group rather then on the base 
(Figure 1.21). Therefore, when a nucleotide is incorporated in a polymerase 
reaction, the fluorophore is cleaved from the nucleotide and diffuses in the small 
reaction-chamber volume (20 xlO 21 liters) where each strand is localised with a 
single molecule of a DNA polymerase. It is possible to detect each incorporation 
event in real time against the background fluorescence of the unincorporated 
nucleotides, which float in the un-illuminated part of the chamber. In fact each 
zero-mode waveguide (ZMW) is a cylindrical hole (few tens of nanometers in 
diameter) illuminated through a transparent surface by a laser light. The wavelength 
of the light is too big to pass through the waveguide's aperture, therefore only the 
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Figure 1.21 Fluorescent nucleotide used in SMRT technology 
Pacific Biosciences claims that, by 2013, this technology will enable the analysis of 
the human genome in just 15 mm. Thanks to its speed, high data quality and the 
ability to analyse long reads, this platform will be used in a broad range of 
applications, such as de novo sequencing and whole genome resequencing. 75 
A FRET-based single molecule sequencing technology is being currently developed 
by Visigen. 75 Like the SMRT approach, fluorescent nucleotides labelled on the y 
phosphate group are used to monitor DNA synthesis by a polymerase in real time. 
Each of the four nucleotides has a different acceptor fluorophore; the donor 
fluorophore is attached to the polymerase. During extension, energy transfer from 
the polymerase to the nucleotide, generates a fluorescence signal, which reveals the 
identity of the incorporated nucleotide. After incorporation, the pyrophosphate 
labelled with the dye is released in solution and the FRET signal quenched. 
This "third generation sequencing method" is expected to analyse DNA with a 
speed of 1 million bases per second and a whole genome in less than one hour. 
1.5.5.2 	Nanopore Sequencing 
Nanopore sequencing is a single molecule approach based on the measurement of 
fluctuations in the electric conductance of a nanapore as DNA passes through it. 8° 
A nanopore can be represented by a protein pore in a membrane (biological pore) or 
by an artificial pore (solid state pore). 75 ' 81 ' 82 When a nanopore is immersed in a 
conducting fluid and a voltage is applied, a current of ions is generated through the 
pore. Because the intensity of this current depends on the size of the pore, when a 
DNA molecule pass through it, the differences in the chemical and physical 
properties of the nucleotides are translated in changes of current. 
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This technique, introduced for the first time in I 989, is still at a proof-of-the-
principle stage. The interest for this technique is mainly due to the possibility of 
sequencing single molecule DNA without the need for sample preparation and with 
high speed (PCR amplification or labelling). Significant advances in pore 
engineering will be necessary to identify single bases with a high accuracy. 
1.6 	Aims of the project 
As shown in the previous sections, a variety of DNA sequencing technologies have 
been proposed as an alternative to the classic Sanger chain termination method to 
satisfy the demand for rapid, accurate and cheap DNA sequencing platforms. 
In this context, sequencing by synthesis technologies based on cyclic reversible 
termination have proven to be so far among the most competitive methods in terms 
of throughput, accuracy and analysis of homopolymeric sequences. Current 
reversible terminator consist of chemically cleavable or photocleavable nucleotides 
and require the use of chemicals or irradiations for the cleavage which can result in 
damage to DNA. Therefore, there is a strong interest in developing new reversible 
terminators that have efficient incorporation and deprotection kinetics and that can 
be cleaved in mild conditions. 
The aim of the project was to design and synthesise a new class of enzymatically 
cleavable nucleotides and to verify the feasibility of using them in primer extension 
reactions on a solid surface for application in DNA sequencing by synthesis. 
To reach this objective, nucleoside triphosphate-peptide conjugates have been 
prepared and labelled with different fluorescent dyes in order to identify the base 
incorporated during primer extension by virtue of the colour. After detection, the 
fluorophore will be removed by enzymatic cleavage using a protease (Chapters 3 
and 4). 
In order to be able to interrogate a large number of DNA molecules in parallel, this 
method will be adapted to a solid phase platform, such as a DNA microarray 
(Chapter 5). 
The application of dNTP-Peptide-Dye conjugates in DNA sequencing by synthesis 
offers several advantages. Firstly, all steps (incorporation and cleavage) are 
mediated by enzymes (polymerases and proteases), allowing for rapid, fast and 
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specific reactions. Additionally, the peptide moiety is relatively stable, easy to 
handle and can be easily modified to control each step. 
The synthesis of fluorescently labelled peptides and nucleotides requires the 
availability of fluorescent dyes with different excitation and emission spectra. For 
this purpose, the cyanine dyes have been considered. To overcome the limitation of 
the high cost and lack of high-yielding protocols for their preparation, a practical 
method for the synthesis of cyanine dyes has been developed by combining solid 
phase chemistry and microwave heating (Chapter 2). 
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2 	Development of a practical method for the synthesis of 
cyanine dyes 
The purpose of this chapter is to provide a detailed description of the synthesis of 
fluorescent cyanine dyes for the labelling of enzymatically cleavable nucleotides. 
2.1 	Introduction 
The development of a novel four-colour DNA sequencing technology, based on the 
detection of fluorescent dye-labelled nucleotides, requires the availability of highly 
fluorescent dyes with different excitation and emission spectra and 
chemical/physical stability. Ideal fluorophores for application in microarray-based 
DNA sequencing technologies must also be pH insensitive and display non-specific 
binding to biomolecules and surfaces in order to reduce the signal-to-noise ratio. 
Cyanine dyes have all these requirements 83  and are widely used in fluorescent 
applications, such as microarray detection, 30 DNA sequencing,84 flow cytometry85 
and in vivo imaging. 86,87  Therefore they were selected for the preparation of our 
fluorescent nucleotides. However, the main limitation to their use is the high cost 
(175 £.mg) and the lack of practical and high-yielding synthetic methologies. 
The idea behind the work described in this chapter was to develop a practical and 
easy method for the synthesis of cyanine dyes spanning the whole colour range. 
Cyanine dyes of different colours and optical properties can be prepared by 
modulating the length of the polymethine chain (building block II) and the 
heterocycles at its ends (building blocks I and III),88  (Figure 2.1). 
For the purposes of the project, the synthesis of trimethine dyes with ?, ax  = 540-
600 nm and pentamethine dyes A = 640-700 nm was investigated. The solid 
phase synthetic strategy was also applied to the preparation of heptamethine dyes, 
commonly used for in vivo imaging applications, 89,90  and to sulfonated dyes, widely 
used for biomolecule labelling because of their water solubility and 
biocompatibility. 83 
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n = 1, 2,3. 
Figure 2.1 General structure of cyanine dyes 
2.1.1 Cyanine dyes 
The cyanme dyes are a family of highly fluorescent molecules belonging to the 
group of the polymethine dyes (Figure 2.2).' They were first developed as spectral 
sensitisers for silver halide emulsions films for the photographic industry. 92 
Afterwards they have found application in optical data storage and as fluorescent 
labels for biomolecules. 88 '93 '94 
Cyanine dyes contain electron donor (D) and acceptor (\) groups connected by a 
polyene chain and can be classified in cyanine, hemicyanine or streptocyanine, 
depending on whether or not the N atoms are part of a ring (Table 2.1 
),91 
A*9 D 
Figure 2.2 Generic structure of polymethine dyes 
The groups A and D are part of a highly conjugated system where the positive 
charge is delocalised, as shown by the two mesomeric structures la and lb 
(Scheme 2.1). By varying the length of the polymethine bridge along with the 
terminal heteroaromatic rings, it is possible to tune their absorption profile. The 
absorption maxima of cyanine dyes increase, almost linearly, by 100 nm with n (so-
called vinylene shift) while spectral fine-tuning is obtained by varying the 
substituents A and D. 95 
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Scheme 2.1 Mesomeric structures of polymethine dyes. Scheme adapted from ref. 9 ' 
The cyanine dyes have tunable wavelengths across the visible and near-Infrared 
(NIR) spectrum and intense colours, therefore they are ideal probes for highly 
sensitive multicolour detection. Their long fluorescence wavelengths are remote 
from the natural autofluorescence of biomolecules and their small molecular size is 
a desirable feature for fluorescent labels in order not to interfere with the system to 
be probed. In addition, cyanine dyes have excellent photophysical properties and 
narrow spectral widths. 83 '96'97 









Table 2.1 Groups of polymethine dyes. Table adapted from ref, 9 ' 
MM Synthesis of cyanine dyes 
The first synthetic cyanme dye was obtained by Williams in 1856.98  However, it 
was only in 1912 that structure elucidation  99  paved the way for a rational approach 
to the synthesis of polymethine dyes. 
Conventional synthetic methods for the preparation of unsymmetrical cyanine dyes 
are based on the condensation of two different heterocyclic quaternary salts 2 and 8 
with a polyene-chain precursor such as orthoformate, malonaldehyde or vinylogous 
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Scheme 2.2 General scheme for the synthesis of cyanine dyes: a) Ac 20: AcOH (1:1), reflux; b) 8, 
pyridine, 110 °C. Scheme adapted from ref. 9 ' 
Indolenine quaternary ammonium salts 2 (Scheme 2.2) undergo elimination of 
hydrogen halide HX, even in neutral conditions, to afford the stable Fisher's base, 
which behaves as nucleophile in the methylene base form.' °° Generally, after in situ 
deprotonation by a tertiary base, they react with an elecrophilic polyene-precursor, 
activated by acetylation or with a Lewis acid, to give a hemicyanme intermediate 4. 
The isolation and purification of such intermediate is vital for the synthesis of 
unsymmetrical cyanine dyes, in order to avoid contamination of the final product 6 
by hemicyanine 4 and the symmetrical derivative 5. 
The reaction can be easily monitored by UV spectrometry to reduce the formation 
of the symmetrical dyes. However, purification by chromatography is always 
required to afford unsymmetrical dyes in high purity and often is a difficult and 
time-consuming process since the impurities have similar properties to the desired 
products. 
2.1.3 Solid phase synthesis of cyanine dyes 
Fluorescent probes have attracted a large interest because of their high sensitivity 
and ease of handling, compared to radioactive labels.' ° ' However, they are often 
difficult to synthesise or purify and consequently have high costs, when 
commercially available. 
The use of solid supports avoids extensive work-up and chromatographic 
purifications, facilitates slow or difficult reactions by the ability to use high 
concentrations of reagents and allows for automation of the synthetic process.' 02 
Combinatorial chemistry is widely applied in medicinal chemistry or chemical 
biology for the discovery of drug candidates or biologically active compounds and 
has been also applied to the discovery of dyes. 103106 Two solid-phase approaches 
have been recently reported in the literature for the synthesis of cyanine dyes 
(Scheme 2.3). 
The first example was by Isacsson et al. in 2001,107  and based on the loading of a 
carboxy-flmctionalised heterocycle onto the solid support 9 followed by 
condensation with a hemicyanine, such as 10, to give a trimethine dye 11, Scheme 
2.3. The final product 12 was then isolated by acidic cleavage from the resin while 
the excess of hemicyanine was washed away from the resin in the previous step, 
avoiding purification of the final product by chromatography. 
In 2005 Balasubramanian proposed an alternative solid-phase method for the 
preparation of cyanine dyes based on attack of the heterocyclic carbon nucleophiles, 
such as 14a, on polyene-chain precursors immobilised onto a solid support 13b to 
form unsymmetrical trimethine or pentamethine dyes, such as 16, Scheme 2.3. 108  In 
this approach the hemicyanine intermediate I Sc is prepared on a solid support. 
Therefore, libraries of cyanine dyes with different functional groups and properties 
can be easily synthesised without the need for isolation and purification of the 
hemicyanine intermediates. 
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Scheme 2.3 Solid phase synthesis of cyanine dyes by Isacsson: a) Et 3 N, DCM, 3h; b) 95% 
TFA/water; and by Balasubramanian: a') BF 3 . DCM, 6h; b') 1-ethyl4-methylquinolinium, Ac 20, 
DIEA, pyridine. 
However, the compounds described in this work were not suitable for the labelling 
of biomolecules since they did not have functional groups for conjugation. In 
addition, this method cannot be applied to the preparation of cyanine dyes bearing 
sulfonated groups on both heterocycles because of the low reactivity of the 
sulfonated heterocycles during the loading reaction step. 
Therefore, there was still a need for the development of a facile and general 
synthetic method for the preparation of hydrophobic and hydrophilic cyanine dyes 
amenable to biomolecule conjugation and available in different colours. 
a 
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2.2 	Microwave-mediated synthesis of multicolour cyanine dyes 
The main focus of the work described in this chapter was to develop a common 
synthetic pathway for the preparation of a wide-colour-range of hydrophobic and 
hydrophilic cyanine dyes, Scheme 2.4, suitable for bioconjugation, in large scale (? 
100 mg scale) and without the need for chromatographic purification. The method 
described by Balasubramanian' °8 was optimised to allow the parallel synthesis of 
carboxyl functionalised cyanine dyes in a microwave, Scheme 2.4. 
The synthetic procedure reported, herein starts with the N-alkylation of 
indolenines (Section 2..2. 1 ). 
2.2.1 	Synthesis of N-alkyl quaternary ammonium salts 
N-alkyl substituted quaternary ammonium salts derived from benzothiazole, 
benzoxazole, benzoselenazole, indole and quinoline bearing an activated methyl 
group in 2-position are generally synthesised by heating the corresponding 
heteroaromatic base, at 100-120 °C, with an excess of alkylating agent such as, 
alkyl iodide or bromide (3-5 eq.) in aprotic solvents such as 1,2-dichlorobenzene 
and acetonitrile, Scheme 2.5.83,109,I10  The N-alkylation requires 1-3 days to be 
1,112 depending on the solvent, alkylating agents and substituents on the 
aromatic ring. 
Consequently, the molecular diversity of cyanine dyes and the combinatorial 
approach to the discovery of new fluorescent probes are limited by the long reaction 
times required for the synthesis of these precursors. 
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Scheme 2.4 Parallel synthesis of cyanine dyes 
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RI 	 a 
239: R 1 , R2 = H 
23b: R 1 , R2 = -( CH=CH) 2 
R2 	 R2 
R 1 H -_- HX 
R 1 , R2 = H, R Me, X= 
R 1 , R2 = -(CH=CH)2 , R = Me, X = I 
R 1 , R2 = H, R = -(CH 2)5-COOH, X = Br 
R 1 , R2 = -(CH=CH)2 , R = -(CH2 )5-COOH, X = Br 
Scheme 2.5 N-alkylation of trimethylmdolenine: a) RA, 1,2-0 2C61­14 or acetonitrile, 100-120 °C 
N-Alkylation of 23a-b with bromohexanoic acid or methyl iodide was carried out 
by refluxing the reaction mixture at 100-120 °C, in acetonitrile. Yields and reaction 
time are shown in Table 2.2. 
During our work on the synthesis of cyanine dyes, we were interested in 
investigating whether microwave heating could lead to an improved protocol for the 
N-alkylation of indolenines, especially in terms of reaction time. Microwave 
heating and its application to the N-alkylation of indolenines are discussed in the 
sections 2.2.1.1 and 2.1.1.2. 
Entry Compound T (°C) t Yield (%) 
14a 100-120 64h 68 
2 14b 100-120 16ha 77 
3 14c 100-120 16h 84 
4 14d 100-120 48 72 
Table 2.2 N- alkylation of indolenines. 'Precipitation of the product from the reaction mixture was 
observed after 2h. 
2.2.1.1 	Microwave heating 
High-speed synthesis with microwaves was reported by Gedye and 
Giguere/Majetich in 1986•U3,h14  Microwaves are a form of electromagnetic 
radiations defined as having frequencies between 300 MHz and 300 GHz." 5 
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Irradiation of a sample, with microwave frequencies, results in the dipoles or ions 
aligning with the applied electric field. When the applied field oscillates, the 
dipoles or ion try to realign itself with an alternating electric field, the molecule 
thus try to continually "realign" itself and consequently, heat is generated through 
molecular friction and dielectric loss. 116  
The conversion of electromagnetic energy into heat depends on the dielectric 
properties of a particular substance and its so-called tans = c'/c, where E is the 
dielectric loss, which depends on the efficiency with which the electromagnetic 
energy is converted into heat and c' is the dielectric constant. 116 
Solvents can be classified according to their tans, as high (tanö >0.5), medium (tanö 
0.1-0.5), and low microwave absorbing (tans <0.1). However, a low tans value 
does not preclude the use of a particular solvent, if the reagents or substrates are 
polar, or if polar additives such as ionic liquids are added to the reaction mixture. 
The advantage of microwave heating is that the sample is heated uniformly, 
whereas in the oil-heated vessels the solution in contact with the walls is heated 
first and unevenly.' 6 
2.2.1.2 	N-Alkylation of indolenines and microwave heating 
The alkylation of indolenines with alkyl halides is a SN2  reaction, which involves 
the displacement of the halide by the nucleophile (indolenine) and the formation of 
a quaternary ammonium salt. 
N-Alkylation of indolenines 23a and 23b, Figure 2.3, is expected to be accelerated 
by the use of microwave irradiations, since the reaction results in the formation of 
an ion pair, in addition to thermal microwave effects." 5,117,118 
R1 5 4> 
R,, R2 = H 
R,, R2 = -(CHCH)2 
Figure 23 Indolenines 23a and 23b 
SN2 reactions generally require the use of polar aprotic solvents (Table 2.3), since 
polar protic solvents stabilise the nucleophile. However, the use of water as a 
reaction media in conjuction with microwave irradiation is an emerging method for 
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the development of enviromentally friendly organic reactions and has been applied 
to various organic reactions and to nucleophilic substitutions,' 9 therefore water was 
considered for our experiments. 
In order to find the best conditions for the microwave-assisted alkylation of 
indolenines, polar aprotic solvents with high dielectric constant and loss factors 
were selected: dimethylformamide, and acetonitrile. DMSO was not tested, due to 
its high boiling point and the difficulty of removing it from the reaction mixture by 
evaporation. 
Water, DMF and acetonitrile were tested for the alkylation of 2,3,3-
trimetilindolenine 23a with bromo-hexanoic acid at 150 °C for 30 mm, Figure 2.4. 
We found 150 °C to be the optimal temperature for this reaction since higher 
temperatures cause formation of unidentified by-products (HPLC analysis), while at 
lower temperatures the reaction rate was too low and consequently low conversion 
values were obtained for all solvents. As shown in Figure 2.4, the highest 
conversions were obtained in DMF and acetonitrile at 150 °C for 30 mm. 
Solvent Dielectric costant tans 
1,4-Dioxane 2.3 n.a. 
Tetrahydrofuran (THF) 7.5 0.047 
Dichioromethane (DCM) 9.1 0.042 
Acetone 21 0.054 
Acetonitrile (MeCN) 37 0.062 
Dimethyl formamide (DMF) 38 0.161 
Dimethylsulfoxide (DMSO) 47 0.825 
1,2 Dichlorobenzene 2.8 0.280 
Table 2.3 Dielectric costants and tans of polar aprotic solvents 
These two solvents were further tested to push to completion the conversion of 
indolenine into the quaternary ammonium salt (Figure 2.5). 
The alkylations were carried out in sealed microwave vials by applying 3 cycles of 
microwave irradiation, of 30 minutes each. The highest conversion (73%) was 
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obtained using acetonitrile as solvent. After prolonged heating unidentified by-
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Figure 2.4 Microwave-assisted alkylation of 23a with bromohexanoic acid at 150 °C for 30 min in 
various solvents. 
Alkylation of 2,3,3-tetramethylindolenine 23a with bromohexanoic acid at 150 °C 
for lh, in acetonitrile, under microwave irradiation, afforded the quaternary salt 1-
(5-carboxypentyl)-2,3 ,3-trimethyl-3 H-indolium bromide (14c) in 66% yield. After 
evaporating acetonitrile in vacuo, the final compound 14c was precipitated with 
diethyl ether and then washed several times with diethyl ether and dichloromethane 
to remove starting materials. 
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Figure 2.5 Optimisation of the synthesis of 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-indolium 
bromide (14c) under microwave irradiation 
Alkylation of 2,3,3-tetramethylindolenine with methyl iodide was also performed 
under microwave irradiation. The use of microwaves allowed the preparation of the 
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desired product (14a) in only 30 minutes and in 94% yield, while the classical oil 
bath heating afforded the product in 84% yield and required 3 days of refluxing. 
2.2.2 	Preparation of polymer-bound polyene-chain precursors 
2.2.2.1 	Loading of tert-butyl phenylcarbamate and removal of the Boc group 
The starting point for the preparation of the range of cyanine dyes was the loading 
of Ntbutyloxycarbonyl  4-hydroxy aniline onto chioromethyl resin (1 % DVB cross- 
linking, 75-150 pin, 1.75 mmol g') by nucleophilic substitution (Scheme 2.6).b08120 
CI 	 a, b 
Rl N ,L ) 
Merrifield resin 	
H  
= Boc 17 
R, = H 181 (b) 
Scheme 2.6 Formation of 4-aminophenol PS: a) N-tbutyloxycarbonyl 4-hydroxy aniline, CsCO 3, K!, 
acetone, reflux, 16h; b) 20% TFA in DCM 
The protocol reported by Balasubramanian was modified by refluxing the reaction 
mixture at 70 °C in acetone (instead of the reported heating at 50 °C in 
dimethylformamide). These reaction conditions were preferred since a more 
efficient stirring of the resin was expected to be obtained by reflux. In addition, the 
exchange of the chloride on the resin with iodide, known as the Finkelstein 
reaction, 121  is more efficient in acetone where KCI and K! have different 
solubilities. While Kl dissolves readily in acetone, the solubility of KC1 is low, thus 
the equilibrium of the reaction is shifted by the precipitation of the insoluble salt. 
The reaction was monitored by a colorimetric test based on the reaction of 4-(4-
nitrobenzyl) pyridine (NBP) with the chloromethyl groups on the polystyrene 
resin. 122  Formation of the desired product was also confirmed by gel-phase 
NMR,' 23 and elemental analysis (quantitative by N analysis, 96% by Cl analysis, 
94% by I analysis). 
Removal of the Boc protecting group to form 18 was carried out with TFA (20% in 
DCM) for 2h. Merrifield resin is stable to treatment with this moderately strong 
acid. 124  The completion of the deprotection was confirmed by gel-phase NMR, 
while the loading of the resin was determined by elemental analysis. 
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2.2.2.2 	Formation ofpolymer-bound polyene-precursors (n = I and n=3) 
Conversion of 18 into the corresponding polyene-chain precursors 13 was achieved 
following the method proposed by Balasubramanian et al.' 08 The polymer-bound 
imidate ethyl 4-hydroxyphenylimidoformate (n=l), intermediate of the trimethine 
dye synthesis, was obtained by reacting 18 with triethylorthoformate in the 
presence of BF 3 Et2O (Scheme 2.7). The Lewis acid was added first to a solution of 
triethylorthoformate in DCM. Afterwards the reaction mixture was added to 18 and 
left under agitation, at room temperature, for 6 hours in a solid phase extraction 
(SPE) cartridge. The reaction mixture was then neutralised with 10 % triethylamine 
in DCM. 
The polymer-bound imidate (n=3), intermediate of the pentamethine dye synthesis, 
was obtained by reacting 18 with 1,1,3,3-tetramethoxypropane, under the same 
reaction conditions (Scheme 2.7). The formation of polyene-precursors was 
confirmed by the change in the colour of the resin (orange for 13a and dark blue for 
13b). 
Imidate formation was also confirmed by a sharp characteristic peak at 1645 cm' 
(C=N stretch) in the FTIR spectrum and by gel-phase NMR. 




18 	 13a:R=OEt 
13b: R = -CH-CH-OMe 
Scheme 2.7 Formation of PS-polyene precursors: c) triethylorthoformate or 1,1,3,3-
tetramethoxypropane, BF 3 Et20, DCM, 6h. 
The reaction of formation of imidates is a variation of the solution-phase method 
proposed by Roberts.' 25  The postulated mechanism for the reaction in solution 
involves two steps: A-formation of diphenylformamidine (rapid) and 13-reaction 
with another mole of orthoformate (slow) to give the N-phenylformimidate. Step B 
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Scheme 2.8 Formation of imidate in solution 
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Scheme 2.9 Formation of imidates on solid support 
On the solid phase, the nucleophilic attack of a second molecule of aniline does not 
occur, and the imidate 13a is thus directly obtained. The proposed mechanism for 
the formation of imidates on the solid phase is described in Scheme 2.9. 
2.2.2.3 Formation ofpolymerboundpolyene-precursors (n = 5) 
Further studies were carried out to apply this solid phase method to the synthesis of 
heptamethine cyanine dyes. In recent years, heptamethme dyes have attracted great 
interest as fluorescent probes for in vivo imaging applications as they have excellent 
penetrating ability through the tissues and absorption/emission spectra in the near 
infrared (NIR) region, where biomolecules and tissue autofluorescence is low. 89,90 
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In our initial investigation, the polymer-bound polyene intermediate 13c was 
obtained by reacting 18 with glutaconaldehyde hydrochloride I in DCM, in the 
presence of BF 3 Et2O. However, 13c was obtained in only 45% yield (by N 
elemental analysis), probably due to low solubility of the amidino pentadienylium 
salt in the solvent. Moreover, it was difficult to wash away the excess of reagent 
from the resin. Neither DMF, neither the presence of a tertiary bases could improve 
the solubility of the reagent, since they form complexes with BF 3 . Hence, it was 
investigated the use of acetic anhydride and diisopropylethylamine (DIEA) to 
activate glutaconaldehyde hydrochloride I to the nucleophilic attack of 18, as 
shown in Scheme 2.10. It was expected that phenylacetamide would be eliminated 
in preference to the more basic resin-bound aniline, during the loading step. 
However, also in this case, the yield was still low (49% by N elemental analysis). 
The extent of reaction was unclear from gel-phase NMR but was confirmed by 
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Scheme 2.10 Formation of polyene precursor with n = 5: a) DIEA, Ac20, DCM; b) DMF 
An alternative pathway to the preparation of polymer-bound unsymmetrical 
polyene-intermediates for heptamethine dyes, would be the use of precursors of 
glutaconaldehyde hydrochloride, such as 1,1 ,3,5,5-pentaethoxy pentane  126  in the 
presence of Lewis acids. However, such an intermediate is not commercially 
available and additional steps would be required for the preparation of supported 
imidate intermediates. Therefore, a catch-and-release strategy was considered for 
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the preparation of heptamethme dyes on a solid support. The description of this 
approach will be discussed in the section 2.3. 
2.2.3 Formation of hemicyanines 
2.2.3.1 Hemicyanines with n = 1 and n = 3 
Preparation of immobilised hemicyanines from precursors 13a-b was performed by 
condensation with quaternised indolenine derivative 14a-b at 120 °C for 15 mm 
under microwave heating (Scheme 2.11), in a variation of the method originally 
proposed by Balasubramanian. 108 
The formation of hemicyanines involves the reactivity of nucleophilic indoleninium 
salts 14 a-b with 13 a-b to form another ion pair where the positive charge is highly 
delocalised. The interaction of microwaves with the solvent (DMF) and the 
reagents determines an increment of the reaction rate due to thermal effects 
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Scheme 2.11 Formation of hemicyanines by microwave heating: a) 14a-b, 120 °C, lico, 15 mm. 
Formation of hemicyanines was confirmed by the disappearance of an IR peak at 
1630 cm 1 , indicative of the presence of the conjugated bond (C=N) in the imidate 
precursor. The polymer bound dimethine hemicyanine 15a was obtained in 66% 
yield (N elemental analysis), while the tetramethine hemicyanine lSc was obtained 
51 	0 
in quantitative yield. This result was in agreement with the yields of trimethine 20a 
and pentamethine 20c dyes 68% and 94% respectively (yields of the cleavage step) 
(see section 2.2.4). 
The use of microwave heating, during formation of the hemicyanine, leads to 
higher yields and purity of the final compound (68% yield for trimethine dye 20a, 






Figure 2.6 Trimethine dye 20a 
Any symmetrical impurity obtained by nucleophilic attack of two equivalents of 
indolenium would be automatically cleaved from the resin and removed by simple 
washing, thus avoiding difficult separation by chromatography. 
The use of microwaves instead of classical heating offers also the advantage of 
shorter reaction times (15 min at 120 °C instead of 4 h at 80 °C), allowing for easy 
automation of the synthetic process. 
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Figure 2.7 Effect of temperature/microwave heating on the yield of the trimethine dye 20a (cleaved 
from the resin in solution). 
52 
Figure 2.8 Purity of the crude trimethine dye 20c. 
2.2.3.2 	Hemicyanine with n = 5 
Formation of the hemicyanine intermediate 15e (with n = 5) was carried out by 
acetylating 13c in the presence of DIEA and acetic anhydride followed by reaction 
with 14a in DMF under microwave heating at 120 °C for 15 mm. However, the 
final heptamethine dye was obtained in low yield (<10%). Additionally, by-
products absorbing at lower wavelength (550-650nm) were also observed. 
It is known that NIR heptamethine dyes have poor chemical and photochemical 
stability, due to photooxidation.' 27 Interaction of an excited dye molecule with 
dioxygen can lead to the formation of singlet oxygen ( 1 02) and superoxide anion 
(02) which accelerate the photofading of dyes by oxidation.' 28  To avoid thermal 
degradation of the heptamethine dye, the formation of the hemicyanmne intermediate 
was carried out at room temperature, in the presence of DIEA, and acetic anhydride 
to activate the polyene-precursor 13c to nucleophilic attack of the quaternised 
heterocycle 14a (Scheme 2.12). However, this alternative protocol did not give the 
final dye in high yields. In fact, reaction of the indolenium salt 14a with the 
intermediate Be forms the desired supported hemicyanine 15e by loss of N-
phenylacetamide, but is also likely to result in the release of the hemicyanme 19e in 
solution by cleavage from the resin and formation of the symmetrical dye, with 
consequent decrease in the yield of the final compound (Scheme 2.12). 
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2.2.4 
Because the use of the intermediate 13c is not ideal for the solid phase synthesis of 
heptamethine dyes, an alternative strategy to afford these dyes in higher purity and 
yield was developed and a detailed description of this method is reported later in 
this chapter. 
Formation of mono-carboxylated cyanine dyes 
Purification of asymmetrical mono-reactive cyanine dyes synthesised in solution is 
a time-consuming process, because the formation of the desired compound is often 
complicated by the formation of impurities such as unreacted hemicyanme 19, 
symmetrical dyes 21 and 22 and unreacted heterocycles 14a,c which are difficult to 
remove by chromatography (Scheme 2.13). 
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Scheme 2.12 Formation of hemicyanine and by-products: a) Ac 20, DIEA, pyridine; b) 14a. 
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Solid phase synthesis allowed the preparation of cyanine dyes by reaction of a 
nucleophilic heterocycle 14c-d with the hemicyanine intermediates 15a-f, activated 
by acetylation in the presence of pyridine, DIEA and acetic anhydride, Scheme 
2.13. The reaction was carried out at room temperature for 1-2h and the fluorescent 
dyes were cleaved from the resin directly in solution, allowing removal of the 
unreacted hemicyanine 15a-f by filtration and avoiding the presence of symmetrical 
dye such as 21. 
Formation of 22 was prevented by ensuring that hemicyanines intermediates 15a-f 
were formed in good yields from the imidates 13a-c and using substoichiometric 
amounts of heterocycles 14c-d in the last step. Any unreacted heterocycle was 
removed from the reaction mixture by aqueous washings while the desired product 



















N J O:N. 
20 
n=1; R3, R4 = H 	 20a: n=1; R3 , R4 = H 
n=1; R3, R4 = -(CHCH)2 	 20b: n=1; R3, R4 = -(CHCH)2 
n=3; R3, R4 = H 	 20c: n=2; R3 , R4 = H 
n3; R3, R4 = -(CHCH)2 	 20d: n=2; R3, R4 = -(CH=CH)2 
n=5; R3, R4 = H 	 20e: n=3; R3 , R4 = H 
n=5; R3 , R4  = (CH:CH)2 	 20f: n=3; R3 , R4 = -(CH=CH)2 
Scheme 2.14 Cleavage of cyanine dyes from the resin: a)14c-d, Ac 20, DIEA, pyridine 
20a-f was extracted into DCM. The fluorescent dyes were then precipitated and 
washed with diethyl ether, removing any residual pyridine. 
This synthetic pathway allowed the preparation of trimethine and pentamethine 
fluorescent cyanine dyes in good yield (Table 2.5), purity (Figures 2.9-2.10) and on 
a 100 mg scale (-15 mmol). Further purification by column chromatography was 
carried out, when necessary, and only to ensure full characterisation of all the dyes. 
As already mentioned, the heptamethine dye 20e (n = 5) was obtained in low yield 
and purity. In fact, the low loading level of the hemicyanine 15e meant there was a 
higher percentage of unreacted heterocycle 14a in the last step. 
Various attempts were carried out in order to increase the yield by varying the 
equivalents of heterocycle and acetic anhydride and the reaction temperature during 
hemicyanine formation and cleavage. However no significant improvement was 
observed. 
The synthetic protocol for the formation of heptamethine dyes required further 
improvement in order to obtain the final product in higher yield and purity and 
avoid thus further purification. More details will be given in section 2.3. 
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Figure 2.9 HPLC analysis of the crude pentamethine dye 20c. Detection: ELSD and at 650 nm 
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Figure 2.10 'H NMR of the pentamethine dye 20c 
2.3 	Catch and release synthesis of heptamethine dyes 
Heptamethine dyes synthesised by stepwise condensation of nucleophilic 
heterocycles with polystyrene bound glutaconaldehyde were obtained in poor yield 
and low purity, as previously reported in the section 2.2.4. 
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This limitation led to the development of an alternative catch-and-release-strategy, 
see Scheme 2.15, based on the formation of the hemicyanine intermediate in 
solution 19e and on its loading onto the solid support to form a polymer-bound 
hemicyanine 15e. This procedure allowed the separation of the final dye 20e from 
the hemicyanine by simple filtration. 
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Scheme 2.15 Catch and release approach for the synthesis of heptamethine dyes: a) 14a, Ac20, 
AcOH, 120 °C, 2.5h; b) 18, DCM, lh, ii 
Balasubramanian et al. reported a similar strategy, which involves formation of 
hemicyanine in solution, activation with sulfonyl chloride resin and then 
nucleophilic attack of a nucleophilic heterocycle to give the desired dye (Scheme 
2.16). 129  The advantage of the protocol presented herein is the possibility to use a 
common polymer-bound precursor, such as 18, to synthesise all the range of 
cyanine dyes, including heptamethine dyes. The hemicyanine 19e was synthesised 
by firstly activating glutaconaldehyde dianilido hydrochloride to the nucleophilic 
attack of a quaternary indoleninium salt 14a by treatment with a mixture 1:1 of 
acetic anhydride and acetic acid, Scheme 2.1 5•96  The reaction was monitored by 
UV spectrometry, in order to avoid or reduce the formation of symmetrical dye. 
After removal of acetic acid and acetic anhydride in vacuo and removal of starting 
material by aqueous washings, the hemicyanine 19e was dissolved in 
dichioromethane and added to the polymer bound aniline 18. The reaction mixture 
was left under agitation for 1 h at room temperature to allow the polymer bound 
aniline 18 to attack the hemicyanine and displace a molecule of acetanilide. It is 
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important, during this time, to avoid prolonged exposure of such intermediates to 
light. 
MeO 	 OMe 	
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Scheme 2.16 Catch and Release strategy described by Balasubramanian et al' 29 Reagents and 
Conditions: a) (EtO) 3CH, EtOH, 80 0  2h; b) DIEA, DCM, it, 4h; c) DIEA, pyridine, rt, 30 minutes. 
Afterwards the resin was washed extensively with dichioromethane, DMF and 
methanol, to remove the unreacted hemicyanine and then dried in vacuo to give the 
polymer bound hemicyanine 15e in 83% yield (nitrogen elemental analysis). 
The desired dark-green dye was cleaved from the resin by nucleophilic attack of a 
second heterocycle 14c onto the hemicyanine in the presence of pyridine and acetic 
anhydride, Scheme 2.17. Following this protocol, the unsymmetrical heptamethine 
dye 20e (Cy7) was obtained in high yield (86%) and purity (-95%), as determined 
by HPLC (Figure 2.11) and 'H NMR analysis (Figure 2.12), without the need for 




Scheme 2.17 Cleavage of heptamethine dye 20e in solution: a)14c, Ac 20, pyridine 
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The catch-and-release method was also successfully applied to the synthesis of the 
heptamethine dye 20f, Figure 2.13. This dye has excitation and emission 
wavelengths in the NIR region, above 800 nm and therefore ideally suited for 
multicolour imaging in tissues. 
Figure 2.11 HPLC analysis of the crude heptamethine dye 20e. Detection: ELSD and at 750 rim. 
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Figure 2.13 Heptamethine dye 20f 
2.4 	Synthesis of water soluble cyanine dyes 
The use of microwave heating and solid phase chemistry was successfully applied 
to the preparation of hydrophobic cyanine dyes with excitation and emission spectra 
ranging from 547 to 807 nm. These fluorophores were prepared for the labelling of 
modified nucleotides to be used in our four-colour DNA sequencing technology. 
However, preliminary experiments carried out on microarray chips (see Chapter 5) 
showed that nucleotides labelled with hydrophobic cyanine dyes can bind in a non-
specific manner to DNA giving misleading results. 
The non-specific binding was probably caused by a combination of hydrophobic 
interactions with the DNA base-pairs and ionic binding to the negatively charged 
phosphate 30 
The presence of negative charges onto the fluorophore should reduce this 
phenomenon. 83 Therefore, water soluble cyanine dyes bearing a sulfonate group on 
the heterocyclic moieties were synthesised. In order to prove the principle, two 
different colours were initially needed. The cyanine dyes Cy3 and Cy5 absorbing at 
550 nm and 650 run, respectively, were ideal fluorophores since modem microarray 
readers can detect both dyes and distinguish between them. 
These compounds are generally synthesised by following the procedure described 
by Waggoner et al. 83 
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2.4.1 N-Alkylation of sulfonated indolenines 
The use of microwave heating for the alkylation of indolenines proved to be very 
useful for the preparation of quaternary salts 26a-b from 2,3,3-trimethyl-3H-indole-
5-sulfonate 25, see Scheme 2.18. 
These compounds are important starting material for the preparation of water 
soluble cyanine dyes, widely used for biomolecules labelling. 
Sulfonated indolenines are less reactive than the non-sulfonated,, because of the 
electron-withdrawing properties of the sulfonate groups. Consequently, longer 
reaction times are often required to afford the desired products in good yield. 
Classical oil bath heating usually requires 48h to ensure completion of N-
alkylation. 83 
R= Me 
R = -(CH2)5COOH 
Scheme 2.18 Synthesis and alkylation of sulfonated indolenine: a) 3-rnethyl-2-butanone, acetic acid, 
3h, reflux; b) Me!, acetonitrile, 150 °C, MW, 60-90 min for 26a or 6-bromohexanoic acid, 
acetonitrile, 150 °C, MW, 3h for 26b 
Compound 25 was prepared by conventional Fisher indole synthesis,'  31,132  by 
refluxing hydrazinobenzene sulfonic acid 24 with 3-methyl-2-butanone in acetic 
acid, for 3 hours. The cyclisation involves the formation of the phenylhydrazone of 
isopropyl methyl ketone followed by ring closure at the tertiary carbon to give 2-
methylindolenines. Compound 25 was precipitated as the potassium salt with a 
saturated solution of KOH in 2-propanol and afterwards alkylated to give the 
quaternary salt 26. By applying microwave heating it was possible to reduce the 
reaction time for N-alkylation of indolenines to 1-3 hours, Table 2.4. Acetonitrile, 
dimethylformamide (DMF) and 1,2 dichlorobenzene were tested as solvents for the 
microwave mediated N-alkylation of 25 (Figure 2.14). The alkylations were carried 
out at 150 °C in sealed vials and the conversions measured by HPLC analysis. As 
expected, longer reaction times were necessary for the alkylation of sulfonated 
indolenines. The highest conversion (88%) was obtained by performing the reaction 
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in acetonitrjle at 150 °C for three hours (three cycles of one hour each). Small 
amounts of DMF were also added to increase the solubility of the starting materials. 
Yield 
Entry Compound 	Temperature (°C) 	Time (Ii) 	
(/o) 
150 	1.5(j.t(o) 	95 
1 	26a 	
150 	24 (reflux) 	1 33  
2 	26b 
	 150 	 3(j.i() 	80 
150 	48(reflux) 	89 
Table 24 N-Alkylation of sulfonated indolemnes 
In order to avoid contamination of sulfonated dyes by various intermediates, it is 
important to ensure that the sulfonated heterocycles 26 are not contaminated by 
starting materials, that would be difficult to remove by chromatographic column 
and that could react with imidates or hemicyanines to form other undesired cyanine 
dyes. Methyl iodide and bromo-hexanoic acid can be easily removed by washings 
with diethylether. However, the removal of 25 is more challenging since sulfonated 
indolenine and alkylated products are both, water soluble. Removal of 25 from the 




















In conclusion, alkylation of sulfonated and non-sulfonated trimethylindolenines was 
efficiently perfomed by microwave heating. The great advantage of the use of 
microwaves instead of the classical oil bath heating, is the possibility to easily and 
rapidly synthesise in parallel and in shorter time (Figure 2.15) various nucleophilic 
heterocycles useful in discovery chemistry for the screening of dyes with new 
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Figure 2.15 N-alkylation: microwave heating vs reflux. 
2.4.2 
	
Synthesis of sulfonated cyanine dyes 
The trimethine dye Cy3 was prepared by heating to reflux quaternary salt 26a and 
N,N'-diphenylformamidine in a mixture 1:1 of acetic acid and acetic anhydride 
(Scheme 2.19). The reaction was monitored by UV to avoid/reduce the formation of 
any symmetrical dye and drive to completion the synthesis of the hemicyanine 
intermediate 28. 
The reaction mixture was left under agitation until the signal at 286 nm 
(heterocycle) disappeared and the signal at 380 nm (hemicyanine) arose. After 
evaporation of acetic acid and acetic anhydride and removal of the excess N,N'-
diphenylformamidine 27a (by washing with ethyl acetate), the hemicyanine was 
dried in vacuo and used directly for the next step. The hemicyanine was activated in 
the presence of pyridine and acetic anhydride and reacted at 80 °C with 26b. The 
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reaction mixture was heated until the signal at 380 nm completely vanished. After 











Scheme 2.19 Synthesis of sulfonated cyanine dyes: a) 26a, Ac2 0, AcOH, reflux, 2h; b) 26c,Ac 20, 
pyridine, 80 °C, 20 min- lh 
The dye obtained contained various impurities, such as symmetrical dyes and 
unreacted quaternary salt. Therefore, chromatography was perfomed in order to 
obtain the desired compound in high purity. However, this procedure was laborious 
and often required two consecutive purifications to obtain the dye in > 95% purity. 
Water soluble trimethine dye 29a was obtained in 36% yield. 
Water soluble pentamethine dye Cy5 was prepared following the same synthetic 
procedure. Quaternary salt 26a was refluxed with malonaldehyde dianyl 
hydrochloride to form the hemicyanine 28b, in a mixture 1:1 of acetic acid and 
acetic anhydride. After isolation, 28b was condensed with a different quaternary 
salt 26b in the presence of pyridine and acetic anhydride. The signal at 445 nm in 
the UV spectra vanished while the absorption at 650 nm rose correspondingly. 
After 20 minutes, the solvent was removed and the product precipitated in diethyl 
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ether and then centrifuged. Purification by chromatography was performed eluting 
with a DCM: MeOH gradient (100% DCM -p DCM:MeOH 1:1). 
The pentamethine dye 29b was obtained as a blue glassy solid in 91% purity (by 
ELSD) (Figure 2.16) and in 40% yield. 
Figure 2.16 HPLC trace of 29b prepared in solution. Detection at X = 650 rim. 
2.5 	Solid-phase synthesis of water-soluble cyanine dyes 
Purification by chromatography of cyanine dyes is difficult, in particular when they 
are purified in larger amounts (? 100 mg) and often, more then one purification is 
required to afford them in high purity. This is the reason for their very high cost. 
Solid phase chemistry represents an attractive strategy for the practical synthesis of 
water-soluble cyanine dyes since chromatography can be avoided for the 
purification of the desired dye. 
The application of solid phase methods to the preparation of water-soluble cyanine 
dyes is discussed in the section 2.5.1. 
2.5.1 	From polymer-bound imidates 
Our first attempts to synthesise water-soluble cyanine dyes, were carried out by 
following the method proposed by Balasubramanian et al. 108  This synthetic protocol 
involves the condensation of water-soluble trimethylindoleninium salts 26a-b with 
the imidate immobilised onto polystyrene resin 13b, Scheme 2.20. As reported in 
published work, sulfonated heterocycles do not react well during condensation with 
immobilised imidates, but they reacted well during the cleavage of the dye from the 
resin. 
We postulated that microwave heating would be useful to afford cyanine dyes with 
sulfonated groups on both heterocycles. 
Following this protocol, water-soluble cyanme dyes bearing sulfonate groups on 
both heterocyclic moieties were generated. However, yield (10%) and purity of the 
final dye were not satisfactory. One main limitation was the low solubility of the 
sulfonated heterocycle in DMF and other organic solvents and consequently, the 
difficulty to react with the imidate on the resin and to be washed away afterwards 
from the beads. To overcome this limitation, Jiang et a!, recently, suggested the use 
of poly(ethylene glycol), a soluble polymer support which combines homogenous 
reaction and therefore, high reactivity with solid phase techniques (easier isolation 
and purification of products). 133  However, this type of support is hard to handle 
(difficulty in completely separating product and impurities) and low yields, due to 
loss of the product during precipitation and to the low loading of the Support. 134 
So 
Me0 	
a 'Cr 	 0 
30b 
Scheme 2.20 Synthesis of sulfonated cyanine dyes on solid phase: a) 26a, DMF, 150 °C, go), 15 
mm; b) 26b, Ac2 0, Pyridine. 
Therefore we considered the possibility of applying an alternative catch-and-release 
strategy (Scheme 2.21). The hemicyanine is more hydrophobic than the sulfonated 
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heterocycles and therefore more soluble in organic solvents, where the resin has 
good swelling properties. This should improve the loading reaction and the removal 
of any unreacted hemicyanine from the resin. 
2.5.2 	Catch and release approach 
Hemicyanine 28b was prepared as described in section 2.4.2. After completion of 
the reaction, the hemicyanine was precipitated with diethyl ether and then washed 
with ethylacetate to remove excess N-[(lE,3ff)-3-(phenylimino)-1-propenyl] aniline 
hydrochloride. After drying in vacuo, 28b was used directly for the next step, 
without further purification, avoiding excessive exposure to light and prolonged 
storage at room temperature. 
The hemicyanine 28b was added to the resin 18 and shaken for 1 hour at room 
temperature in a mixture 3:1 of DCM and DMF (Scheme 2.20). The immoblised 
hemicyanine 30b obtained was washed extensively with DCM and MeOH to 
remove any residual hemicyanine or symmetrical dye absorbed onto the beads 
before being reacted at room temperature with 26b in the presence of pyridine and 
acetic anhydride until all the sulfonated heterocycle 26b was consumed. It was 
important to avoid the contamination of the dye with such compound since a 
chromatographic purification would be necessary to separate them. The 
sulfoindocyanine 29b was obtained in excellent yield (97%) and purity (--98%, by 
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Scheme 2.21 Catch and release synthesis of water soluble pentamethine dye 29b: a) 18, DCM:DMF 
3:1, rt, Ih; b) 26b, Ac 20, pyridine. 
Figure 2.17 HPLC trace of crude pentamethine dye 48. Detection: ELSD and at A = 650 nm. Peak at 
0.75 min is not attributable to the sample 48. 
2.6 	Summary and Conclusions 
In conclusion, two practical approaches to the solid phase synthesis of 
unsymmetrical cyanine dyes suitable for bioconjugation have been reported in this 
chapter. The catch-and-release approach and the application of microwave heating 
to the synthesis of cyanine dyes, allowed the preparation of cyanine dyes spanning 
the whole colour range (Table 2.5 and Figure 2.18), in a few steps, overcoming the 
limitations of the method described by Balasubramanian. 
Through a catch-and-release strategy we have also been able to synthesise, on the 
solid phase, heptamethine and water soluble cyanine dyes in high yields and purity 
without the need for chromatographic purification, thus providing an easy route to 
the preparation of these fluorescent probes. 
Figure 2.18 Normalised absorbance spectra of cyanine dyes prepared on solid phase. 
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Table 2.5 Cyanine dyes prepared on solid phase. a  Yield of isolated product in the final step (based 
on the amount of heterocycle used in the cleavage step 
Dye 
A max, abs 
Amax ,.,(nm) Yield' (nm) _ 
KI L N , 
I 547 561 68% 
HO 
20a 
587 603 49% 
20b 








743 765 86% 
HO 
20e 




0* 	 0 0 
647 667 97% 




2.7 	Cyanine dyes and their applications 
In the past few years, cyanine dyes have found wide application in biology and 
biomedical imaging, in multiplexed experiments requiring multicolour fluorescent 
probes. 
Today, they are the most commonly used dyes for the labelling of nucleic acids,' 35 
in DNA sequencing, 84  SNPs analysis 136,137  and gene expression profiling 
experiments. 138,139  They are also widely used for the labelling of proteins and in 
vivo experiments because of their absorbance in the NIR region. 140 
Biological tissues exhibit high photon absorbance in the visible wavelength range 
(350-700 rim, due to haemoglobin and tissue pigments) and in the infrared range 
(>900 nm, due to lipids and water). However the absorbance of biomolecules reach 
minima in the NIR region. Hence, NIR dyes (such as Cy5.5, Cy7 and Cy7.5) offer a 
great advantage for the imaging of physiological and pathological states. 141 
Thanks to development of our synthetic protocol for the easy preparation of cyanine 
dyes, a number of projects in our laboratory took advantage of the availability of 
multicoloured fluorescent molecules. In this part of the chapter, some of the 
applications of the dyes synthesised by microwave-mediated solid-phase chemistry 
are reported. 
In vitro cellular uptake of labelled peptoids and microspheres shows the 
applicability of these labels in flow citometry and in vivo imaging while the use of 
cyanine dyes in research projects, based on SNP's analysis and DNA sequencing, 
shows the importance of multicolour labels in microarray analysis for the labelling 
of nucleotides, oligonucleotides and PNA. 
2.7.1 	Labelled peptoids for in vivo imaging applications 
Peptoids are oligomeric peptidomimetics that consist of N-substituted glycines. 3 " 42 
They have a polypeptide backbone with side chains bounded to amidic nitrogen 
rather then to the a-carbon. They have the advantage of protease-resistance, 
biocompatibility and easy incorporation of diverse side chains. Nine-mer peptoids, 
prepared by Geraldine Escher were labelled with the pentamethine dye 20c and the 
heptamethine dye 20e (Figure 2.19) and tested (by Geraldine Escher) for cellular 
uptake in vitro, in mammalian cells such as HeLa (human ovarian cancer) and 
B 1 6F 10 (mouse melanoma) cells and in vivo (in primary murine monocytes and 
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primary human monocytes) in collaboration with the Centre for Inflammation 
Research at Edinburgh. HeLa and B16F1O cells were incubated with the 9-mer 
peptoid 31b and analysed by FACS (Fluorescence Activated Cell Sorting). 
Prelimary results have shown that the cellular uptake of 31b is very efficient in 
both cell lines and even the dye alone seems to have a great penetrability. 
Encouraged by these preliminary results, in vivo imaging studies of cells labelled 
with 31b were also carried out. 
Primary murine monocytes incubated with 31b were instilled into the lungs of a 
mouse. After one day, the labelled cells were visualised in the mouse by a charge 
coupled device which showed their accumulation in the lung, as expected (Figure 
2.20-a). Bioluminiscence studies also proved the non toxicity of the labelled 
peptoid. Labelled cells were transfected with adenovirus encoding firefly 
luciferase' 43 and instilled into the lungs of a mouse injected intraperitoneally with 
luciferin. Whole body imaging of the mouse showed that cells labelled with 31 b are 
also bioluminescent and that consequently the viability of the cells is not affected 
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Figure 2.19 Labelled 9-mer peptoid 
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Figure 2.20 Accumulation of primary murine monocytes in the lungs: optical imaging at 750 nm 
(left) and luciferase imaging (right). Mouse on the right is a control: does not contain cells 
transfected with Luciferase 
Another experiment was carried out in vivo, using primary human monocytes 
labelled with 31b. These cells were injected via the tail vein into a mouse with 
peritoneal inflammation. Visualisation of the cells by optical imaging revealed that 






Figure 2.21 Accumulation of prirnai\ huiiiari monocytes in the inflammation site 
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2.7.2 	Labelling of microspheres/ doughnuts & in vivo imaging 
Another important application of NIR cyanine dyes is the labelling of nano and 
microparticles for in vivo imaging applications.'' 
Polystyrene beads (of 0.1-5 l.tm)  are widely used in immunoassays and for cellular 
labelling, often in combination with flow cytometry. In recent years, beads have 
been fluorescently dyed for purposes of encoding. 145  It is possible to either 
covalently bind the fluorescent dyes onto the modified surface of the microparticles 
or to dissolve the dyes into the particles. For covalent coupling, the beads and the 
fluorophore must have functional groups for binding. Incorporation of dyes inside 
the beads requires the use of lipophilic fluorophores. This method is usually 
preferred because it reduces the interference of the dye with the surface chemistry 
and additionally there is more dye incorporated since there is more space available 
inside the bead for the fluorophore. Hydrophobic cyanine dyes described in this 
chapter are ideal for this pourpose. In a recent work, carried out in the group, 20a 
and 20b were used for the labelling of microspheres and micro-donughts, in order 
to visualise the accumulation of these materials inside the cells (in vitro) and in the 
liver of a mouse after intravenous injection (in vivo) (Figure 2.22). 146 
Figure 2.22 Optical whole body image ofCy7 labelled doughnuts (yellow) in the liver 
In another experiment, primary human neutrofils incubated with 0.5 .tn1 
microspheres labelled with 20 e were injected into a thigh of a mouse. Optical 
imaging of the whole mouse showed how the microparticles labelled with 20e 
could be easily discriminated from a 9-mer peptoid labelled with 20c. This 
experiment shows the importance of the availability of cyanine dyes in different 
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colours for the simultaneous investigation of various biological processes in vivo 
(Figure 2.23). 
Figure 2.23 Primary human neutrofils incubated with 0.5 gm microspheres labelled with Cy7(left) 
or Cy5-labelled peptoid (right) and injected in two different thighs 
2.7.3 	Labelling of nucleic acids & nucleotides 
There is a great interest in labelling oligonucleotides and nucleotides with 
fluorophores, because of their application in DNA sequencing and DNA 
hybridisation studies. Functional groups able to react with fluorophores are usually 
absent in oligonucleotides. A common method is to introduce an amino reactive 
group into a synthetic oligonucleotide as the last step in a synthetic process. Then 
the label can be introduced into the oligonucleotide via a reactive group such as a 
NHS ester which binds to the amino group. 147  The most important method to label 
DNA is the use of fluorescent phosphoroamidites obtained by reacting a phosphine 
derivative with a fluorophore containg an hydroxyl group. 148 
Labelled nucleotides are generally synthesised by coupling allylamine or 
propargylamine-dNTP to succinimidyl ester derivatives of fluorescent dyes. 84.135 
Some companies include also a spacer between the dye and the nucleotide to 
improve enzymatic incorporation of the modified nucleotides. More details on the 
labelling and applications of nucleotides will be provided in Chapters 3-5. 
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Design & Synthesis of Enzymatically Cleavable 
Nucleotides 
The purpose of this chapter is to describe in details the synthesis of a new family of 
reversible terminators for DNA sequencing by synthesis. 
3.1 	Reporter Nucleotides for DNA Sequencing by Synthesis 
The read-length of a DNA sequencing by synthesis (SBS) technology is determined 
by 1) the efficiency of incorporation of reversible terminators, 2) the efficiency of 
cleavage of the fluorophore and 3) the efficiency of deprotection of the 3'hydroxyl 
group from the extension product (when the 3' hydroxyl group is blocked to avoid 
multiple extensions). If one cycle of SBS, comprising incorporation, imaging, 
deprotection/cleavage has a low efficiency, the read length (the number of times the 
cycle can be repeated) of the method will be low (see Figure 
Therefore, research efforts for the development of new SBS methods have mostly 














Figure 3.1 Left: a SBS cycle. Right: the maximum read-length decreases dramatically as the cycle 
efficiency lowers. Table and scheme adapted from ref. 1. 
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In order to obtain a high sequencing by synthesis cycle efficiency, the following 
requirements for the cleavable moiety of the reversible terminators has to be 
considered: 
It must be stable during the reaction with DNA polymerase. 
It must be easily conjugated with nucleotides and fluorophores. 
It must not prevent nucleotide recognition by DNA polymerases. 
It should be cleaved under mild conditions compatible with the stability of 
DNA and biochip surfaces 
It must be cleaved as close to the nucleotide as possible to minimize 
distortions in the structure of the growing DNA strand that could impair the 
ability of DNA polymerase to further extend the primer. 29,149 
Another important issue that must be addressed to sequence DNA using reversible 
terminators is the termination of the polymerase reaction after the incorporation of 
a single nucleotide. If the 3' hydroxyl group is left unprotected, multiple extensions 
might occur in the presence of all four nucleotides making difficult to determine 
the sequence of the DNA template. It is possible to cap the 3'-OH with a protecting 
group. However the protecting group must be stable during primer extension and 
also be efficiently and rapidly removed after incorporation of the nucleotide to 
regenerate the 3'-OH to allow the next primer extension to take place. DNA 
strands that have a remaining 3'-OH blocking group are not extended and will not 
contribute to the detection of the incorporated base, reducing thus the intensity of 
the fluorescent signal. However, if that blocking group is removed in the next 
deprotection cycle, it will generate a false signal which will contribute to increase 
the noise. 29 
Alternatively, the 3'-OH can be left unprotected and the cleavable moiety on the 
base designed such that multiple incorporations of nucleotides by DNA polymerase 
do not occur. 
With these considerations in mind it was sought to design a series of modified 
nucleotides that would incorporate a cleavable fluorescent moiety for imaging but 
that were nonetheless still able to be recognised by a DNA polymerase. 
3.1.1 Design of a Novel Reporter Nucleotide 
To design reporter nucleotides, it is important to consider the structure of a DNA 
polymerase complexed with a double stranded DNA and an incoming nucleotide. 
In Figure 3.2, it can be seen that the 5-position of the nucleotide points away from 
the catalytic pocket of the polymerase, while the 3'-position of the ribose ring is 




Figure 3.2 The active site of DNA potymerase I from Thermus Aquaticus (grey surface) in complex 
with a double stranded DNA terminated by a dideoxynucleotide (orange sticks) and a 
dideoxynucleotide (colored sticks) bound to the active site. The orange and blue arrows indicate the 
5-position and 3'-position of the free dideoxynucleotide. This structure was downloaded from the 
Protein Data Bank (PDB), 15° (code 2ktq)' 5 ' and the image created with the program VMD.' 52 
Thus, any group that is attached at the 3'-position must be small enough not to 
inhibit the polymerase activity or reduce the fidelity of the enzyme. On the 
contrary, large bulky groups at the 5 position of pyrimidines (C and T) and 7 
positions of purines (A and G) are well tolerated by modified polymerases. 
Numerous works published in the literature supports this fact. 29,66,67,153 
We proposed to link the fluorophore to the nucleotide at the 5 position while the 3' 
hydroxyl group is left unprotected. We postulated that, with an adequate choice of 
linker and fluorophore, the stenc hindrance of the reporter moiety may confer 
termination properties to the nucleotide and that protection of the hydroxyl group 
in 3' position may not be necessary in this case. This would avoid carrying out an 
additional protection step during the synthesis and one deprotection step during 
SBS cycles. 
Recently, the use of fluorescent nucleotides with unprotected 3' hydroxyl groups as 
terminators of DNA polymerisation has indeed been reported, supporting the idea 
that the protection of the 3' site might be not necessary in particular reaction 
conditions and with an appropriate reporter group. 66,149,154,155 
Several types of cleavable linkers have been used in the past for the synthesis of 
reversible terminators, including chemically cleavable 51,66,72  and photocleavable 
linkers' 56  (Chapter 1). However, removal of reporter/terminator groups by 
chemicals or irradiation can cause damage to DNA (crosslinking, depurination, 
transformation). 
As an alternative to chemical and photocleavable reporters, it was thought to use a 
small peptide to link the fluorophore to the base (Figure 3.3). It was envisioned that 
the peptide would be cleaved in a mild, fast and efficient way using proteases. 
Additionally, by varying its sequence of amino acids it should be possible to 
modulate the properties (e.g. steric hindrance, hydrophilicity/hydrophobicity, 
polarity) of the peptide in order to find a reversible terminator able to stop multiple 
base additions without inhibiting the polymerase. 
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Figure 3.3 Design principles for enzymatically cleavable fluorescent nucleotides 
Given a series of modified nucleotides as shown in Figure 3.3 the sequencing by 
synthesis technology here proposed would therefore consist in the following steps 
described in Figure 3.4. 
Unknown single stranded DNA's bearing complementary sequences to a 
primer are hybridised onto the array of chip-immobilised primers. 
Chain extension then takes place with a DNA polymerase and four modified 
nucleotide analogues (A, T, C, G) each bearing a fluorescent label with a 
unique colour connected through the peptide substrate. 
Only one matched nucleotide out of the four nucleotides is incorporated into 
the growing DNA strand and chain extension is temporarily terminated due 
to the structure of the unnatural nucleotide analogue. Therefore, the first 
unknown base next to the primer can be identified by the "colour" of the 
fluorophore. 
The fluorescent reporter is cleaved by a protease to allow a second 
polymerase reaction to occur. 
Steps 2-4 are repeated until the unknown DNA template has been sequenced 
entirely. 
The rest of this chapter will discuss the synthesis of the modified nucleotides shown 
in Figure 3.3. 
Template 
i 	 TL 
JL 
DNA polymerase 	 Protease 
Repeat 
Hybridisation 	Primer Extension by DNA Polymerase 	Cleavage of the fluorescent label 
by Protease 
Figure 3.4 DNA Sequencing by Synthesis on chips using protease cleavable nucleotides 
3.1.2 Synthetic strategy 
The major challenge in the preparation of reversible terminators is the synthesis of 
nucleoside triphosphates. They are difficult to synthesise, isolate and 
characterize. 157  Therefore, it is always preferable to carry out the triphosphorylation 
reaction in the very last step of a synthetic pathway that involves nucleotides. 
In view of this consideration, the best approach for the preparation of enzymatically 
cleavable nucleotides would be 1) to couple the reporter group (peptide labelled 
with a fluorophore) to a nucleoside modified on the base with an aminopropargyl 
group 2) to carry out the triphosphorylation of the dye-peptide-nucleoside conjugate 
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Scheme 3.1 Retrosynthesis of enzymatically cleavable nucleotides 
Previous efforts to develop a synthetic protocol based on this approach have been 
reported. However, the low yield of the triphosphorylation step led to an 
insufficient amount of product making difficult the isolation and characterization of 
the final compound. 149  In addition, the amide bonds of the cleavable moiety are not 
stable to tnphosphorylation agents. 
Therefore an alternative route B (Scheme 3.1) based on the coupling of the 
aminopropargyl nucleotide 2 with the reporter group 3 was considered. This 
approach is commonly used for the preparation of fluorescent nucleotide analogues 
and is well documented in the literature. 158-160 
In summary, the synthetic protocol for the preparation of enzymatically cleavable 
nucleotides (Scheme 3.2) comprises the following steps, which are described in 
details in sections 3.3, 3.4 and 3.5: 
Peptide synthesis and labelling with a fluorescent dye 
Synthesis and triphosphorylation of aminopropargyl nucleosides 
Final coupling between the nucleotide and the labelled peptide to 
form the reporter nucleotide. 
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Scheme 3.2 General scheme for the synthesis of protease-cleavable nucleotides. R = resin 
3.2 	Design and Synthesis of Labelled Peptides 
As mentioned earlier, the reporter group (peptide and fluorophore) of the cleavable 
nucleotides must satisfy a number of requirements to ensure a high efficiency in the 
sequencing by synthesis cycle. 
'c The peptide used to link the base to the fluorophore must be designed such that 
its bulkiness does not inhibit its incorporation in a DNA strand by a DNA 
polymerase but does terminate the extension after the first incorporation. 
The digestion of the peptide by a protease must be fast, complete and as close as 
possible to the aminopropargyl group. 
+ The protease and the polymerase must tolerate the close proximity of the 
nucleotide and the fluorophore to be able to digest efficiently the peptide. 
3.2.1 Design of the Peptidic Linker 
Previous work was carried out in our lab by Dr. Karin Johnson, to find the best 
combination of fluorescent nucleoside-peptide conjugates and proteases by 
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Figure 3.5 General structure of fluorescent peptide-nucleoside conjugates 
A library of 57 compounds was prepared by solid phase parallel synthesis, from 
resin-bound nucleosides, and screened with seven different types of proteases 
(proteinase K, elastase, subtilisin, papain, thermolysin, trypsin, enterokinase). The 
cleavage efficiency for each combination of peptide and enzyme are represented in 
Figure 3.6. 
The library included peptides varying in length, polarity, bulkiness and 




















Time course experiments proved that subtilisin and proteinase K exhibited high 
digestion efficiency for all the peptides and fast cleavage (within 10 seconds) for 
the following sequences: Ala-Ala-Ala, Ala-Ala-Leu, Gly-Ala-Gly-Leu.' 49 
These sequences were selected as possible cleavable linkers for the synthesis of our 
reporter nucleotides. 
Figure 3.6 Protease assay for the selection of the best peptide sequences. The cleavage efficiency 
was measured after 2h of incubation. This figure was reproduced from Karin Johnson PhD thesis. 149 
3.2.2 Selection of the fluorophore 
Fluorescence detection is among the technical innovations that contributed, in the 
last twenty years, to an increase in the throughput of DNA sequencing 
technologies. 12,29,30  Because fluorescent dyes have different spectral properties, they 
can be mixed and discriminated in virtue of their colours. 
The selection of fluorescent dyes is critical in the design of fluorescent nucleotides 
and in particular of reversible terminators because their properties (size, 
hydrophobicity and polarity, number of charges) can influence the fidelity and the 
efficiency of the polymerase,' 6 ' the termination properties of the nucleotide, and the 
solubility of the final compound in aqueous buffers. Fluorescent dyes used in DNA 
sequencing must also have distinct excitation and emission spectra and good 
photophysical properties to ensure high sensitivity during detection. Moreover, they 
must tolerate high temperatures (>90°C) when used with thermostable DNA 
polymerases in thermal cycle sequencing. 
Xanthine dyes (fluorescein and rhodamine derivatives) have been used for the 
labelling of primers and dye-terminators for DNA sequencing (Figure 3•7)•29 
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Figure 3.7 Dyes used in DNA sequencing 
The common dye set used in DNA sequencers is the REG, RI 10, TAMRA and 
ROX series. 29 These fluorophores have been used in combination with FAM for 
FRET-based detection (see Chapter 1). Despite their popularity, xanthine dyes 
suffer from quite a few drawbacks (e.g pH sensitivity, photobleaching and broad 
emission spectrum) and therefore have been recently replaced by other classes of 
dyes such as the cyanine and BODIPY dyes. 162 
In recent years, cyanine dyes (Figure 3.8) have been attracting growing interests for 
the labelling of biological compounds thanks to their high photostability, quantum 
yield and solubility in water. They are available in different colours; therefore they 
are routinely used in multiplexed experiments for the labelling of nucleic acids and 
antibodies and are the most popular choice in microarray applications. 94,162 
BODIPY dyes (Figure 3.8) have also found application in DNA sequencing, as 
substitutes of xanthine dyes, because of their narrow emission bandwidths that 
reduce cross-talking between different detection channels and because they exhibit 
minimal influence on the mobility of fragments in gel electrophoresis. 18 
N . _N 
F B....F 
CYANINE DYES 
Cy3 Excitation= 550 nm 
Emission = 570 nm 
Excitation = 649 nm 
Cy5 Emission = 670 nm 
BODIPY DYES 
Bodipy 503/512, R1=R2=Me 
Bodipy 523/547, R2=Ph 
Bodipy 564/570, R2=Ph(CH=CH) 
Bodipy581/591, R2=Ph(CH=CH) 2 
Figure 3.8 Cyanine and BODIPY dyes 
3.2.3 Synthesis of the fluorophores 
The cyanine dyes were selected for the labelling of protease-cleavable fluorescent 
nucleotides. A detailed description of the synthesis of cyanine dyes used for this 
purpose has been reported in the Chapter 2. However, during our early 
investigations on the synthesis of fluorescent nucleotides, the preparation of 
cyanine dyes was still in progress and therefore rhodamine and fluorescein 
derivatives were selected. Despite the disadvantages mentioned earlier, they are 
available at relatively low prices and can be prepared or derivatised on large scale 
from inexpensive precursors. 
The derivatisation of carboxyfluorescein and rhodamine B dyes is described in the 
sections 3.3.3.1 and 3.3.3.2. 
To ensure peptide accessibility to the protease and minimize the steric hindrance 
caused by the fluorophore to the polymerase, it was thought to incorporate an 
additional spacer between the dye and the peptide. The presence of a spacer offered 
also the advantage of facilitating the labelling of the peptide during synthesis. Dyes 
are in general difficult to purify by chromatography, therefore practical synthetic 
protocols were sought, using solid supports and microwave heating whenever 
possible, in order to be able to purify them by filtration or extraction instead of 
chromatography. 
3.2.3.1 Synthesis ofAhx-Carboxyfluorescein 
5(6)-Carboxyfluorescein is a fluorescent dye with an excitation maximum of 494 
nm (in the blue-green region) and an emission maximum of 515 nm (in the green 
region). It is commercially available and it usually sold as a mixture (40:60) of two 
isomers: 5 and 6 carboxyfluorescein. Isomerically pure carboxyfluorescein is also 
available, although in milligram quantities and at a higher cost (125 fold higher 
than the mixture). 163 
5(6)-Carboxyfluorescein display a pH-dependent equilibrium between the lactone 
and the open form. The open form (carboxylic acid group in position 2 is free) has 
fluorescence properties due to its conjugated 7t-system and is present in aqueous 
solutions with pH above 5. By increasing the pH, the absorbance of 
carboxyfluorescein is shifted from 450 nm to 495 nm due to the ionization of the 
phenol and the carboxylic groups. In the lactone form, normally present in organic 
solvents, the carboxylic group in position 2 is involved in the formation of a lactone 
and the dye is not fluorescent (Figure 39)34 
lactone 	 open form 
Figure 3.9 Tautomerism of carboxyfluorescein 
1.11.1 
In order to be coupled to the peptides, 5(6)-carboxyfluorescein was derivatised with 
a spacer by coupling the carboxylic group in position 5(6) with aminohexanoic acid 
methylester. 
The use of PyBOP as coupling reagent for the denvatisation of 5(6)-
carboxyfluorescein has been previously reported. 164 Here the coupling was 
performed in the presence of PyBOP and DIEA under microwave heating at 60 °C 
for 20 mm (Scheme 3.3). The product was purified by extracting the excess of 
amine and the coupling reagent in the aqueous layer and the product in a mixture 
2:1 of 2-propanol and DCM. Afterwards, the methyl ester was hydrolised with 
LiOH in a mixture 1:1 of THF and water. After evaporation of the solvents, the 
residue was dissolved in water and precipitated with 2M HC1 to afford the 
fluorescent compound 47 which was used for the labelling of peptides without 







Scheme 3.3 Synthesis of Ahx-carboxyfluorescein. a) PyBOP (1.5 eq.), DIEA, 6-aminohexanoic acid 
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Figure 3.10 HPLC trace of 47 (detection at X = 495 urn) 
3.2.3.2 Functiona/isation of Rhodamine B 
Because 5(6)-tetramethylcarboxyrhodamine is a relatively expensive dye (k629/g), 
Rhodamine B (f1/g) was selected as starting material for the preparation of a 
functionalised fluorophore to use for peptide labelling. 
Rhodamine B base has only one carboxylic group in the 2 position and has the 
advantage of not having two isomers. However, the use of this dye has been limited 
by the fact that this carboxylic group (and any amide derivative) rapidly cyclize and 
is difficult to couple to amines. 165 
To address this problem, Francis et al. proposed a practical method for the 
preparation of tertiary amides from Rhodamine B (Scheme 3.4). This approach 
allows one to prepare rhodamine derivatives in multigram scale and high purity 
without any chromatographic purification. 165 
Rhodamine B was first treated with piperazine (4 eq.) and AlMe 3 (2 eq.) in 
refluxing DCM. After purification by simple workup, the dye was functionalised 
using succinic anhydride, NEt3 and DMAP to afford the product 43 in high purity 
(95%) and with an overall yield of 70% (Figure 3.11). 
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Scheme 3.4 Derivatisation of Rhodamine B. a) 2M AIMe 3 in toluene (2 eq.), piperazine (4 eq.), 
DCM, reflux, 24h; b) succinic anhydride, DMAP, DCM 
The procedure described by Francis was slightly modified, as it was found 1 M HC1 
to be too strong for the acidic workup of the dye. Indeed, these conditions were 
causing hydrolysis of the product forming the starting material rhodamine B. This 
problem was overcome by using a 0.1 M solution of HCI. Rhodamine B was shown 
to be stable to TFAIDCM (95:5) and I M HCl in dioxane. The HPLC trace of 43 is 






Figure 3.11 HPLC trace of 43 (detection at ? = 565 nm) 
Fluorescein and Rhodamine derivatives were chosen for the first attempts of 
nucleotide labelling. 
The development of this project required the use of four dyes with different 
excitation/emission spectra, therefore cyanine dyes were also considered. As 
mentioned in chapter 2, this class of dyes had excitation/emission spectra that could 
be tuned by modifying the length of the polymethine chain and the heterocycles. In 
addition, their fluorescence is not pH dependent and their non-specific binding to 
biomolecules is low. Most importantly, all the cyanine dyes have similar properties. 
Cyanine dyes are commercially available. However, because of their high cost, an 
efficient way to synthesise them by following a single protocol it was sought (see 
Chapter 2). 
3.2.4 Peptide Labelling 
The peptide was assembled on a Wang resin 166,167  by Fmoc chemistry (Scheme 
3.5). The first amino acid was loaded using DIC (3 eq.) and a catalytic amount of 
DMAP in DMF. For the other couplings, equimolar solutions of reactants (3 eq. 
relatively to the resin) were prepared by adding DIC to a mixture of HOBt and 
Fmoc amino acid in a solution 1:2 of DMF and DCM. Deprotection of Fmoc amino 
acids was carried out with a 20% solution of piperidine in DMF. Coupling and 
deprotection steps were monitored by qualitative ninhydrin test' 68  carried out on 
small portions of resin. After successful preliminary enzymatic tests carried out in 
solution using the nucleotide dUTP-(A) 3-Rho, it was thought to focus mainly on the 
labelling and nucleotide conjugation of the sequence H-Ala-Ala-Ala-OH. 
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The resin 32 was separated in five different portions (100 mg each). Each portion 
was treated with a solution of the dye previously activated as NHS ester. The dye, 
dissolved in a mixture 1:1 of DMF and pyridine, was activated by reaction with 
disuccinimidyl carbonate (DSC) at 60 °C for 13h.Ho  It was important to purify the 
NHS ester from the excess of DSC before labelling in order to avoid any reaction 
with the amino group of the peptide. 
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Scheme 3.5 Synthesis of Dye-Ala-Ala-Ala-OH. Reagents and conditions: a) Solid Phase Peptide 
Synthesis (SPPS): i) H-Ala-OH, DIC (3 eq), DMAP (0.3 eq.) in DCM/DMF (2:1, vlv); ii) piperidine 
in DMF (1:4, v/v); iii) H-Ala-OH, DIC (3 eq.), HOBt (3 eq), in DCM/DMF (2:1, v/v); repeat step ii) 
for Fmoc-deprotection and step iii) for coupling; b) Activation of the dye: DSC (-1.5 eq.), 
pyridine/DMF (1:1, v/v), 60 °C, 1-2h; then coupling to 32 in DMF; c) TFAlwater or TFA/DCM 
(95:5, v/v), 15 mm (twice). 
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Therefore, after removing the solvents from the product, the residue was washed 
with Et20 and then centrifuged to remove the supernatant containing DSC and 
traces of pyridine. This activation method was preferred to the use of DIC and 
HOBt as unreacted or hydrolised dyes could be reused after coupling. This was 
particularly important in the case of the valuable cyanine dyes. 
The coupling was carried out by mixing the activated dye (3 eq.) dissolved in DMF 
with the resin 32 for 1 h (or longer when necessary). The excess of unbound dye 
was usually removed using DCM and DMF. However in the case of the dye peptide 
FAM-Ala-Ala-Ala-OH 46, the resin was also treated with a 20% solution of 
pyridine in DMF in order to cleave any side product formed from the acylation of 
the phenolic groups with the activated carboxyfluorescein derivative. 169  The 
efficiency of the washings was confirmed by the absence of dyes (and colour) in the 
filtrate. 
Because of the availability of large amounts of dyes, it was possible to push the 
reaction of labelling to completion often without the need for purifications by RP-
HPLC. 
Figure 3.12 HPLC traces (overlapped) of the labelled peptides. From left to right: Cy3(S)-(Ala) 3 -
OH, FAM-(AIa)3-OH, Cy5(S)-(Ala) 3 -OH, Rho-(Ala) 3 -OH, Cy5(H).-(AIa) 3-OH. Detection at A = 490 
nm, 550 nm, 650 nm. 
Unbound dyes washed away from the resin, were recovered by evaporating the 
solvent and by precipitating the residue, dissolved in the minimum amount of DMF, 
in a 25 or 50 mL Falcon tube filled with Et20. After centrifugation, the supernatant 
was removed; the precipitate was dried and used again for other labelling reactions. 
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3.3 	Aminopropargyl nucleoside triphosphates 
Aminopropargyl nucleoside triphosphates are important precursors of fluorescent 
nucleotides. However, the high cost and the challenging chemical synthesis place a 
limitation to their use. 
To address this issue, two different solid phase methods have been developed in 
parallel in our lab for the tnphosphorylation of nucleosides. One method is based 
on the use of a solid supported triphosphorylation reagent: the Ludwig-Eckstein 
reagent.' The second is based on the triphosphorylation of supported nucleosides 
using the classic Ludwig-Eickstein reagent. The latter approach was developed by 
Dr. Jin Ku Cho, who collaborated in the realisation of this project, and was applied 
to the preparation of enzymatically cleavable nucleotides. 
The synthetic scheme for the preparation of aminopropargyl nucleoside 
tnphosphates is described in Scheme 3.6 for the amino-modified nucleotide dCTP. 
The primary 5'-OH was protected selectively with a DMT group followed by a 
Sonogashira reaction 170,171  with trifluoroacetylpropargyl amine to introduce the 
aminopropargyl linker on the base. After succinylation of 3'-OH, the nucleoside 
was loaded onto an amino-methylated silica resin. The unreacted amino groups on 
the resin were capped by acetylation. 
After removal of the DMT group, solid phase triphosphorylation was carried out 
using the Ludwig-Eckestein method: the nucleoside derivative H was reacted with 
2-choloro-4H- 1 ,3,2-benzodioxaphosphorin-4-one to afford an activated phosphite 
III. Reaction with pyrophosphate gave the cyclic intermediate IV that was oxidised 
and hydrolised to give the correspondent triphosphate V. 157 
Treatment of IV with aqueous ammonia cleaved also the product from the resin in 
solution and deprotected the aminopropargyl group. 
The advantage of this approach is the feasibility of carrying out the 
tnphosphorylation reaction on a solid support: the use of excess of reagents and 
removal of side-products from the resin by filtration ensure that the final 
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Scheme 3.6 Synthesis of aminopropargyl nucleoside triphosphates on solid phase. a) DMT-Cl (1 
eq.), DMAP, pyridine; b) succinic anhydride, TEA, DMAP, 1,2-DCE; c) CHCCH 2NHCOCF3 , 
Pd(PPh3 )4, Cu!, Amberlite-IRA 67, DMF; d) CPG-NH 2 , DIPCDI, HOBt, DMF; e) 3% TCA in 
DCM; f) IM chloro-4H-1,3,2-benzodioxaphosphorin-4-one in THF; g) 0.5 M bis(tri-n-
butylammonium) pyrophosphate in DMF; h) 0.5 M 12 in pyridine/water (98/2); i) NH 40H. 
This method was efficiently applied by Dr. un Ku Cho to the synthesis of all four 
amino-modified nucleotides (dUTP, dCTP, dATP and dGTP) which were all 
obtained in good yields (53-61%) after HPLC purification. 
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3.4 	Enzymatically Cleavable Nucleotides 
The position of the reporter group on the base is critical for the successful 
incorporation of the nucleotide into DNA. For the pyrimidines (C and T), the 
attachment of a linker at the 5 position is optimal as it is less likely to destabilise the 
duplex secondary structure. For the purines, the linker can be attached either at the 
7 or at the 8 position although it is known that substituents at the 8 position can 
destabilise the DNA secondary structure (Scheme 3.8). 172,173 
The amino-modified nucleotides used for the synthesis of enzymatically cleavable 
nucleotides were mainly Am-dCTP V and Am-dUTP VI (Scheme 3.7). These 
compounds were obtained in larger amounts than Am-dGTP and Am-dATP and 
were easier to obtain as they did not require additional protection steps for the 
bases. 
To ensure that the succinimidyl ester of the dye and the nucleotide were soluble and 
stable in the solvent used for the coupling, TEAB buffer was selected as solvent for 
the coupling reaction and for the purification, as offered the advantage of being 
easily removed from the product by liophilisation and to solubilise both dyes and 
nucleotides. Furthermore, pH 8.5 of the buffer ensured that the amino group linked 
to the base was in the unprotonated form and avoided the hydrolysis of the 
triphosphates and of the succinimidyl ester, which would normally occur in 
aqueous buffers. The labelled peptides activated as NHS esters, were coupled to the 
aminopropargyl nucleoside triphosphates, V or VI, in 0.1 M TEAB buffer at pH 
8.5. Reaction times varied from 30 min to 2h depending from the properties of the 
fluorophore used for the labelling. 
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Scheme 3.7 Synthesis of the NHS esters of the labelled peptides and coupling to the amino-modified 
nucleotides V and VI. a) DSC (-4.5 eq.), (1:1) pyridinefDMF, 60 °C; b) V or VI, 0.1 M TEAB 
buffer, 30 min to 2h. 
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Scheme 3.8 Guanosine labelled at the 8 position (VII) or at the 7 position (VIII) 
Different combinations of dye-labelled peptides and nucleotides were prepared. The 
detailed preparation and characterisation of these compounds are described in the 
sections 3.5.1-3.5.3. 
This part of the project was carried out in collaboration with Dr. Jin Ku Cho who 
worked on the synthesis and labelling of the amino-modified nucleotides. 
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3.4.1 Coupling of labelled peptides to Am-dUTP 
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Figure 3.13 Structures of dUTP-(Ala) 3-Rho 46 and dUTP-(Ala)3-Cy3 35 
3.4.1.1 Synthesis of dUTP-(Ala) 3-Rho 46 
The dye peptide 45 was activated as NHS ester by reaction with DSC (1.5 eq.) in a 
mixture 1:1 of dry pyridine and dry DMF for lh at 60 °C. The NHS ester thus 
obtained was precipitated in Et20 and then washed several times with dry ethyl 
acetate or dry Et20. Afterwards, the amino-modified nucleotide Am-dTUP VI (3 
p.mol) dissolved in 100 ptL of 0.1M TEAB buffer was mixed with 100 jtL of the 
labelled peptide 45 (3 eq.) previously dissolved in the same buffer. The coupling 
reaction, carried out at room temperature, was monitored by TLC and the product 
purified by semi-preparative RP-HPLC using 0.1 M TEAB buffer and acetonitrile 
as eluents. Analysis by HPLC of the reaction mixture showed the presence of the 
product 46 (peak 1) (Figure 3.13), the unreacted labelled peptide 45 (peak 2) and 
additional small peaks 3, 4, 5, which were formed during the coupling reaction and 
during the purification by hydrolysis of the rhodamine dye and of the triphosphate 
W. 
(Figure 3.14). Fraction I was isolated and analysed by MALDI-TOF giving a peak 
at m/z 1326. 50 nmoles of cleavable nucleotide (1.5% yield) were obtained, as 
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Figure 3.14 HPLC trace of dUTP-(Ala) 1 -Rho 46 before (green) and after (blue) purification. 
Detection at A. = 567 nm. Dr. Jin Ku Cho's analysis. 
The yield of the reaction could be eventually improved by prolonging the reaction 
time; because it was important avoiding the decomposition of the triphosphate and 
eventually of the dye in the buffer it was preferred to keep the reaction time to 30 
min-2h. 
3.4.1.2 Synthesis of dUTP-(Ala) 3-Cy3 35 
The synthesis and the purification of dUTP-(Ala) 3-Cy3 were earned out 
analogously to dUTP-(Ala) 3 -Rho. 35 was obtained in 2.1% yield (=50 nmoles). The 
HPLC chromatograms of the product before and after purification are reported in 
Figure 3.15. 
Figure 3.15 HPLC trace of dUTP-(Ala) 3-Cy3 35 before (green) and after (blue) purification. 
Detection at A. = 567 nm. Dr. Jin Ku Cho's analysis. 
Cy5-sulfonated = 
It is important to notice that the peptide labelled with the sulfonated cyanme dyes 
Cy3 and activated as NHS esters in pyridine/DMF was used for the coupling with 
the nucleotide as pyridinium salts without further purification by ion exchange 
chromatography. Because the purification by RP-l-IPLC of the nucleotides labelled 
with water soluble cyanme dyes is more difficult to carry out as the dye derivatives 
have very similar retention time, it is critical to use high purity nucleotides and 
labelled peptides in order to avoid complicated and time-consuming purifications. 
The isolated fraction containing the desired nucleotide 35 was analysed by MALDI-
TOF. A peak at m/z 1333 corresponding to the mass of nucleotide 35 was found. 
3.4.2 Coupling of labelled peptides to Am-dCTP 
NJNAN DYE NH 
NfH 	 H 
O 0 0 	ON 
- 	 II 	II 	It 
I 	I 	I 
O—P—o—P—o— P —o-- 





5(6)-Ahx-carboxyfluorescein = 	0 
Figure 3.16 Structures of dCTP-(AIa) 3 -Cy5(H) 41, dCTP-(A1a) 3-Cy5(s) 38 and dCTP-(AIa) 3 - FAM 
51. 
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3.4.2.1 Synthesis of dCTP-(A Ia) - FAM51 
The nucleotide dCTP-(Ala)3- FAM 51 (Figure 3.16) was prepared analogously to 
the other nucleotides described in the sections 3.5.1.1 and 3.5.1.2. However, the 
activation of the peptide 49 as NHS ester required a prolonged reaction time. 
Furthermore, the NHS ester seemed to be more labile than other NHS esters in 
TLC. Because the dye has two isomers 5 and 6, the HPLC trace showed 4 peaks, 
the first and the third being the dye-peptide 49 and the second and the forth being 
the product 51 (Figure 3.17). The isolated product was analysed by MALDI-TOF 
giving three peaks at m/z 1202 (M-2H), 1204 M and 1224 (M-3H+Na). 
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Figure 3.17 HPLC chromatogram of the crude nucleotide dCTP-(AIa) 3 - FAM 51. Detection at X = 
490 run. Dr. un Ku Cho's analysis. 
3.4.2.2 Synthesis of dCTP-(Ala)3- Cy5 38 and 41 
Activation of the dye peptide Cy5-(Ala) 3-OH as NHS ester was carried out as for 
the other dye peptides although the reaction seemed far more efficient than for the 
other dye-peptides. Also the coupling with the Am-dCTP was faster: analysis by 
TLC showed formation of the product within the first 10 mins. The cleavable 
nucleotide was purified as usual by semi-preparative RP-HPLC. The HPLC 
chromatograms of the crude reaction mixture and of the purified product are shown 
in Figure 3.18. The isolated fraction analysed by MALDI-TOF MS gave two peaks 
at m/z 1197 (M-3H) and 1199 M. 60 nmoles (1.4% yield) of dCTP-.(Ala) 3- Cy5 41 
were obtained, as confirmed by UV-visible analysis. 
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Cy5 -(Ala) s-OH 
dCTP-(AIa) 3-Cy5 
15 	20 	25 	30 	35 
Figure 3.18 HPLC chromatogram of Cy5-AAA-dCTP before (green) and after (blue) purification. 
Detection at X = 650 mm Dr. un Ku Cho's analysis. 
The nucleotide dCTP-(Ala) 3 -Cy5 41 was initially prepared to perform dual colour 
primer extension experiments on microarray chips. HPLC analysis of primer 
extension using dCTP-(Ala) 3-Cy5 41 in solution (Chapter 4) showed that the 
nucleotide was efficiently incorporated by DNA polymerase into a growing DNA 
strand. However, single nucleotide primer extension conducted on microarray chips 
showed non-specific binding of this nucleotide to DNA due to the hydrophobic 
nature of the dye and to the presence of a positive charge (Chapter 5). 
Consequently, the water soluble cyanine dye Cy5 with sulfonate groups (negative 
charges) on the heterocycles was considered for the labelling of Am-dCTP V in 
order to reduce the non-specific binding to DNA. dCTP-(Ala) 3 -Cy5 38 was 
obtained in 1% yield (30 nmol), as confirmed by UV-visible analysis. The HPLC 
chromatograms of dCTP-(Ala) 3-Cy5 38 before and after purification by 
semipreparative HPLC are shown in Figure 3.19. The presence of a peak at m/z 
1358 (M-2H), 1360 (M), 1380 (M-2H+Na) in the correspondent MALDI-TOF 
MS spectrum confirmed the formation of the desired product 38. 
Cy5-AJa-OH 
dCTP-(Ala) 37Cy5 
15 	20 	25 
Figure 3.19 HPLC chromatogram of dCTP-(Ala) 3-Cy5-sulf6nated before (green) and after (blue) 
purification. Detection at X = 650 run. Dr. Jin Ku Cho's analysis. 
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3.4.3 Coupling of FAM-(Ala)3-OH to Am-dGTP 
Despite the fact that purines labelled at the 8 position can destabilise DNA, the 
labelling and incorporation of the amino-modified nucleotide Am-dGTP, modified 
with a linker in position 8, was also investigated. Indeed, the preparation of the 
nucleotide VII requires fewer steps than the nucleotide analogue modified at the 7-
position VIII therefore it was attractive synthesising and testing such a substrate. 
Synthesis and purification of the nucleotide dGTP-(Ala)3-FAM 50 (Figure 3.20) 
were carried out analoguosly to the other nucleotides described in the section 3.5. 
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Figure 3.20 Structure of dGTP-(Ala) 3-FAM 50 
All the fractions isolated after HPLC purification (Figure 3.21) of the reaction 
mixture were analysed by MALDI-TOF MS; a peak at m/z 1258 (M-4H+NH4) was 
found. However, when tested in a primer extension reaction by a DNA polymerase 
on a microarray chip, no extension product was detected using this nucleotide. 
FAM.IAIa)OH 
dGTP-AIa) (FAM 
-  - ,--- - 	 1 	 - 	 -) 
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Figure 3.21 HPLC trace of dGTP-(A) 3 -FAM before purification. Detection at X = 490 mm Dr. Jin 
Ku Cho's analysis. 
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3.5 	Conclusion 
The design, the synthesis and the characterisation of enzymatically cleavable 
nucleotides have been described in detail in this chapter. Amino modified 
nucleoside triphosphates, prepared with a novel solid phase triphosphorylation 
method, were successfully coupled to a small peptide (Ala-Ala-Ala-H) labelled 
with diverse fluorophores, Table 3.1. 
Fluorophores and peptide derivatives were obtained in relative high amounts (30 
mg scale for peptides, 100mg-i g scale for the dyes) and often without the need for 
purification by chromatography. 
Further work will be necessary in the future for the preparation of a set of four 
labelled nucleotides. 
As a practical solid phase method has been optimised (Chapter 2) for the synthesis 
of water soluble cyanine dyes, the use of Cy3, Cy3.5, Cy5 and Cy5.5 is proposed 
for the labelling of the four bases. 
The synthesis and use of cleavable nucleotides containing Am-dGTP and Am-
dATP needs further investigation. 
Table 3.1 Fluorescent Protease-Cleavable Nucleotides 
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4 	Single Nucleotide Primer Extension with Enzymatically 
Cleavable Nucleotides: Proof of the Principle 
The major challenges facing any novel sequencing by synthesis technology is the 
design and the synthesis of reversible terminators with the desired properties 
(Chapter 3) and the identification of a DNA polymerase which can recognise these 
substrates with high selectivity/fidelity. 
The aim of the work described in this chapter was to assess the ability of DNA 
polymerases to incorporate the enzymatically cleavable nucleotides described in the 
Chapter 3 and verify the feasibility of using proteases for the cleavage of the 
reporter group linked to the base. 
4.1 	Single Nucleotide Primer Extension 
Initial efforts focused on the selection of a DNA polymerase that would tolerate and 
efficiently incorporate nucleotides modified on the base with a labelled peptide and 
evaluation of the extent of incorporation in a primer extension reaction in solution. 
4.1.1 DNA Polymerase 
4.1.1.1 	Introduction 
Since the discovery of the first DNA polymerase in 1958 by Kornburg,' 74 many 
DNA polymerases able to catalyse the incorporation of deoxyribonucleotides into a 
growing DNA strand have been identified. Based on their sequence homology, they 
have been sorted into seven different families: A, B, C, D, X, Y, RT. 
Most of the DNA polymerases used with labelled nucleotides are of the so-called 
A-family and include Kienow DNA poll, T7, Taq DNA polymerases,and B-family 
DNA polymerases such as T4, TliIVent, Pfu, Tgo. 173 
The original enzyme used by Sanger in DNA sequencing was the Kienow fragment 
of Escherichia Co/i DNA polymerase I, an enzyme which retains 5' to 3' 
polymerase activity but lacks 3' to 5' exonuclease activity (proof-reading 
activity). 175  Indeed, enzymes retaining exonuclease activity cannot be used in DNA 
sequencing because they could degrade the extended primers, removing the dye 
labelled terminator and allow further unwanted growth by incorporating unmodified 
dNTPs. 
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Kienow has been routinely used in DNA sequencing; however more recently it has 
been replaced by other enzymes because of its low processivity (average length of 
DNA synthesized before the enzyme dissociates from the template), long 
elongation rate' 76  and lack of thermal stability. 
The polymerases currently used in DNA sequencing are mostly genetically 
modified T7 and Taq DNA polymerases. T7 DNA polymerase, developed by Tabor 
and Richardson, is a chemically modified polymerase able to preserve the high 
processivity and elongation rate of native polymerases. It lacks a 5'—*3' 
exonuclease domain but has a 3'—*5' exonuclease activity that is 1000-fold higher 
than Kienow; therefore it is not recommended for DNA sequencing. 177 
However, a genetically engineered form of T7 DNA polymerase able to retain 
polymerase activity with almost no 3 '--+5' exonuclease activity was developed. 
This polymerase (marketed as Sequenase version II) is often used for high quality 
manual DNA sequencing; it is highly processive and able to incorporate nucleotide 
analogues for sequencing (dideoxy NTPs, a-thio cIATP, dITP, 7-deaza-dGTP, 
etc.). 178 
However, currently thermostable DNA polymerases are principally used as they 
enable rapid amplification of extremely small amounts of DNA in a polymerase 
chain reactions (PCR) and thermal cycling. 
Taq polymerase is a thermostable DNA polymerase isolated from the thermophilic 
bacterium Thermus aquaticus and is often used in polymerase chain reactions 
(PCR). It does not have significant 3'—.5' exonuclease activity and in part because 
of this, has low replication fidelity. Indeed, it is often used in combination with the 
polymerase Pfu in PCR reactions in order to combine its high processivity with the 
proofreading activity of Pfu polymerases. 37" 76 
In 1995 Tabor and Richardson developed two genetically modified Taq 
polymerases (marketed as AmpliTaq® and Thermo Sequenase) containing single 
point mutations that reduced significantly the exonuclease activity of the 
polymerase and the discrimination against ddNTPs and labelled nucleotides. 176 For 
these reasons AmpliTaq and Thermo Sequenase are generally preferred for DNA 
sequencing methods using dye-terminators. 
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4.1.1.2 Selection of a DNA Polymerase 
For the purpose of the project, commercially available DNA polymerases were 
tested in order to find one able to recognise our substrate. The first polymerase 
assayed was Sequenase v. II. As mentioned earlier, this polymerase does not have 
proofreading activity and is able to recognise modified nucleotides. 
Sequenase v. II was first assayed using unlabelled dNTPs in order to find the best 
conditions for the analysis and purification of the extended primer by HPLC (see 
section 4.1.2). However, when tested with the protease-cleavable fluorescent 
nucleotides, primer extension did not occur. 
As alternative, DNA polymerase Thermo Sequenase, a thermostable DNA 
polymerase specifically engineered for DNA sequencing, was considered. The 
thermostability of this polymerase makes cycle sequencing possible, combining the 
processivity of T7 Sequenase DNA polymerase with the sensitivity and reliability 
of cycle sequencing. It is well known that Thermo Sequenase can recognize and 
efficiently incorporate fluorescently labelled ddNTPs and that is highly tolerant to 
extensive modifications to the base of a nucleotide with large groups, such as 
energy transfer dyes. 156" 79 For all these reasons, Thermo Sequenase seemed very 
promising for the realization of our project and was thus tested with our reporter 
nucleotides (section 4.2). 
4.1.2 Analysis of Primer Extension 
The oligonucleotide sequences, generated during primer extension reactions using 
fluorescent nucleotides, are usually separated by polyacrylamide gel electrophoresis 
and visualised by laser-induced fluorescence detection 180  (oligonucleotides can be 
also labelled with isotopes and examined by autoradiography or can be stained with 
ethidium bromide or SYBR-Gold and visualised under UV light, 177  but these 
methods are now used infrequently). 
Analysis of extended oligonucleotides by high performance liquid chromatography 
(HPLC) using 0.1 M TEAB buffer and acetonitrile was perfomed. The advantage of 
this method is the possibility to easily purify the desired sequence from unreacted 
nucleotides or oligonucleotide primer and template and to monitor the incorporation 
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of the fluorophore by IJVIVis detectors. In addition, the isolated fraction containing 
the extended primer can be analysed by MALDI-TOF to identify the peak. 
Oligonucleotides were analysed by MALDI-TOF MS, using 3-hydroxypicolinic 
acid (3-HPA) as matrix. To obtain good quality MALDI-TOF MS spectra, it was 
critical for the sample to be concentrated, free of non-volatile cations and agents 
which disturb crystallization (detergents, urea, DMSO). Indeed, the presence of 
salts can make MALDI-TOF analysis extremely difficult because of the formation 
of adducts between the negatively charged nucleic acids and the cations. 181 
Moreover, the matrix tend to form crystals at the edge of the sample spotted onto 
the plate causing an inhomogeneous distribution of DNA and matrix, which 
requires a time consuming search for the hot spots of the sample. To improve the 
sensitivity of MALDI-TOF MS analysis, the extension products, purified by RP-
HPLC and lyophilised, were also desalted using the commercially available C 18 
ZipTips.' 82 
4.2 	Primer Extension with Enzymatically Cleavable Nucleotides 
To verify the feasibility of using enzymatically cleavable fluorescent nucleotides as 
reversible terminators in Sequencing by Synthesis, the nucleotide dUTP-(A) 3-Rho 
was tested in a primer extension reaction performed in solution using Thermo 
Sequenase DNA polymerase (Scheme 4.1). 
The oligonucleotide sequences and the reaction conditions reported by Ju et al. 
were considered for this proof-of-the-principle experiment. A synthetic 60-mer 
oligonucleotide corresponding to a portion of exon 7 of the human p53 gene was 
used as template I to perform the primer extension reaction. 156 
Template I and primer I sequences: 
3'-GGCCTGTGTTATCTCCTAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTG- 5' 
5' -AGAGGATCCAACCGAGAC-3' 
The first nucleotide in the template adjacent to the annealing site of the 1 8-mer 
primer I was "A", meaning that the complementary nucleotide to be incorporated 
during polymerase reaction was "T" (or "U"). The polymerase extension reaction 
mixture consisted of 200 pmol of primer, 320 pmol of p53-exon7 template, 640 
pmol of the nucleotide analogue dUTP-(Ala) 3-Rho 46, 16 units of Thermo 
Sequenase DNA Polymerase and I x  Thermo Sequenase reaction buffer in a total 
volume of 50 tL. 
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Scheme 4.1 Left: Principle of DNA sequencing using fluorescent-tagged peptide nucleotide 
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Figure 4.1 a) HPLC chromatogram of the primer extension reaction. Detection at 260 rim (blue) and at 
565 jun (red); b) MALDI-TOF MS of the extended primer!! 
The incorporation of the modified nucleotide 46 by Thermo Sequenase DNA 
polymerase was investigated by HPLC analysis using two different wavelengths to 
follow the progress of the reaction: 260 nm to measure the UV absorbance of DNA 
and 567 rim to measure the absorbance of the dye rhodamine B (Figure 4.1). 
A peak at 6.4 min absorbing only at 260 rim, corresponded to the oligonucleotide 
template while a peak at 7.2 mm, which was detected in both channels, 
corresponded to the extension product II. The nucleotide 46, which was added in 
excess, was detected at 13.7 mm. MALDI-TOF MS analysis of the purified 
extended primer II confirmed that the labelled nucleotide 46 was successfully 
incorporated, into the primer, by Thermo Sequenase. 
Primer extension was repeated using a reporter nucleotide labelled with a different 
fluorophore dCTP-(A) 3- Cy5 41 (Scheme 4.2). 
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Scheme 4.2 Left: Reaction of Primer extension with dCTP-(A) 3- Cy5. Right: Structure of the extended 
primer IV 
In this case, the nucleotide in the template H adjacent to the annealing site of the 
I 8-mer primer I was 
Template 11 and primer I sequence: 
3'-GGccTGTGTTATcTccTAGGTTGGCTCTGGCTGTACCACCATCCACTACAACTACATGTG - 5' 
5' -AGAGGATCCAACCGAGAC- 3' 
The incorporation of the modified nucleotide 41 by Thermo Sequenase was 
investigated by HPLC analysis using again two different wavelengths to follow the 
progress of the reaction (260 nm and 641 nm). The HPLC chromatogram is shown 
in Figure 4.2. A peak at 6.9 min absorbing only at 260 run, corresponded to the 
oligonucleotide template II while the peak at 9.2 mm, which was detected at both 
wavelengths, corresponded to the extension product IV; the nucleotide 41, which 
was added in excess, was detected at 15.6 mm (Figure 4.2). 
HPLC analysis of the primer extension reaction, shown in Figure 4.2, indicated that 
the modified nucleotide dCTP-(Ala) 3-Cy5 41 was recognised and successfully 




Figure 4.2 HPLC chromatogram of primer extension by Thermo Sequenase using dCTP-(A) 3- Cy5. 
Detection at 260 nm (red) and at 641 nm (blue). 
Removal of the Reporter Group 
Because the read length of a SBS technology is highly dependent on the efficiency 
of removal of the fluorophore from the extended primer, the enzymatic cleavage of 
the labelled peptide from the extension product 11 (Scheme 4.1 and 4.3) was 
investigated by HPLC and MALDI-TOF MS analysis (Figure 4.3). 
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Scheme 43 Left: Digestion of primer 11 by subtilisin. Right: Structure of primer III. 
10 min of incubation at 37 °C of the primer II with the protease subtilisin A 
resulted in the disappearance of the peak at 7.9 min from the HPLC chromatogram 
and in the formation of two new peaks at 6.3 mm (detected at 260 nm) and at 15.7 
mm (detected at 567 nm). The peak at 6.3 min was isolated and analysed by 
MALDI-TOF MS to produce three fragments (m/z 5865, 5936, 6007). The main 
peak (m/z 5865) resulted from cleavage between the aminopropargyl linker and the 
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labelled peptide while two small peaks were obtained from the cleavage at the sites 
P1' (m/z 5936) and P1 (m/z 6007), Figure 4.4. The peak at 15.7 min in the HPLC 
chromatogram was the dye-peptide cleaved from the extended primer. 
These data demonstrated that the reporter group (fluorophore and peptide) was 
completely released from the extended primer H during incubation with the 
protease subtilisin and consequently that no residual signal from the fluorophore 
was left on the extended primer HI. 
b) 
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Figure 4.3 a) HPLC chromatogram of the digestion of primer H by subtilisin. Detection at 260 nm 
(blue) and at 565 nm (red); b) MALDI-TOF MS of oligonucleotide III. 
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Figure 4.4 Cleavage sites of the enzyme subtilisin for the fluorescent nucleotide 35. 
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4.4 Investigation of the Termination Properties of Enzymatically 
Cleavable Nucleotides 
To verify the termination properties of the enzymatically cleavable nucleotides, 
primer extension was performed on a DNA template III containing a 
homopolymenc region with three consecutive bases "A" adjacent to the annealing 
site of the primer, Scheme 4.4. The primer and the template were incubated with the 
nucleotide dUTP-(Ala) 3-Rho and Thermo Sequenase, as reported in the section 4.2. 
Template III and primer I sequences: 
3 * —GGCCTGTGTTATCTCCTAGGTTGGCTCTGAAAGTACCACCATCCACTACAACTACATGTG - 5' 
5' —AGAGGATCCAACCGAGAC-3' 
Primer I 
57 	 I LL' 	 I 
3' 	 AAAGTACC— 5 
Template III 	 5 
AGAGOATCCAAcCOAGAC 	 ro 	o 
dUTP.(ARhodamine 	 () 
 
Primer II 
5' 	 u 	 Primer 11 
3 	 AAAGTACC s 	
OH 
TemplateL 
Scheme 4.4 Left: Primer extension with dUTP-(A)3 Rho 46 and the homopolymeric template M. 
Right: structure of primer II. 
HPLC analysis of the reaction mixture revealed the presence of a peak at 7.1 mm, 
which was postulated to be the primer extended with one nucleotide dUTP-(A)3-
Rho 46 as the retention time was similar to that of primer H (see figures 4.1 and 
4.5). If multiple incorporations would have occurred, three peaks corresponding to 
the incorporation of 1, 2 and 3 nucleotides all absorbing at 565 rim, would be 
expected in the HPLC chromatogram. 
Figure 4.5 HPLC chromatogram of a primer extension using dUTP-(A) 3-Rho and a homopolymeric 
template. Detection at 260 nm (blue) and at 565 nm (red) 
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Attempts to identify the extended oligonucleotide by MALDI-TOF MS were 
carried out; however no peak could be detected corresponding to any extension 
product due, likely, to the presence of salts and matrix-crystals in the sample 
spotted on the MALDI plate. 
To investigate the termination properties of the enzymatically cleavable 
nucleotides, another experiment was carried out by incubating a primer and the 
corresponding template with Thermo Sequenase and two protease cleavable 
nucleotides dUTP-(Ala)3-Rho 46 and dCTP-(Ala)3-Cy5 41 (Scheme 4.5). 
Template IV contained the nucleotides "A" and "G" next to the annealing site of 
the primer. 
Template IV and primer I sequences: 
3 ' -GGCCTGTGTTATCTCCTAGGTTGGCTCTGAGAGAGAGAGTCCACTACAACTACATGTG - 5' 
5' -AGAGGATCCAACCGAGAC-3' 
In the case of multiple incorporations, two peaks would be expected to be 
visualised in the HPLC chromatogram for the extension products: an extended 
primer corresponding to II absorbing at 565 nrn and another extended primer 
absorbing at both 565 and 641 nm corresponding to V (Figure 4.6). In the case of 
termination by the first incorporated nucleotide, only one extension product 
absorbing at 565 nm and corresponding to the primer II should be found in the 
HPLC chromatogram. 
Primer I 
5• 	 3' 
3' 	 AGAGAGAO— 5' 
Template IV 
fl dUTP-(AJa),-Rho 
I I dCTP-(AIa)3-Cy5 'tV> DNA Polyrnerase 
Primer 11 	41 
I I 
3 	 AGAGAGAO— 5 
Template IV 
Single incorporation  
Primer II 100 
iWIIHI 
3 	 AGAGAGAO- 
Template IV 
Multiple incorporations 
Scheme 43 Primer extension with dUTP-(A) 3-Rho and dCTP-(A) 3 -Cy5. Primer H is obtained when 
only the nucleotide dUTP-(A) 3-Rho is incorporated. Primer V is obtained when both nucleotides 
dUTP-(A) 3 -Rho and dCTP-(A) 3 -Cy5 are incorporated. 
In the HPLC chromatogram of the extension reaction represented in Scheme 4.5, 
the major peak consisted of the termination product II obtained by incorporation of 
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the nucleotide dUTP-(A)3-Rho (Figure 4.6). A small peak at 7.4 min absorbing at 
641 nni was also found however the identity of this peak could not be determined 
by MALDI-TOF MS as the amount obtained was not sufficient. This peak might 
correspond to an impurity of the starting material 41 rather than to the extension 
product V. In this case a peak corresponding to the incorporation of both 
nucleotides would be expected to be found at a higher retention time due to the 
hydrophobicity of both dyes. In fact, the primer extended with 41, shown in Figure 
4.2 had a retention time of 9.2 mm. 
Figure 4.6 HPLC chromatogram of DNA chain extension by Thermo Sequenase using Cy5-(A) 3 - 
dCTP and dUTP-(A)3 Rho B. Detection at 260 nm (grey), at 565 nm (red), at 641 nm (blue), 
4.5 	Conclusion 
In summary, it has been proved that enzymatically cleavable nucleotides (such as 
dUTP-(Ala) 3-Rho and dCTP-(Ala) 3 -Cy5) could be successfully incorporated by 
Thermo Sequenase DNA polymerase into a DNA primer and could be completely 
cleaved (within 10 mm) by a protease to release the fluorophore. 
The termination properties of enzymatically cleavable nucleotides are important 
when four fluorescent nucleotides need to be used at the same time in sequencing 
by synthesis cycles. The termination properties of the reporter nucleotides were 
investigated by I-IPLC analysis. Preliminary results have shown that in the presence 
of homopolymeric templates or of a mixture of cleavable nucleotides, the major 
extension product consisted of a primer extended by a single nucleotide. Further 
tests need to be carried out to identify this extension product by MALDI-TOF. 
Encouraged by the results of primer extension and cleavage experiments in 
solution, presented in this chapter, enzymatically cleavable nucleotides were tested 
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in polymerase reactions on DNA microarrays. The results of these experiments will 
be described in the next chapter. 
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5 	Chip-Based Interrogation of DNA Sequences with 
Enzymatically Cleavable Nucleotides 
The purpose of this chapter is to describe the use of enzymatically cleavable 
nucleotides in chip-based polymerase reactions. Incorporation of these modified 
nucleotides into DNA primers immobilised on a solid support and protease-cleavage of 
the fluorophore are presented 
5.1 	Introduction 
The demand for ultra-high-throughput re-sequencing for personal medicine 
encouraged the development of non-electrophoretic platforms to enable scientists to 
sequence DNA in a massively parallel and highly automated fashion. DNA 
sequencing by synthesis (SBS) approaches combined with microfluidic systems, 
microarray technology and ultra-sensitive optics (e.g. SMRT technology developed 
by Pacific Biosciences and the SBS technologies developed by Helicos and 
Illumina)46 '47183 contributed to lower the cost of whole genome sequencing. 29 
Therefore, once it had been proven that the nucleotide analogues were incorporated 
by a DNA polymerase in a primer extension reaction in solution (Chapter 4), it was 
necessary to implement the method on a microarray format for sequencing 
applications. 
In the novel SBS approach, here proposed, unknown single stranded DNA's would 
be hybridised to an array of DNA primers immobilised on a chip (Figure 5.1-a). 
Four nucleotide analogues designed such that each is labelled with a unique 
fluorescent dye linked to the base through a peptide would be utilised (Figure 5.1-
b). Upon addition of the four nucleotide analogues and a DNA polymerase, only the 
nucleotide analogue complementary to the next nucleotide on the template would 
be incorporated by the polymerase on each spot of the array. In this manner the first 
unknown nucleotide adjacent to the primer would be identified by virtue of the 
"colour" of the incorporated base. At the same time chain extension is temporarily 
terminated by inhibition of the DNA polymerase induced by the bulk of the 
fluorophore and the peptide. 
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After incorporation and detection, the "colour" is removed and the base 
"unblocked". At this stage the DNA primer is ready for the next cycle of the 
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Figure 5.1 a) DNA SBS on chips using protease cleavable nucleotides; b) Structure of a protease 
cleavable nucleotide. 
The experiments presented in this chapter were aimed to prove the principle of our 
new technique and optimise chip-based enzymatic assays by addressing the 
following issues: 
Construction of a DNA microarray and optimisation in relation to DNA 
sequences (templates and primers) and reaction conditions. 
Evaluation of enzyme activity and specificity on the array. 
a) 
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3. 	Evaluation of enzymatically cleavable nucleotides as reversible terminators. 
	
5.2 	DNA Microarrays: Templates 
Most sequencing methods require an amplification step, 55 so that the DNA to be 
sequenced is present in sufficient copy numbers to achieve the required signal. A 
recent advance in DNA template preparation is the emulsion-PCR technique 47,50 
which has been implemented in a number of SBS approaches (e.g. the 
pyrosequencing technology developed by 454 Life Science) (see Chapter 1).47 
The advantage of DNA sequencing by synthesis technologies is that sequence 
information can be also obtained from single DNA molecules. A number of 
companies (e.g. Helicos, Pacific Biosciences, Visigen Biotechnologies) have 
developed single molecule DNA sequencing technologies, reducing time, costs and 
avoiding potential biases (due to sequences that amplify poorly). 73 
In both cases, the DNA fragments to be sequenced are physically separated in an 
array and subjected to repeated cycles of enzymatic manipulation to produce the 
sequence. 
Because the main goal of the work here reported was to characterise fluorescent 
cleavable dNTPs in polymerase-mediated extension reactions for their ability to 
behave as DNA polymerization transient terminators, proof-of-the-principle 
experiments have been carried out using synthetic model oligonucleotides, instead 
of cloned DNA. 
More details on the design of DNA primers (or "targets") and DNA templates (or 
"probes") will be provided in the section 5.4.1. 
5.3 	DNA microarrays: Surface and Immobilisation Chemistry 
The design of our novel SBS approach required, first of all, the construction of 
DNA microarrays on which to perform polymerase reactions. 
The quality of the microarrays is determined by various factors: 
Immobilisation chemistry. 
Target and probe density. 
Target and probe design (length, melting temperature, etc.). 
Buffer composition (pH, salt concentration, etc.). 
Surface-compatibility with enzyme functionality. 
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6. 	Easy removal of enzyme and labelled compounds from the surface. 
The primary requirement in the immobilisation of DNA is that the coupling 
reaction must occur in high yields and in conditions compatible with DNA 
handling. Another ideal property required for the functional groups to be coupled 
(one from the DNA and the other on the surface) is the stability of the groups under 
aqueous conditions. 
A variety of attachment chemistries have been used for the immobilisation of DNA 
on surfaces. Lindroos et al. 184  have compared the immobilisation chemistries of 
different surface-oligonucleotide interactions and found that amino-modified 
nucleotides immobilised on the commercially available CodeLinkTM  slides (Figure 
5.2) provided the best environment for solid phase minisequencing (Table 5.1). 
Slide type 5 '-modification on Functional group on 
Relative 
signal 
(glass slides) primer slide intens 
NH2 -(CH2)6-0-(P0)2- 
Isothiocyanate oligonucleotide -N=C=S 1.0 
NH2 -(CH 2)6-0-(PO) 2 - 
'Superaldehyde' oligonucleotide -CHO 0.09-0.20 
NH2-(CH 2 )6-S-S-(CH2)6- 
0-(PO)2-oligonucleotide 




EZ-RAYS CH 2=CH-CO-NH-R- 3D with —SH groups 0.19 
oligonucleotide 
CodeLink' 
NH2-(CH2)6-0-(PO)2 - N- hydroxysuccinimidyl 7.7 
oligonucleotide ester 
Unmodified none 0.80 
(glass slide) 
Table 5.1 Efficiencies of the reaction between the 5' functional group on the oligonucleotide and the 
reactive groups on the slide. Table adapted from ref. 6. 'After incorporation of labelled nucleotides 
Experimental results (shown later in this chapter) confirmed the high quality and 




pH > 7.0 
5 ' 
3' end 	OH 
Figure 5.2 Attachment chemistry of a DNA molecule, modified at the 5' end with an amino group 
to an activated CodeLinkTm slide. Figure adapted from www.pga.mgh.harvard.edu . 
The more affordable aldehyde slides (Genetix), in which DNA molecules were 
covalently bound to the glass surface through formation and reduction of a Schiff's 
base, showed poor results and lower quality data after primer extension reactions 
(Figure 5.3), 
Figure 5.3 Fluorescence images (scanned using a Cy-3 filter) 01 aldehyde slides after primer 
extension with dUTP-(A) 1 -Rho; a) before image processing; b) after image processing. 
One main drawback of these slides is the difficulty of washing off fluorescent 
compounds sticking onto the surface. In particular, the enzymatically cleavable 
nucleotide dUTP-(A)3-Rho, used in primer extension reactions, was difficult to 
remove from the surface of the chip, because of the hydrophobic nature of the dye. 
Since the dye Rhodamine B is soluble in aqueous solutions at acidic pH, the slides 
were treated with citrate/phosphate buffers ranging from pH 6.5 to pH 5. However, 
the dye could not be efficiently removed. The use of an organic solvent (such as 2- 
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propanol) in which the dye is highly soluble, did not improve the quality of the 
background. 
This limitation was easily overcome using CodeLinkTM  slides which, thanks to the 
hydrophilicity of the coating, avoided non-specific dye binding and provided 
microarray data with high signal to noise ratios. An example of the quality of the 
images obtained with CodeLinkTM  slides is shown in Figure 5.4. 
Figure 5.4 fLuorescence images scanned using a Cy3 filter) of CodeLinkrM  slides after primer 
extension with dUTP-(A)3-Rho; a) before image processing; b) after image processing 
Single nucleotide primer extension was performed on both CodeLinkTM  and 
aldehyde slides, and fluorescence intensities (average values for all the 
oligonucleotides on each slide) after single nucleotide primer extension were 
measured at Aem = 585 rim using the FIPS software (LaVision BioTech). The 










CODEUNK 	 ALDEHYDE 
Figure 5.5 Diagram of normalised fluorescence intensities acquired for CodeLinkTM  and aldehyde 
slides (X, = 585 rim) after primer extension with dUTP-(A) 3-Rho. The error bars represent the 
standard deviation of the mean (SEM). 
In the course of this work, nucleotides labelled with various fluorescent dyes 
(carboxyfluorescein, rhodamine derivatives, cyanine dyes) having different 
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properties (hydrohobicity/hydrophilicity) have been tested on CodeLinkTM  slides. 
All dyes could be easily removed without the need for extensive washings. 
5.4 	DNA microarrays: printing and hybridisation 
5.4.1 Design of target and probes sequences 
The design of target and probe sequences is crucial for the success of primer 
extension reactions onto a solid surface. To evaluate and optimise our method, 
DNA sequences previously used in minisequencing experiments published in the 
literature were selected. 136  Target/probe physical characteristics were analysed 
using the Oligo Analyzer 3.1 program and modified, where necessary, to improve 
the performance of hybridisation and incorporation assays. 
The following DNA properties were considered for the design of DNA 
sequences' 85,186 : 
Primer and template length. 
Stability of DNA duplexes. 
Cross-homology. 
When designing oligonucleotides for DNA analysis on a microarray slide, it is 
important to ensure that all probes and targets hybridise at the same temperature. 
Additionally, to allow the formation of DNA duplexes, the hybridisation must occur 
at temperatures lower than the melting temperature (Tm) that is the temperature at 
which a double stranded DNA molecule dissociates into single strands. The Tm of 
DNA duplexes depends on the length and on the sequence of a DNA molecule. 
Generally, long heteroduplexes with a high GC content have higher Tm because of 
the higher number of interactions between base pairs.' 87 
DNA primers and templates chosen for primer extension experiments on 
microarray, consisted of 25-3 imer oligonucleotides (with overlapping regions of 
20-25 bp) with a GC content of 40-60%. All selected probes and targets had a Tm 
in the range of 65-85 °C. 
The hybridisation temperature must be carefully selected as a too low hybridisation 
temperature may lead to the formation of non-specific hybridisation products 
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caused by a high number of base pair mismatches while a too high hybridisation 
temperature can result in low extension yields.' 86,187 
Taking into account all these factors, hybridisation and primer extensions were 
carried out at -55 °C. This temperature ensured hybridisation specificity and at the 
same time was well tolerated by the coating of CodeLinkTM  slides. 
When designing probes and targets for primer extension reactions, it is also 
important to avoid cross-hybridisation and the formation of secondary structures 
(e.g. homo- and heterodimers and hairpins) produced by intermolecular or 
intramolecular interactions of DNA molecules.' 87  The formation of secondary 
structures can be predicted using specific softwares, such as the Oligo Analyzer 3.1 
program, and must be avoided. In fact, if primers and templates form secondary 
structures stable above the hybridisation temperature, they will be unable to 
hybridise and therefore primer extension will not occur.' 86 
5.4.2 Optimal target and probe density 
The quality of DNA microarrays depends on two important factors: the optimal 
density of bound target molecules on the microarray surface and the optimal 
concentration of probe molecules that provide the strongest signal in a primer 
extension microarray assay. 187 
When target and probe molecules hybridise each other on the microarray surface, 
there are important physical and/or steric properties that must be taken into account. 
High target concentration produces too many target molecules on the microrray 
surface causing quenching of fluorescence or preventing incoming probes from 
hybridising or DNA polymerase from extending the primer, thus reducing the 
fluorescent signal. On the other hand, insufficient target density determines a 
weaker fluorescent signal. 187 
Probe and target concentration together with enzyme and nucleotide concentration, 
can also affect the specificity of nucleotide incorporation by DNA polymerases. To 
reduce the probability of misincorporations, dual colour primer extension reactions 
have been carried out using different concentrations of primers, templates, enzyme 
and nucleotides (see Appendix). 
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5.4.3 Immobilisation of DNA Primers on CodeLinkTM slides and Hybridisation 
5.4.3.1 Printing 
DNA microarrays were constructed with synthetic DNA primers modified in their 
5'-ends with amino groups in order to be linked to NHS ester-derivatised slides. 
DNA primers were first dissolved in a 50 mM sodium phosphate buffer at a 
concentration of 20 pM and then coupled to CodeLinkTM slides at pH 8.5 in a 
humid environment, after contact printing with a Genetix QArray robot. Because 
the NHS ester groups onto the surface are moisture sensitive, printing was 
performed in an environment with relative humidity < 50 %. This humidity ensures 
stability of NHS esters and, at the same time, prevents samples from drying due to 
excessive evaporation of water. 
After immobilisation of DNA, CodeLinkTM slides were treated with a solution 50 
mM of ethanolamine to "block" the un-reacted NHS groups on the surface and then 
washed at 50 °C with a 4 x SSC (saline-sodium citrate) buffer containing SDS 
(sodium dodecyl sulfate). 
SDS and washings at higher temperature are commonly used to reduce non specific 
binding of DNA. After washing, the slides were dried by centrifugation at 4000 rpm 
for 5 mm. The protocol proposed by the manufacturer, suggests to centrifuge at 800 
rpm for 3 mm. However, this centrifugation time was not sufficient to completely 
dry the surface of the slides, while higher speed resulted in their breakage. 
A 5'-amino modified oligonucleotide, labelled in the 3' position with fluorescein, 
was used as a control in order to check the quality of printing on the surface. 
Fluorescence images of the slides were scanned using the appropriate filter for the 
detection of fluorescein in order to show the fluorescence signal of the labelled 
DNA primers. An example of CodeLinkTM slide printed with labelled DNA primers 
is shown in Figure 5.6. 
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Figure 5.6 Left: fluorescence image of a CodeLinkTM  slide, scanned using the filter for the detection 
of fluorescein, after immobilisation of DNA primers, a) unlabelled DNA primers, b) DNA primers 
labelled in the 3' position with fluorescein. Right: schematic representation of a DNA primer (white 
bar) immobilised onto a microarray surface (in grey), a) unlabelled, b) labelled in the 3' position 
with fluorescein (green star). 
5.4.3.2 Hybridisation 
DNA primers immobilised onto CodeLinkTM  slides were hybridised to 
complementary DNA templates with known sequences. A preheating step at 85 °C 
was carried out in order to remove any secondary structure formed in the probe 
sample. As mentioned earlier, a hybridisation temperature of 55 °C was found to 
provide good results for all the primers selected for primer extension experiments. 
Therefore, the hybridisation was performed at 55 °C for 3 h in an automated 
hybridisation system using the following hybridisation buffer (Genetix): 50% 
formamide, 2 mg/mL herring sperm DNA, 0.4 % SDS and 8.4 x  SSC. The buffered 
herring sperm DNA is composed of small DNA fragments which blocks non-
specific binding during prehybridisation and nucleic acid hybridisation. 
Successful hybridisation could be determined by using an oligonucleotide template 
labelled in the 5' position with fluorescein, as hybridisation control. Fluorescence 
images of the slide were scanned using a FITC filter to verify the success of the 
hybridisation step. 
The DNA primers printed onto the slide shown in Figure 5.6 were hybridised to a 
DNA template labelled in the 5' position with fluorescein. The fluorescence image 
of this slide after hybridisation is shown in Figure 5.7. Although, primers and 
templates of the subarray B were both labelled with fluorescein, the average 
fluorescence intensity value (5.2 1 05)  of the correspondent signals was very similar 
to the values obtained for the array A (4.9 10 5 ). 
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Primer/Template duplexes 	 Position 
5'-H 2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-3' A 
3 1 -ATA CTG TGG CAG TAG TCG TCA TCA G-FJ-5'  
5'-H 2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-F1-3' E 
3 1 -ATA CTG TGG CAG TAG TCG TCA TCA G-Fi-5  
Table 5.2 Oligonucleotides sequences and their positions as shown in Figure 5.6 and 5.7. Fl = 
fluorescein  
I 
Figure 5.7 Left: Fluorescence image (scanned using a FITC filter) of a CodeLink 7III slide after 
hybridisation. A) unlabelled primers hybridised to templates labelled in the 5' position, B) DNA 
primers labelled with fluorescein in the 3' position and hybridised to DNA templates labelled with 
fluorescein in the 5' position; Right: a) schematic representation of a DNA primer (white bar) 
immobilised onto a microarray surface (in grey) and hybridised to a DNA template labelled in the 5' 
position with fluorescein (white bar with a green star). 
5.5 
	
Single Nucleotide Primer extension using Fluorescent 
Dideoxynucleotides 
Before testing the enzymatically cleavable fluorescent nucleotides in sequencing by 
synthesis assays, solid phase minisequencing experiments were carried out to test 
the reaction conditions for primer extension and gain important informations in 
relation to: 
Discrimination, by our detection system, of differently labelled oligonucleotides 
after incorporation of fluorescent nucleotides. 
Specificity of hybridisation/incorporation. 
Efficiency of incorporation of fluorescently labelled nucleotides by Thermo 
Sequenase DNA polymerase. 
A total of 102 DNA primers were coupled to the surface and used to prime 102 
synthetic DNA templates corresponding to gene regions containing SNPs. Each 
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slide contained four duplicates of an array of 102 heteroduplexes. The primed 
templates were incubated in an automated hybridisation system with Thermo 
Sequenase DNA polymerase (1 U/L) and four fluorescent dideoxynucleotides (2.5 
pM) labelled with four fluorophores, each coding for a different base (A, C, 1, G): 
Texas Red-ddATP, Fluorescein-ddCTP, Cy5-ddUTP and TAMRA-ddGTP. After 
incubation and washing, scans of the microarray surface with a microarray scanner 
equipped with four different filter settings allowed for detection of the incorporated 
base for each of the DNA templates (Figures 5.8-5.15). 
The four labelled dideoxynucleotides were chosen on the basis of the following 
criteria: 1) four distinguishable colors as fluorescent labels; 2) commercial 
availability; 3) previous works published in the literature.' 36 
5.5.1 Optical Read-Out 
Biochips were scanned using a microarray reader featuring a white light source, 
four colour filters and a CCD camera detection system. Unlike lasers, which have a 
defined monochromatic emission, white light sources emit many colours 
simultaneously and are thus said polychromatic. 
The following filters were used to scan the microarray slides (excitation wavelength 
± bandwidth of transmission/emission wavelength ± bandwidth of transmission): 
FITC: (480 nm ± 40/ 535 nm ± 50); Cy 3: (546 nm ± 12x/ 585 rim ±40); Texas-
Red: (560 nm ± 55/ 645 nm ± 75); Cy 5: (640 tim ± 20/ 680 tim ± 30). 
Because the emission wavelength for a given dye is longer than the excitation 
wavelength and because the emission spectra often extends over 50-100 nm, 
emitted light or signal from one channel can be erroneously detected in a second 
channel. 187 
A common standard for cross-talk is 10% from channel to channel, absolutely 
necessary for the detection of different labels' 87 . As shown in Figures 5.13-5.16, 
cross-talk occurred when the microarray slides were scanned using TAMRA and 
Texas Red filters because TAMRA and Texas Red dyes have very similar spectra. 
Normalised fluorescence intensities were measured for all the extended primers 
using the FIPS software (LaVision BioTech) after scanning the slides with four 
different filters (Cy5, FITC, Texas Red and TAMPA). 
Figures 5.9 and 5.11 show that the normalised fluorescence intensities measured for 
the primers extended with Cy5-ddUTP and Fluorescein-ddCTP are distinguishable 
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from the signals given by the primers extended with Texas Red-ddATP or 
TAMRA-ddGTP, which have shown normalised fluorescence intensities :S 0.2. 
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Figure 5.8 Left: Fluorescence image (scanned using a Cy5 filter) of DNA duplexes after 
incorporation of Cy5-ddUTP. Right: expected pattern for primer extension (the letters A, C, G, T 
indicate the base expected to be incorporated in the DNA duplex immobilised onto the slide). F= 
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Figure 5.9 Normalised Fluorescence Intensitites () 1 = 680 nm) of 102 heteroduplexes after primer 
extension with four fluorescent dideoxynucleotides. The blue squares correspond to the fluorescence 
intensities of primers extended with Cy5-ddUTP. The grey diamonds correspond to the fluorescence 
intensities of primers extended with the other three fluorescent dideoxynucleotides. 
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Figure 5.10 Left: Fluorescence image (scanned using a FITC filter) of DNA duplexes after 
incorporation of FITC-ddCTP. Right: expected pattern for primer extension (the letters A, C, G, I 
indicate the base expected to be incorporated in the DNA duplex immobilised onto the slide). F= 
fluorescein (printing control). 
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Figure 5.11 Normalised Fluorescence Intensitites (X e,,, = 480 run) of 102 heteroduplexes after primer 
extension with four fluorescent dideoxynucleotides. The green squares correspond to the 
fluorescence intensities of primers extended with FITC-ddCTP. The grey diamonds correspond to 
the fluorescence intensities of primers extended with the other three fluorescent dideoxynucleotides. 
On the other hand, Figures 5.13 and 5.15 show that cross-talk occurred when the 
slide was scanned using the Texas Red and TAMRA filters. Cross-talk is usually 
minimized using a number of strategies, including a careful choice of 
excitation/emission filters, use of lasers (monochromatic emission instead of 
polychromatic light) and appropriate dye sets. 187 
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incorporation of TAM RA-ddGTP. Right: expected pattern for primer extension (the letters A, C, G, 
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Figure 5.13 Normalised Fluorescence Intensitites (A,,= 585 nm) of 102 heteroduplexes after primer 
extension with four fluorescent dideoxynucleotides. The orange squares correspond to the 
fluorescence intensities of primers extended with TAMRA-ddGTP. The grey diamonds correspond 
to the fluorescence intensities of primers extended with the other three dideoxynucleotides. 
To reduce cross-talk between TAMRA and Texas Red channels, a different filter 
set emitter (602±1 3x/631±23nm) was selected for Texas Red. However, the two 
dyes could still not be discriminated. As confirmed by the filter manufacturer 
(Chroma), TAMRA and Texas-Red are difficult to distinguish using microarray 
imagers with white light source. 
A similar dye set (Cy5, Texas Red, TAM RA, R-1 10 G) was used by Syvanen in a 
four color multiplexed minisequencing experiment in 2002136.  In this work, cross- 
talk between different channels was reduced using lasers instead of a light source 
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imager. However, they also reported that the fluorescence signals of primers 
extended with a ddNTP labelled with TAMRA could be detected when a Texas Red 
filter was used. 
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Figure 5.14 Huorescence Image (scanned using a Texas Red filter) of DNA duplexes after 
incorporation of TxR-ddATP. Right: expected pattern for primer extension (the letters A, C, G, I 
indicate the base expected to be incorporated in the DNA duplex immobilised onto the slide). 
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Figure 5.15 Normalised Fluorescence Intensitites (X cm= 645 nm) of 102 heteroduplexes after primer 
extension with four fluorescent dideoxynucleotides. The pink squares correspond to the fluorescence 
intensities of primers extended with TxR-ddATP. The grey diamonds correspond to the fluorescence 
intensities of primers extended with the other three dideoxynucleotides. 
5.5.2 Analysis of enzymatic primer extension 
The single nucleotide primer extension assay was primarily performed to gain 
experience on primer extension on chips and to provide information useful for our 
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next goal: primer extension using protease cleavable nucleotides. The enzymatic 
assay showed that: 
The hybridisation was specific 
Our microarray imager was able to distinguish Cy5, Fluorescein and 
TAMRA but that cross-talk occurred between Texas Red and TAMRA 
channels. 
Thermo Sequenase DNA polymerase was able to incorporate ddCTP and 
ddUTP accurately. Incorporation of ddGTP and ddATP was more difficult 
to evaluate due to cross-talk between channels. 
As mentioned in Chapter 2 and 3, the dyes originally selected for labelling our 
protease cleavable nucleotides were Cy3, Cy3.5, Cy5, Cy5.5. 
These dyes have different absorption/emission spectra, similar chemical/physical 
properties and high fluorescence intensity. In addition, they could be easily 
synthesized following the protocol described in Chapter 2. 
However, the single nucleotide primer extension assay suggested that this set of 
cyanine dyes would require mathematical corrections and post-processing analysis 
due to overlap of their signals in different channels (Cy3 and Cy3.5 have similar 
spectra to TAMRA and Texas Red). The same observation was also reported in the 
work published by Richert where the same dye set was used for labelling specially 
modified phosphoramidates.' 37 
5.6 Primer Extension using Protease Cleavable Fluorescent Nucleotides: 
proof-of-principle experiments. 
5.6.1 Incorporation of dUTP-(A)3- Rho 
Encouraged by the results obtained in the solution tests (Chapter 4) and on the 
microarray using fluorescent ddNTPs, enzymatically cleavable nucleotides were 
tested in chip-based primer extension reactions. Arrays of four short synthetic 
primer/template duplexes with known sequences were used to demonstrate the 
feasibility of the technique. Each primer (Table 5.3) was spotted in a 10 x  10 
pattern, in duplicate. The fluorescent primer used as printing control was detected 
using a FITC filter (Figure 5.16-a). Hybridisation with complementary synthetic 
DNA templates was performed in an automated hybridisation chamber. The 
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fluorescence signals of fluorescently labelled templates used as hybridisation 
controls are shown in Figure 5.16-b. Then, the primed templates were incubated at 
55 °C for 15 min with Thermo Sequenase DNA polymerase (IU/l1.tL) and dUTP-
(A)3- Rho (2.5 l.LM)  in Thermo Sequenase reaction buffer (lx). 
At the beginning of our investigation, the incubation time for primer extension in 
our experiments was lh. However, we found that an incubation time of 15 min was 
adequate for all primer extension experiments. 
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Figure 5.16 Left: a) fluorescence image (scanned using a FITC filter) of a CodeLink slide after 
immobilisation of 5'-amino modified primers; b) fluorescence image (scanned using a FITC filter) 
of a CodeLink slide after hybridisation of complementary templates; c) fluorescence image (scanned 
using a Cy3 filter) of a CodeLink slide after incorporation of dUTP-(A) 3 -Rho by Thermo Sequenase 
DNA polymerase; Right: expected pattern. Fluorescein is represented in green. Rhodamine is 
represented in red. 
Scanning using the appropriate filter for the detection of rhodamine (Figure 5.16-c) 
showed that all primers were efficiently extended except the controls in position P1 
and P3 (primers labelled with fluorescein in the 3' position). The data shown in 
Figure 5.16 demonstrated qualitatively that Thermo Sequenase polynierase was 
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able to incorporate our modified nucleotide in all primers and that, as expected, the 
labelled nucleotide did not bind in a non-specific manner to the DNA duplexes. 
Primer/Template duplexes Position 
5 1 -H 2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-F1-3' P1/P3 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
5'-H 2N-TTT TTT CAG GAC CTA GAA CGG GCA GC -3' P2/P4 
3'-GTC CTG GAT CTT GCC CGT CGA TCA G-5' 
5'-H 2N-TTT TTT TAT GAC ACC GTC ATC AGC AG -3' P5 / P7 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
5'-H 2N-TTT TTT CCT TCT TGC TGG CAC CCA AT -3' P6/P8 
3'-GGA AGA ACG ACC GTG GGT TAA TCA G-5' 
Table 5.3 Oligonucleotide Sequences and their positions as shown in Figure 5.17. Fl = fluorescein. 
5.6.2 Two Steps in One: Hybridisation & Extension 
All polymerase reactions, previously described, were performed with double 
stranded DNA already immobilised onto the chip. Each primer extension 
experiment consisted of three steps: 
printing of primers onto the chip 
hybridisation of DNA templates 
primer extension by DNA polymerase. 
To reduce the number of steps necessary for each experiment, steps 2 and 3 were 
carried out together by adding to the slide a reaction mixture containing DNA 
templates, enzymatically cleavable nucleotides and Thermo Sequenase DNA 
polymerase in its reaction buffer. DNA primers and templates used in this 
experiment are shown in Table 5.4. 
The reaction mixture was first preheated at 90 °C and then added to the slide. 
Annealing of DNA templates and incorporation of dUTP-(A) 3-Rho were carried out 
at 55 °C for I h. Afterwards, the slide was cooled down to 35 °C and scanned using 
the appropriate filter for the detection of rhodamine (Figure 5.17). The primers 
printed in the subarray P1 were modified in the 3' position with fluorescein in order 








Figure 5.17 Left: fluorescence image of a CodeLink slide (scanned using a Cy3 filter) after primer 
extension with dUTP-(A) 3-Rho. Right: expected pattern. The primers are immobilised on the slide 
(in brown) and hybridised to complementary DNA templates. Primers and templates used as printing 
and hybridisation controls are labelled with fluorescein (green star). Rhodamine is represented by a 
red star. 
Primer/Template duplexes Position 











TCA TCA G-1I-5' 
P 
5'-H 2N-TTT TTT CAG GAC CTA GAA CGG GCA GC - 
3'-GTC CTG GAT CTT GCC CGT CGA TCA G-5'  
P2 











TCA TCA G-F1-5 
P3 
5 1 -H 2N-TTT TTT CCT TCT 










TA TCA G-5'  
p4 
Table 5.4 Oligonucleotide Sequences and their positions as shown in Figure 5.17. Fl = fluorescein 
Generally, DNA Sequencing by Synthesis requires all the nucleotide analogues 
labelled with different dyes to be added simultaneously to the slide for decoding the 
sequence of the DNA templates. 
Before reaching this phase, it is critical to prove that each nucleotide analogue is 
incorporated faithfully by DNA polymerases. Experiments were therefore carried 
out aimed at evaluating the performance of the sequencing by synthesis method 
using a unique label and adding one base at the time. After proving that dUTP-(A)3-
Rho could be incorporated into a growing DNA strand, single nucleotide primer 
extension was performed using nucleotide analogues labelled with different dyes 
(Cy5, Cy3, and FITC). All these nucleotides could be efficiently incorporated by 
the polymerase Thermo Sequenase. 
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5.6.3 Incorporation of dCTP-(A)3-FITC 
The polymerase reaction was also carried out with the nucleotide dCTP-(A)3-FITC. 
The primers (Table. 5.5) immobilised onto the slide and hybridised to 
complementary DNA templates were extended by Thermo Sequenase DNA 
polymerase, as described in the section 5.6.2. After washing the slide with 
appropriate buffers, the extension of the primer by the fluorescent nucleotide dCTP 
was confirmed by scanning the slide, using a FITC filter (Figure 5.18). The primers 
immobilised in the sub-array P1 were not extended during the polymerase reaction. 
The fluorescent signals corresponding to this sub-array were attributed to the 
primers used as printing control (primers modified in the 3' position with 
fluorescein) and to the complementary DNA templates (labelled in the 5' position). 
Primer/Template duplexes Position 
5'-H 2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-F1-3' P1 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
5-H 2N-TTT TTT GGT GGA GAA CTG CCA GCT C-3' P2 
3 1 -CCA CCT CTT GAC GGT CGA GAC TCG GAC G-5' 
5'-H 2N-TTT TTT TAT GAC ACC GTC ATC AGC AGC-31 P3  
3-ATA CTG TGG CAG TAG TCG TCG TCA G-F1-5' 
5 1 -H 2N-TTT TTT TCT GGA TGA ATA CTG CAG CTG C-3 
3-AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G-5' 
Table 5.5 Oligonucleotide Sequences and their positions as shown in Figure -').18. H = iluorescein 
Pi P2 
P3 P4 
Figure 5.18 Left: fluorescence image of a CodeLink slide (scanned using a FITC filter) after primer 
extension with dCTP-(A) 3-FITC. Right: expected pattern. The primers are immobilised on the slide 
(in brown) and hybridised to complementary DNA templates. The primers printed in the sub-array 
P1 were used as printing controls and were modified in the 3' position with fluorescein. Fluorescein 
is represented by a green star. 
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5.6.4 Incorporation of dCTP-(A)3-Cy5 (hydrophobic) 
Primer extension was carried out also using dCTP-(A) 3-Cy5 and Thermo Sequenase 
DNA polymerase, in the same conditions described above. This experiment was 
aimed at evaluating the incorporation of dCTP-(A)3-Cy5 by a DNA polymerase for 
application in dual color polymerase reactions and multiple extensions. 
dCTP-(A) 3-Cy5 was preferred to dCTP-(A)3-FITC as it was available in higher 
amounts. In addition, pH sensitivity and photo bleaching made 5(6)-
carboxyfluorescein less suitable than Cy dyes for this application. 162 
Preliminary tests carried out using dCTP-(A)3-Cy5 (labelled with Cy5 hydrophobic) 





Figure 5.19 Left: fluorescence image of a CodeLink slide (scanned using a Cy5 filter) after primer 
extension with dCTP-(A) 3 -Cy5. Right: expected pattern. The primers are immobilised on the slide 
(in brown) and hybridised to complementary DNA templates. Primers and templates used as printing 
and hybridisation controls are labelled with fluorescein (green star). Cy5 is represented by a blue 
star. 
Scanning of the chip, using the filter for the detection of Cy5, revealed that the 
primers in the subarray P1, used as printing control, were also fluorescent, though 
they could not be extended because of their modification with fluorescein at the 3' 












P1 	 P3 	 P2 P4 
Figure 5.20 Normalised Fluorescence Intensity (A. c ,= 680 nm) calculated for the subarrays (P1P4), 
shown in Figure 5.20. The error bars represent SEM. 
After incorporation, the slides were washed with buffers at different stringency (salt 
concentration), but non-specific binding could not be completely removed. 
It is known that cyanine dyes are able to interact with DNA by intercalation but also 
by groove binding. 188  Although, the presence of two methyl groups in the 
indolenine ring creates steric hindrance and therefore is expected to make difficult 
the intercalation of the dye in the minor groove. 
The dye used for the labelling of the nucleotide Cy5(A) 3 -dCTP had a single positive 
charge which might have favoured electrostatic interactions with the negatively 
charged DNA. In addition, the hydrophobic nature of the dye might have favoured 
the interaction with the bases. 
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5.7 Primer Extension using Protease Cleavable Fluorescent 
Nucleotides: Optimisation 
To avoid non specific interaction of dyes with immobilised DNA, water soluble 
cyanine dyes bearing sulfonate groups (negative charges) on the indolenine ring 
were prepared. Their synthesis has been extensively discussed in Chapter 2. 
As mentioned, the water soluble cyanine dyes Cy3, Cy3.5, Cy5 and Cy5.5 were 
chosen as fluorescent labels for our nucleotide analogues. 
However, the synthesis and purification of all the range of water soluble cyanine 
dyes is difficult and time-consuming and, at this stage of the project, the solid phase 
protocol for their preparation was not yet optimised. Therefore, before proceeding 
to the synthesis of all hydrophilic cyanine dyes needed for the labelling of the four 
nucleotides, it was decided first to carry out preliminary tests to verify the 
feasibility of using two enzymatically cleavable nucleotides labelled with the 
sulfonated cyanine dyes Cy3 and Cy5 and to optimise the protocol for dual color 
primer extension reactions on chip. 
5.7.1 Dual color primer extension 
A full SBS-based approach requires all four reversible terminators to be added 
simultaneously to the slide for decoding the DNA sequences by identifying the dye 
detected at each cycle of the DNA extension. 
Fluorescent cleavable dNTPs were evaluated for their ability to behave as DNA 
polymerization "deblockable" terminators in dual color extension experiments. 
These experiments would give important insights towards the improvements needed 
for reducing misincorporation and other undesired events. 
It was verified first that the enzymatically cleavable nucleotides labelled with 
sulfonated cyanine dyes were not binding to DNA in a non-specific way. 
Two DNA primers (Table 5.6) were printed onto a CodeLinkTM  slide (6 spots for 
each primer) and then hybridised to complementary DNA templates. 
Primer/Template duplexes 	 Position 
5'-H 2N-TTT TTT CAG GAC CTA GAA CGG GCA GC-F1-3' 	 Pi 
3'-GTC CTG GAT CTT GCC CGT CGA GAG AGA GAG-F1-5' 
5'-H 2N-TTT TTT CAG GAC CTA GAA CGG GCA GC -3' 
P2 
3'-GTC CTG GAT CTT GCC CGT CGA GAG AGA GAG-F1-5'  
Table 5.6 DNA sequences and their positions as shown in Figure 5.21. Fl = fluorescein. 
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A DNA primer and a DNA template labelled with fluorescein were used as printing 
and hybridisation controls. Figures 5.21-A and 5.21-B show the fluorescence 
signals of the labelled nucleotides after printing and after hybridisation. The 
polymerase reaction was carried out in the presence of Thermo Sequenase DNA 
polymerase and the protease cleavable nucleotide dUTP-(A)3-Cy3, labelled with 
sulfonated Cy3. The slide was then scanned using a Cy3 filter. The correspondent 
fluorescence image (Figure 5.21-C) shows that dUTP-(A)3-Cy3 was correctly 
incorporated into the primer of the subarray P2 producing a red signal when excited 
at 546 run. The primer of the subarray P1, labelled in the 3' position with 
fluorescein and used as control for the printing, was not extended and therefore was 






Figure 5.21 Left: A) Fluorescence image of the slide, scanned using a FITC filter, after primer 
printing. The fluorescent primers in P1 were modified with fluorescein in the 3' position; B) 
Fluorescence image of the slide, scanned using a FITC filter, after hybridisation. The fluorescent 
spots correspond to the primer and to the template used as printing and hybridisation controls; C) 
Fluorescence image of the slide, scanned using a Cy3 filter, after incorporation of dUTP-(A) 3-Cy3. 
Right: expected pattern. Fluorescein is represented by a green star and Cy3 by a red star. 
The fluorescence intensities of the primers of the subarrays P1 and P2, measured 
after scanning the slide with a Cy3 filter, are shown in Figure 5.22. 
To verify the ability of Thermo Sequenase DNA polymerase to incorporate the 
correct nucleotide complementary to the corresponding base on the template, seven 
different primers (Table 5.7) were immobilised on the CodeLinkTM slide, hybridised 
to complementary DNA templates and extended with a mixture of dUTP-(A) 3 -Cy3 
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P1 P2 
Figure 5.22 Normalised fluorescence intensities, measured using a Cy3 filter, of the primers in P1 
and P2. The error bars represent SEM. 
The incorporation of dUTP-(A) 3-Cy3 into the DNA primers was detected using a 
Cy3 filter (Figure 5.23-A). The incorporation of dCTP-(A)3-Cy5 was detected using 
a Cy5 filter (Figure 5.23-B). The DNA polymerase Thermo Sequenase incorporated 
the base U with high specificity; only the primers (in P1, P2, P4, P6) hybridised to 
DNA templates containing the base "A" next to the annealing site were extended, 
as expected (Figure 5.23-A). The sequences of the DNA duplexes in PI-P7 are 
shown in Table 5.7 (the base expected to be incorporated in each primer is shown in 
colour). 
Primer/Template duplexes Position 











CGA GAG AGA GAG-5' 
P1 













TAA GAG AGA GAG-5' 
P2 











GAC TCG GAC G-5' 
p3 










CCT C -3' 
GGA GAG ACT ACT ACG A-5' 
p4 









GCA CAT CGT-5' 






GCA TTT 	-3' 
CGT AAA ACT GAT ACT G-5' 
P6 








GAA CAA TTT TTC 
CTT GTT AAA AAG 
G-3' 
CTT CTG TGC T-5' 
Table 5.7 DNA sequences used in dual colour primer extension and their positions as shown in 
Figure 5.23. 
The fluorescence intensities of the extended primers, measured using the FIPS 
software (LaVision BioTech) are shown in Figure 5.24 (? m = 585 nm) and 5.25 
(Xcm 68Onm). 
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The only primers that were expected to incorporate the nucleotide dCTP-(A) 3-Cy5 
during polymerase reaction and to produce a fluorescence signal with Acm = 680 flifl 
(Cy5 emission) were the ones printed in P3 and P5. However, also the primers in P1 
and P2, produced a fluorescence signal when the slide was scanned using a Cy5 
filter (Figure 5.23-B). The average fluorescence intensities calculated for the 
primers in P1 and P2 (1.44 10 5 and 8.8 104  ) at Aem = 680 nm are high, considering 
that they were not expected to be fluorescent in the blue channel and that the 
fluorescence intensities of the primers in P3 and P5 are relatively similar (1.3 10 
and 1.6 1 0) (Figure 5.24 and 5.25). 
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Figure 5.23 Fluorescence image of a CodeLink slide after dual colour primer extension. A) scanned 
using a Cy3 filter to show the incorporation of dUTP-(A) 3-Cy3; B) scanned using a Cy5 filter to 
show the incorporation of dCTP-(A) 3 -Cy5. PI-P7 indicate the primers immobilised onto the slide. 
Each primer is printed in 6 duplicates on the same row. 
There are different possible explanations to this result. Reagent purity, polymerase 
fidelity, mispriming, non specific binding of dyes, and multiple incorporations (see 
sequences in P1 and P2, Table 5.7) can all be source of false-positive signals 189  in 
primer extension experiments. 
One possible explanation is that multiple incorporations occurred for the primers in 
P1 and P2. Indeed, these two primers were hybridised to DNA templates containing 
repeats of identical adjacent bases (AG) (Table 5.7), therefore there is a possibility 





Figure 5.24 Normalised fluorescence intensities (= 585 run) of the primers in P1-P7. The error 
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Figure 5.25 Normalised fluorescence intensities (A= 680 rim) of the primers in P1-P7. The error 
bars represent SEM. 
However, the results reported in the Chapter 4 have shown that the enzymatically 
cleavable nucleotides have termination properties. In addition, the primers P3 and 
P4 (Table 5.7), hybridised to DNA templates containing the bases "AG" or "GA" 
next to the annealing site, were detected predominantly either at Aem = 585 nm or at 
X. = 680 nm, proving that they did not incorporate both nucleotides. 
An alternative explanation to the result obtained in the dual colour primer extension 
experiment is that misincorporation of nucleotides by DNA polymerase occurred 
for the primers in P1 and P2. Misincorporations are very frequent in polymerase 
reactions and they can be sequence-dependent.' 90,191 
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During primer extension reactions, DNA polymerases incorporate preferably 
complementary bases rather than non-complementary bases. In addition, they have 
exonuclease activity; therefore they can remove misincorporated nucleotides 
However, DNA polymerases with exonuclease proofreading activity cannot be used 
in SBS66  (and in general, in DNA sequencing) because sequencing primers would 
be digested and labelled nucleotides would not be efficiently incorporated. 
Therefore Thermo Sequenase,' 92 ' 93 an exonuclease-deficient DNA polymerase' 
94 
with mutations evolved to efficiently incorporate labelled nucleotides, was selected. 
Thermo Sequenase is generally used in combination with a thermostable inorganic 
pyrophosphatase, which is needed to remove the pyrophosphate produced during 
extension reactions. Published works showed that, by optimising reaction time and 
conditions, the likelihood of misincorporation can be reduced and polymerase 
fidelity improved. 66189" 95 
In addition, literature 66,189  and our experimental results suggested that non specific-
events, such as misincorporation can be reduced when multiple DNA sequences are 
used or when all dNTPs are added simultaneously. 
To reduce the probability of misincorporations, dual color extension experiments 
were carried out using different concentrations of primers, templates, nucleotides 
and enzyme. These factors' 95  are known to affect the enzyme fidelity. In addition, 
as Thermo Sequenase is relatively expensive and our nucleotides are not 
commercially available, it was desirable to find the minimum amount of enzyme 
and nucleotides that provided acceptable results. The following conditions provided 
the best results in terms of signal intensity and specificity: 20 tM solution of primer 
for printing, 2 tM solution of DNA template, 1 U/tL of Thermo Sequenase and 2.5 
tM solution of nucleotide. Experimental results of concentration gradient 
experiments are reported in the Appendix. 
5.8 	Removal of the Fluorophore and Second extension 
Complete removal of the fluorophore from extension products is critical for the 
successful application of enzymatically cleavable nucleotides in SBS. 43 HPLC and 
MALDI-TOF analyses proved that the fluorophore Rhodamine B could be released 
completely after incubation of the extended primer with the protease subtilisin at 37 
°C for 10 mm (Chapter 4). 
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Encouraged by this result, the enzymatic cleavage of the fluorophore from the 
labelled nucleotides, after their incorporation in DNA primers immobilised on 
CodeLinkTM slides, was investigated. 
Our aim was to prove that the enzyme subtilisin: 
I. was compatible with the surface of CodeLinkTM  slides and the reaction 
conditions 
could efficiently and rapidly remove the fluorophore from extended primers 
to allow the interrogation of next positions in the template 
could be efficiently removed from the slide by washing, to avoid digestion 
of Thermo Sequenase during the next cycle of the polymerase reaction 
DNA duplexes (Table 5.8) immobilised on CodeLinkTM  slides were treated with 
Thermo Sequenase DNA polymerase and dUTP-(A)3-Cy3. The primers in P2, P3, 
P4, P5 hybridised to DNA templates, having the base "A" next to the annealing site, 
were extended producing a fluorescent signal (? em = 585 nm) when scanned with a 
Cy3 filter (Figure 5.26-A). The primer P1 was not extended because it was 
modified in the 3' position with fluorescein (printing control) while the primer P6 
had the base "C" next to the annealing site, therefore could not incorporate the base 
"U" (Table 5.8). 
Primer/Template duplexes Position 
5 1 -H 2N-TTT TTT TAT 












TCA TCA G-F1-5' 
P1  
5 1 -H 2 N-TTT TTT TAT 












TCA TCA G-F1-5' 
P2 
5'-H 2N-TTT TTT AAA TAC 







CCT C G 
GGA GAC 
3' 
TAC TAC GA-5' 
P3 
5 1 -H 2N-TTT TTT GTG 
3 1 -CAC 
GAG 
CTC 
TGT TTG TTC 






TAC GAC TAC-5' 
p4 
5'-H 7N-TTT TTT CCT 












TAA GAG AGA GAG-5' 
5 1 -H 2N-TTT TTT CCG 







GAA CAA TTT TTC 
CTT GTT AAA AAG 
G-3' 
CTT CTG TGC T-5' 
P6 
Table 5.8 DNA sequences and their positions as shown in Figure 5.26. The bases expected to be 
incorporated are shown in colour. Fl = fluorescein. 
The slide was then incubated with the protease subtlisin, in an automated system 
(GenHyb4) for 15 min at 37 °C. The fluorophore was efficiently removed (? 95 % 
efficiency) and the red signal from Cy3 was almost completely removed, producing 
an image with fluorescence levels close to background (Figures 5.26-B and 5.27). 
To verify that primer extension could take place again after incubation of the slide 
with a protease and that the protease treatment could not interfere with next 
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incorporation, a polymerase reaction was carried out with dCTP-(A)3-Cy5 (labelled 
with Cy5 sulfonated) and Thermo Sequenase. The nucleotide was incorporated in a 
specific manner only into the primer P5 (as expected) producing a strong signal in 
the blue channel (Figure 5.26-C). Afterwards, the fluorophore was removed by 
protease cleavage (Figure 5.26-D). 
A ii: 
Protease Cleavage 





Figure 5.26 A) Fluorescence image of a CodeLink slide after primer extension with dUTP-(A.;-( y 3 
(, = 585 am); B) after protease cleavage (A = 585 nn); C) after primer extension with dCTP-
(A)3-Cy5 (m = 680 nm); D) protease cleavage (A = 680 nm). 
The fluorescence intensities were measured for all primers at each step using the 
FIPS software (La Vision BioTech) (Figure 5.27). 
Figure 5.27 Fluorescence intensities of the primers in P1 -P6: after the first extension (red bars) and 
after the first protease cleavage (pink bars) (A cm = 585 am); after the second extension (light blue 
bars) and after the second cleavage (dark blue bars) (A = 680 nm). 
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5.9 	Conclusion 
In order to obtain an efficient SBS sequencing technology, the following 
requirements must be met: 
I. Amplification of DNA with high throughput methods rather than standard 
cloning techniques. 
Use of a format that allows each template to be probed multiple times and in 
parallel. 
Nucleotides must be reversible terminators so that only a single nucleotide 
is added each step during Sequencing by Synthesis technology. 
The reversible terminator must be efficiently incorporated and the 
fluorescent label easily removed after detection for subsequent nucleotide 
addition. 
Washing and reagents additions between detection cycles must be rapid and 
simple. 
In this chapter, we have proved that enzymatically cleavable nucleotides could be 
efficiently incorporated into growing DNA strands during primer extensions on 
chip, independently from the fluorophore used for the labelling. Furthermore, we 
have shown that the fluorescent label could be easily removed by incubation of the 
extension products with a protease to allow the next incorporations to take place. 
Two SBS cycles were run successfully, allowing the nucleotides dUTP-(A)3-Cy3 
and dCTP-(A)3-Cy5 to be incorporated in two consecutive steps. 
In addition, we have optimised the enzymatic assay through an opportune choice of 
the chip surface, fluorophores and DNA sequences. 
These preliminary experiments proved that our novel SBS method is a promising 
technology, but showed also that many challenges need to be addressed for the 
implementation of this technique. Additional work will be required to test our 
nucleotides with many different DNA sequences, to increase the read-length, 




6.1 	Experimental for Chapter 2 
General Information 
Unless otherwise noted, all solvents and reagents were obtained from commercial 
sources and used without further purification. 1 H NMR and ' 3C NMR spectra were 
recorded at 298 K on a Bruker ARX250 spectrometer (at 250 MHz and 62.9 MHz), 
on a Bruker DPX360 spectrometer (at 360 MHz and 90.5 MHz) and on a Bruker 
DMXSOO (at 500 MHz and 126 MHz), respectively. Gel phase ' 3C NMR spectra 
were recorded on a Bruker DPX 360 spectrometer. Chemical shifts are reported on 
the 8 scale in ppm, using the residual protio solvent as the internal standard. 
Coupling constants (J) are reported in Hz. Symbols such as t (dd), and td (ddd) 
indicate apparent patterns with the results of detailed analyses in parentheses. 
Polymer-bound imidates and hemicyanine could not be analysed by gel-phase 13C 
NMR. Only the imidate 6a could be analysed. Melting points were determined 
using a Gallenkamp melting point apparatus and are uncorrected. Microanalysis 
were performed by MEDAC Ltd., Surrey. Elemental analysis was carried out for 
all the imidates and for one hemicyanine for each class (tn-, penta- and 
heptamethine) to determine the loading efficiency. IR spectra were recorded on a 
FTIR Bruker Tensor series spectrometer with ATR Golden Gate. All samples were 
run neat. Microwave-assisted reactions were performed on either a Biotage 
Initiator 2.0 or a Biotage Smith Synthesizer. Absorption spectra were recorded on 
an 8453 Agilent UV-Visible spectrophotometer. Fluorescence emission spectra 
were recorded on a Jobin Yvon Fluoromax spectrofluorimeter. Analytical thin 
layer chromatography (TLC) was performed on Merck silica Gel 60-F254 plates 
(0.25 mm) with visualizion by ultraviolet (UV) irradiation at 254 rim. Purifications 
by flash chromatography were performed using Merck silica gel 60 (230-400 
mesh). ESI-MS analyses were carried out on an Agilent Technologies LC/MSD 
1100 Series quadrupole mass spectrometer (QMS) equipped with an electrospray 
ionisation source. Major peaks are reported with percentage intensities of the base 
peak. 
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Electrospray high resolution mass spectrometry was performed on a Finnigan 
MAT 900 XTL spectrometer. 
High performance liquid chromatography was carried out on an Agilent 
Technologies HP1 100 Chemstation system coupled to a Polymer Lab 100 ES 
evaporative light scattering detector, eluting with (A) 0.1% TFAIH20, (B) 0.04% 
TFAI MeCN, (C) 0.1% formic acidIH20, (D) 0.10% formic acidlMeOH using the 
methods described below. 
HPLC System I 
Column: Phenomenex Gemini, C18, 110 A, 100 mm x  4.6 mm, 5 p.m. Flow rate: 
1.0 ml, min'. Eluents C and D. Gradient: 95% to 5% C over 6 mm, then 5% C for 
3 mm, then 5% to 95% C over 1 mm. Detection: UV and ELS detection. 
HPLC System II 
Column: Discovery (Supelco) Cl 8, 50 mm x  4.6 mm, 5 p.m. Flow rate: 1.0 mL 
min- '. Eluents A and B. Gradient: 95% A to 5% A over 5 mm, then 5% A for 3 
mm, then 5% to 95% A over 1 mm. Detection: UV and or ELS detection. 
HPLC System III 
Column: Phenomenex Luna, C18(2), 150 mm x  4.6 mm, 100 A. Flow rate: 1.0 ml, 
min- '. Eluents A and B. Gradient: 95% A to 5% A over 8 mm, then 5% A for 6 
mm, then 5% to 95% A over 1 mm. Detection: UV and or ELS detection. 
PREPARATION OF INDOLENIUM SALTS 
1,2,3,3-tetramethy1-3H-indo1ium 	10196 
Classical method 
A mixture of 1,1,2-trimethylindole (40.10 mL, 0.25 mol) and methyl iodide (38.90 
mL, 0.625 mol) in acetonitrile (150 mL) was heated under reflux (110 °C) for three 
days. The reaction mixture was cooled to room temperature and evaporated. The 
residue obtained was washed with diethyl ether several times and then with ethanol 
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until removal of the starting material. The residue was dried in vacuo to give a 
white/pink solid (64.3g, 84%). 
Microwave-assisted alkylation 
A mixture of 2,3,3-trimethyl-3H-indole (0.25 mL, I .6mmol) and methyl iodide 
(0.6 mL, 9.6 mmol) in acetonitrile (1 mL) was heated in a sealed vial at 150 °C for 
30 mm, under microwave irradiation. After cooling to room temperature, the pink 
precipitate was collected by filtration, washed with diethyl ether, ethanol and then 
dried in vacuo to give a white/pink solid (457 mg, 94%). 
Rf: 0.50 (DCM:MeOH 9/1) 
HPLC tR = 4.54 mm, 100% (ELSD) 
MS (ES): m/z (%) 174.2 [M, 100], 175.2 [(M+l), 14] 
'H NMR 8 (250 MHz, DMSO): 6 7.90-7.86 (in, 1H), 7.82-7.78 (m, 1H), 7.63-7.54 
(m, 2H), 3.94 (s, 3H), 2.74 (s, 3H), 1.49 (s, 6H) 
' 3C NMR (62.9 MHz, DMSO): 8 196.34 (C=N), 142.45 (C), 141.95 (C), 129.66 
(CH), 129.16 (CH), 123.65 (CH), 115.48 (CH), 54.28 (C), 35.11 (CH3), 22.06 
(CH3), 14.56 (CH3). 
FTIR 3013, 2964, 2360, 1630, 1480, 988, 938 cm' 
Mp 219 °C (lit. 219-220 oC) 197 
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1,1,2,3-tetramethyl-1H-benzo[e]indolium iodide' 97"98 
14b 
A mixture of 1,2,2-trimethyl-1H -benz[e]indole (55.1 g, 0.26 mol) and methyl 
iodide (40.50 mL, 0.65 mol) in acetonitrile (250 mL) was heated under reflux at 
100 °C for 2h. The reaction solution was cooled to room temperature and 
evaporated. The residue obtained was washed with diethyl ether several times and 
then with ethanol until removal of the starting material. The residue was dried in 
vacuo to give white/yellow solid (66g, 72%). 
Rf: 0.31 (DCM:MeOH 9/1) 
MS (ES): m/z (%) 224.2 [(M, 100], 225.1 [(M+1), 17] 
'H NMR 8 (250 MHz, DMSO): ö 8.36 (d, 1H, J = 8.28 Hz, Ar), 8.29 (d, 1H, J = 
8.96 Hz, Ar), 8.22 (d, 1H,J= 7.58 Hz, Ar), 8.11 (d, 1H,J = 8.90 Hz, Ar), 7.82-
7.68 (m, 2H), 4.19 (s, 3H), 2.97 (s, 3H), 1.84 (s, 6H) 
'3C NMR (62.9 MHz, DMSO): ö 196.26 (C=N), 139.83 (C), 136.86 (C), 133.38 
(C), 130.87 (CH), 130.10 (CH), 128.75 (CH), 127.48 (CH), 123.77(CH), 113.53 
(CH), 55.62 (C), 35.57 (CH3), 21.65(CH3), 14.50 (CH3) 
FTIR 3484, 3419, 2978, 1639, 1583, 1524, 1464, 1133, 800, 736, 704 cm -1 
HPLC tR = 4.80 mm, 100% (ELSD) 
Mp 221-223 °C (lit. 199 oC) 198 
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A mixture of 2,3,3-trimethyl-3H-indole (12.1 mL, 75.4 mmol) and 6-
bromoexanoic acid (30 g, 189 mmol) in acetonitrile (50 mL) was heated at 100 °C 
for 16h. The solution was cooled to room temperature and evaporated. The residue 
obtained was washed with diethyl ether and dichloromethane several times until 
removal of the starting material to give a white-grey solid (1 8g, 68 
Microwave-assisted alkylation 
A mixture of 2,3,3-trimethyl-3H-indole (0.25 mL, 1.6 mmol) and 6-bromoexanoic 
acid (936 mg, 4.8 mmol) in acetonitrile (1 mL) was heated in a sealed vial at 150 
°C for 1 hour under microwave irradiation. After cooling to room temperature, the 
solvent was evaporated. The residue obtained was washed with diethyl ether and 
dichloromethane several times until removal of the starting material and then dried 
in vacuo to give a white-grey solid (374 mg, 66 
Rf: 0.26 (DCM/MeOH 3:2) 
HPLC tR = 3.74 mm, 100% (ELSD, X= 220,254, 280 run) 
MS (ES): m/z (%) 274.2 [Mt, 100], 275.3 [(M+1), 19] 
'H NMR (250 MHz, DMSO): 8 12.34 (br s, 111, COOH), 8.23-8.19 (m, 111), 8.09-
8.06 (m,1H), 7.87-7.80 (m, 2H), 4.69 (t, 2H,J= 7.6 Hz), 3.91 (s, 3H), 2.44 (t, 211, 
J= 7.1 Hz), 2.12-2.00 (m, 2H), 1.83-1.61 (m, 101-I'). 
' 3C NMR (62.9 MHz, DMSO): 8 196.88 (C=N), 174.66 (C0), 142.23 (C), 
141.40 (C), 129.75 (CH), 129.30 (CH), 123.88 (CH), 115.87 (CH), 54.52 (C), 
47.82 (CH2), 33.73 (CH2), 27.31 (CH2), 25.77 (CH2), 24.38 (CH2), 22.37 (CH3), 
14.44 (CH3) 
IR (neat) 3449, 3195, 2817, 1693, 1624, 1481, 1459, 1290, 1174, 872, 775 cm 1 . 
Mp 138 °C (lit. 127-129 oC) 196 
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3-(5-carboxypentyl)-1,1,2-trimethyl-1H-benzo[elindolium bromide 196 
Br 
14d 
A mixture of 1,2,2-trimethyl-1H-benz[e]indole (15.8 g, 75.4 mmol) and 6-
bromoexanoic acid (30g, 189 mmol) in acetonitrile (50 mL) was heated at 120 °C 
for 2 days. The solution was cooled to room temperature and evaporated. The 
residue obtained was washed with diethyl ether and dichioromethane several times 
until removal of the starting material to give a pink-grey solid (23.4g, 77%) 
R: 0.14 (DCM/MeOH 3:2) 
HPLC tR = 4.54 mm, 100% (ELSD) 
MS (ES): m/z (%) 324.3 [M 1 , 100], 325.2 [(M±1)+, 35] 
'H NMR 8 (250 MHz, DMSO): 8 12.38 (br s, IH, COOH), 8.46 (d, IH, J = 8.2 
Hz), 8.37 (d, 1H, J= 8.9 Hz), 8.30 (dd, 111, J= 8.7, 1.4Hz), 8.26 (d, 1H, J = 8.9 
Hz), 7.89-7.77 (m, 2H), 4.68 (t, 2H, J = 7.5 Hz), 3.05 (s, 3H), 2.31 (t, 2H, J = 7.0 
Hz), 2.01-1.93 (m, 2H), 1.68-1.54 (m, 10H). 
13C NMR (62.9 MHz, DMSO): 8 196.74 (CN), 174.67 (C0), 138.86 (C), 
137.31 (C), 133.39 (C), 131.03 (CH), 130.07 (CH), 128.75 (CH), 127.58 (CH), 
123.78 (CH), 113.74 (CH), 55.85 (C), 48.07 (CH2), 33.74 (CH2), 27.52 (CH2), 
25.75 (CH2), 24.42 (CH2), 21.97 (CH3), 14.27 (CH3) 
IR (neat) 2864, 1707, 1474, 1389, 1156, 824, 715 cm 
Mp 234 °C (lit. 211-213 oC) 196 
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PREPARATION OF SULFONA TED INDOLENIUM SALTS 
Potassium 2,3,3-trimethy1-3H-indo1e-5-su1fonate 83 
0 
25 
Hydrazinobenzene sulfonic acid (15g, 79.5 mmol) and 3-methyl-2-butanone (25.2 
mL, 240 mmol) were dissolved in 45 mL of acetic acid. The mixture was heated to 
reflux for 3 h. Acetic acid was removed under vacuum. The residue obtained was 
dissolved in MeOH and then stirred with a saturated solution of potassium 
hydroxide in 2-propanol. The alkaline solution turned yellow and the potassium 
salt of the sulfoindole precipitated as yellow solid almost quantitatively (16.5 g, 
75%) 
Rf: 0.40 (RP, water) 
HPLC IR = 2.6 mm 
MS (ES): m/z (%) 238.0 [(M-1), 100], 238.9 [M, 12], 239.9 [(M+l), 5], 499.0 
[(2M+Na), 10]. 
'H NMR ( 360 MHz, DMSO) ö: 7.63 (d, 1H, J = 1.5 Hz, H-4), 7.56 (dd, 111, J 
7.9, 1.5 Hz, H-6),7.34 (d, 111, J= 7.9 Hz, H-7),2.21 (s, 311), 1.24 (s, 6H). 
'3C NMR (90.5 MHz, DMSO) : 188.67 (C=N), 153.12 (C), 146.91 (C), 144.68 
(C), 124.75 (CH), 118.80 (CH), 117.76 (CH), 52.89 (C), 22.12 (CH 3), 14.78 (CH3). 
IR (neat) 3377, 2966, 2360, 1607, 1572, 1421, 1388, 1180, 1121, 1063, 1029, 833, 
726 cm' 




The potassium salt of 2,3,3-Trimethyl-3H-indole-5-sulfonate (1 g, 3.6 mmol) and 
methyl iodide (2.2 mL, 18 mmol) were heated in acetonitrile under microwave 
irradiation at 150 °C in a sealed vial for 1 h. After cooling to room temperature, the 
solvent was decanted. The yellow-brown precipitate was suspended in diethyl 
ether, filtered, washed with diethylether and dichloromethane and dried in vacuo to 
yield a beige solid (0.86 g, 95%). 
Rf: 0.20 (RP, water) 
HPLC tR = 2.8 min 
MS (ES): m/z (%) 252.1[(M-1), 100], 253.1 [M, 10] 
'H NMR (360 MHz, DMSO) ö: 7.97 (s, IH, H-4), 7.82 (d, 1H, J = 8.3 Hz, H-7), 
7.77 (dd, 1H,J= 8.3, 1.3 Hz, H-6), 3.96 (s, 3H), 2.76 (s, 3H), 1.55 (s, 6H). 
' 3C NMR (90.5 MHz, DMSO): 8 198.32 (C=N), 150.63 (C), 143.45 (C), 142.69 
(C), 127.62 (CH), 119.29 (CH), 116.06 (CH), 55.47 (C), 36.37 (CH 3), 23.06 (CH3), 
15.85 (CH3). 
IR(neat) 3010, 2972, 2354, 1629, 1593, 1470, 1421, 1195, 1118, 1057, 1031 cm -1 





A mixture of potassium 2,3,3-trimethyl-3H-5-indolesulfonate (2.00 g, 7.2 mmol), 
6-bromohexanoic acid (4.20 g, 21.6 mmol) and potassium iodide (0.12 g, 0.7 
mmol) in 1,2-dichlorobenzene (20 mL) was refluxed at 150 °C for 48 h. The 
reaction was monitored by TLC (DCM:MeOH 4:1). After cooling the reaction 
mixture to room temperature, the flask was placed in the fridge for 1 h. After this 
time, a beige solid had formed in the purple solution. The solid was collected by 
filtration, then washed with dichlorobenzene, 2-propanolldiethylether (1:1 v/v) and 
finally with diethylether. After drying in vacuo, overnight, a beige solid was 
obtained (3.0 g, 89%) 
Microwave-assisted alkylation 
A mixture of potassium 2,3,3-trimethyl-3H-5-indolesulfonate (0.25 g, 0.9 mmol) 
and 6-bromohexanoic acid (0.53 g, 2.7 mmol) in a mixture (9:1) of acetonitrile and 
DMF (1 mL) was heated in a sealed vial at 150 °C for 3hs (3 cycles of lh each), 
under microwave irradiation. After cooling to room temperature, the solvent was 
evaporated. The residue obtained was washed with 2-propanolldiethylether (1:1 
v/v) and finally with diethylether and then dried in vacuo to give a beige solid (254 
mg, 80%). 
Rf 0.24 (RP, water) 
HPLC = 3.6mm 
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'H NMR (360 MHz, DMSO),8.02(s, 1H), 7.91 (d, 1H,.J=8.3 Hz), 7.82(d, 1H, 
J = 8.3, 1.1 Hz), 4.44 (t, 2H, J = 7.5 Hz), 2.83 (s, 3H), 2.22 (t, 2H, J = 7.1 Hz), 
1.88-1.77 (m, 2H), 1.57-1.38 (m, IOH). 
' 3C NMR (90.5 MHz, DMSO) 8 198.8 (C=N), 175.8(CO), 151.0 (C), 143.0 (C), 
142.4 (C), 127.8 (CH), 122.2 (CH), 116.4 (CH), 55.8 (C), 49.0 (CH2), 34.8 (CH2), 
28.4 (CH2), 26.9 (CH2), 25.5 (CH2), 23.4 (CH3), 15.6 (CH 3 ). 
MS (ES): m/z (%) 352.0 [(M-2), 100], 353.0 [(M-1), 181, 354.0 [M, 5], 705.2 
[(2M-3), 21]. 
IR (neat) 3039, 2949, 1704, 1474, 1381, 1236, 1154, 1117, 1024, 795 cm' 
Mp 235 °C 
N-('butoxycarbonyl)4-hydroxylaniline PS' 08 
BocHN 
17 
A mixture of N-( tbutoxycarbonyl)-4-hydroxylaniline (6.27 g, 30 mmol), Cs 2CO3 
(9.78 g, 30 mmol), 1(1 (0.17 g, I mmol) and 1% DVB cross-linked chioromethyl 
polystyrene (5 g, 10 mmol) in acetone (45 mL) was heated at 70 °C for 16 h. The 
resin was isolated by filtration, washed with water (4 x  100 mL), DMF (4 x  50 
mL), DCM (3 x  50 mL), Et20 (3 x  50 mL) and dried overnight in vacuo at 40 °C 
to give the product as a beige resin (quantitative by N analysis, 96% by Cl 
analysis). Found: N, 2.13; Cl, 0.27. Calcd: N, 2.08; Cl, 0%. IR (neat) 3399, 3024, 
2919, 1722, 1511, 1217, 1154, 698 cm'. ' 3C NMR (90.5 MHz, CDCI 3) 6 155.5 
(C=O), 154.0 (C-O), 13 1.5-125.5 (Ar-resin + C-N), 119.6 (Ar), 114.2 (Ar), 80.1 
(C), 70.2 (CH2), 40.2 (CH-resin), 28.4 (CH 3 ). 
Colorimetric test for the detection of chioromethyl groups in Merrifield 
resin ' 22 
A 75 mM solution of 4-(4-nitrobenzyl)pyridine in toluene with 5% of 
triethylamine (lmL) was added to 2mg of resin 17. No coloration was observed 
(naked eye). The colorimetric test was then repeated on 2 mg of Merrifield resin 
(1% DVB, 2mmol dig). The resin turned to pink. 
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4-aminophenol PS 108 
H2N 
18 
Resin 17 (5g, 7.5 mmol) was shaken at room temperature with a 20% solution of 
TFA in DCM (75 mL) for 2 h, filtered and washed with DCM (2 x  50 mL). The 
resin was then shaken with a 10% solution of triethylamine in DCM (75 mL) for 
15 mm, filtered, washed with DCM (4 x  50 mL), and dried overnight in vacuo at 
40 °C to give the product as a beige resin. Found: N, 2.56; Calcd: N, 2.33%. IR 
(neat) 3360, 3023, 2917, 1601, 1508, 1217, 698 cm'. ' 3C NMR (90.5 MHz, 
CDC13) ö 134.2-121.3 (Ar-resin, C-O, C-N), 116.1 (Ar), 115.8 (Ar), 70.5 (CH2 ), 
40.2 (CH-resin) 
1R!I f'lf\I 0 ! 
Ethyl 4-hydroxyphenylimidoformate PS 108 
EtON 
13a 
To 4-aminophenol PS 18 (2 g, 3.3 mmol) was added a solution of 
triethylorthoformate (7.50 mL, 45.1 mmol) and BF 3 OEt2 (0.46 mL, 3.7 mmol) in 
dry DCM (10 mL) and the solution stirred at room temperature for 6h. Dry DIEA 
(0.94 ml-, 5.51 mmol) was added and the mixture stirred for 5 mm. The resin was 
isolated by filtration, washed several times with DCM (20 mL), and dried in vacuo 
to give the product as a brown resin. 
Found: N, 2.29; Calcd: N, 2.14. IR (neat) 3024, 2920, 1639, 1503, 1184, 698 cm -1 . 
' 3C NMR (90.5 M1-[z, CDC13) 6 155.0 (CH), 123.1 (Ar), 115.6 (Ar), 71.3 (CH 2 ), 
63.3 (CH 2-Et), 41.5 (CH-resin), 15.4 (CH 3 -Et). 
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To ethyl 4-hydroxyphenylimidoformate PS 13a (1 g, 1.53 mmol) and 1,2,3,3-
tetramethyl-3H-indoliuni iodide (2.3 g, 7.65 mmol) was added DMF (8 mL) and 
the mixture stirred at 120 °C for 15 min under microwave irradiation. After 
cooling, the resin was isolated by filtration, washed with DMF (3 x  10 mL) and 
DCM (3 x  10 mL), and dried in vacuo to give the product as an orange resin (0.72 
mmolg', 66% by N analysis). Found: N, 2.03; Calcd: N, 3.08. IR (neat) 3024, 
2916, 1668, 1506, 1451, 1225, 1014, 907, 824, 754 cm-1 . 







To ethyl 4-hydroxyphenylimidoformate PS 13a (1 g, 1.53 mmol) and 1,1,2,3- 
tetramethyl-1H-benz[e]indolium iodide (2.7 g, 7.65 mmol) was added DMF (8 
mL) and the mixture stirred at 120 °C for 15 min under microwave irradiation. 
After cooling, the resin was isolated by filtration, washed with DMF (3 x  10 mL) 
and DCM (3 x  10 mL), and dried in vacuo to give the product as a dark red-brown 
resin. IR (neat) 3024, 2916, 1685, 1506, 1451, 1206, 1014, 823, 751, 704 cm' 
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2-{( I E,3E)-3-I 1 -(5-carboxypentyl)-3,3-dimethyl- 1 ,3-dihydro-2H-indol-2- 
ylidenel -1-propenyl} -1 ,3 ,3-trimethyl-3H-indolium Inner salt' 
6 C:!:7CaN 





To PS-bound hemicyanine 15a (1.1 g, 0.80 mmol) were added dry pyridine (5 
mL), DIEA (1.3 mL, 7.4 mmol), Ac 20 (0.7 mL, 7.4 mmol) and 1-(5-
carboxypentyl)-2,3,3-trimethyl-3H-indolium bromide (35 mg, 0.10 mmol). The 
mixture was stirred at room temperature for 2 h. Afterwards, the resin was 
removed by filtration and washed several times with DCM (10 mL). The filtrates 
were combined and evaporated and the resulting solid was dissolved in DCM (15 
ml-) and washed several times with water (10 mL). After removal of the solvent in 
vacuo, the crude product was precipitated in Et 20, washed with Et20 and then 
purified by chromatography (DCM -). DCM/MeOH 1:1) to give 20a as a dark 
glassy red solid (31 mg, 68%). 
R1 0.42 (DCMIMeOH 9:1) 
HPLC tR = 10.7 mm, 100% (ELSD, X= 550 nm). 
MS (ES): m/z (%) 457.2 [Mt, 100], 458.2 [(M+ 1) + , 31], 459.2 [(M+2), 4] 
1 H NMR (360 MHz, CD30D) 8 8.55 (t (dd), IH, Jj, J2,3 = 13.5 Hz, CH-H2), 
7.55 (d, 2H, I = 7.4 Hz, Ar-H4, Ar-H4'), 7.53-7.48 (m, 2H, Ar-H6, Ar-H6'), 7.36 
(d, 2H, I = 7.8 Hz, Ar-H7, Ar-H7'), 7.31 (td (ddd) IH, J45  Z 156 Z  7.4, 157 = 1.2 
Hz, Ar-H5 or Ar-H5'), 7.30 (td (ddd), IH, 14,5 Z 15,6 = 7.4, 15,7 = 1.2 Hz, Ar-H5 or 
Ar-H5'), 6.48(d, 1H, J= 13.5 Hz, CH-Hl orH3),6.47 (d, 1H, J= 13.5 Hz, CH-Hl 
or H3), 4.16 (t, 2H, I = 7.5 Hz, CH 2-c), 3.69 (s, 3 H, NCH 3), 2.21 (t, 2H, I = 7.5 
Hz, CH2-a), 1.86 (quintet, 2H, I = 7.7 Hz, CH2-6), 1.77-1.66 (s + quintet, 14H, .1 = 
7.4 Hz, CH2-0 + CH3), 1.56-1.49 (m, 2H, CH 2-7). 
' 3C NMR (90.5 MHz, CDC1 3 ) 6  174.5 (COOH), 173.6 (C=N), 150.5 (CH), 142.7 
(C-Ar), 141.9 (C-Ar), 140.5 (C-Ar), 140.4 (C-Ar), 128.9 (CH-Ar), 125.4 (CH-Ar), 
125.3 (CH-Ar), 122.1 (CH-Ar), 121.9 (CH-Ar), 111.0 (CH-Ar), 110.9 (CH-Ar), 
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104.4 (CH), 103.6 (CH), 51.5 (C), 44.3 (CH 2 ), 40.7 (CH 2 ), 31.8 (CH3), 29.7 (CH 2), 
28.1 (CH3), 27.9 (CH 3 ), 26.3 (CH2), 25.7 (CH2). 
UV/vis (MeOH) ?= 547 rim, Aem= 561 nm, e = 1.06 x  iø M'cm' 
JR (neat) 2927, 2360, 1686, 1558, 1456, 1414, 1199, 1114,926cm' 
HRMS (ES) for C 30H37N202 (M): calcd 457.28496, found 457.28661 
2-{(I E,3E)-3- 13-(5-carboxypentyl)-1 , l-dimethyl-1 ,3-dihydro-2H- 
benzolejindol-2-ylidenel-1 -propeny1}-I,1,3-trimethyl-1H-benzoeJindo1ium 
Inner Salt 
8 	 8 
3a'6 	
9a 	
9a :  
3a N 	 N3a 




To PS-bound hemicyanine 15b (0.5 g, 0.50 mmol)*  were added dry pyridine (3.5 
mL), DIEA (1.0 mL, 5.8 mmol), Ac 20 (0.54 mL, 5.8 mmol) and 3-(5-
carboxypentyl)-1,1,2-trimethyl-H-benzo[e]indolium bromide (24 mg, 0.06 mmol). 
The mixture was stirred at room temperature for 2 h. Afterwards, the resin was 
removed by filtration and washed several times with DCM (10 mL). The filtrates 
were combined and evaporated and the resulting solid was dissolved in DCM (15 
mL) and washed with water (3 x  10 mL). After removal of the solvent in vacuo, 
the crude product was precipitated in Et20, washed with Et 20 and then purified by 
chromatography (DCM - DCM/MeOH 1:1) to give 20b as a purple solid (16 mg, 
49%). 
*based on theoretical loading of the resin 15b 
Rf 0.35 (DCMIMeOH 9:1) 
HPLC 1R = 5.65 mm, 100% (ELSD) 
MS (ES): m/z (%) 557.2 [Mi, 100], 558.2 [(M+1), 40], 559.2 [(M+2), 10] 
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'H NMR (360 MHz, C133013) ö 8.78 (t (dd), 1H, .11,2 Z 12,3 = 13.5 1-[z, CH-H2), 
8.29 (ci, 2H, .1 = 8.2, Hz, Ar-H9, Ar-H9'), 8.10-8.04 (m, 4H, Ar-H4, Ar-H4', Ar-
H6, Ar-H6'), 7.70-7.63 (m, 4H, Ar-H5, Ar-H5',Ar-H8, Ar-H8'), 7.55 (bt (dd), 2H, 
16.7 = J7,8 = 7.2 Hz, Ar-H7, Ar-H7'), 6.50 (d, 1 H, .1 = 13.5 Hz, CH-H 1 or H3), 6.49 
(ci, 1H, I = 13.5 Hz, CH-H1 or H3), 4.30 (t, 2H, I = 7.2 Hz, CH2-c), 3.82 (s, 3 H, 
NCH3), 2.31 (t, 2H, 1=7.2Hz, CH2-a), 2.10 (s, 12H, CH3), 1.94 (quintet, 2H,1 
7.2 Hz, CH2-8), 1.74 (quintet, 2H,J= 7.2 Hz, CH2-0), 1.61-1.52 (m, 2H, CH2-'y). 
13c NMR (90.5 MHz, C133013) 6 182.0 (C00), 177.5 (C:=N),  176.9 (C=N), 150.3 
(CH), 141.2 (C-Ar), 140.5 (C-Ar), 134.5 (C-Ar), 134.3 (C-Ar), 133.2 (C-Ar), 
131.6 (CH), 131.4 (CH-Ar), 130.8 (CH-Ar), 128.9 (CH-Ar), 128.4 (CH-Ar), 125.9 
(CH-Ar), 122.9 (CH-Ar), 111.9 (CH-Ar), 111.7 (CH-Ar), 110.6 (CH-Ar), 102.9 
(CH), 102.8 (CH), 52.0 (C), 51.9 (C), 45.0 (CH2), 38.5 (CH2), 31.7 (CH 3), 28.1 
(CH2), 27.6 (CH 3), 27.5 (CH3), 27.3 (CH2), 26.8 (CH2). 
UV/vis (MeOH) X= 587 nm , A.m = 603 nm, E = 1.05 X105  M'cm' 
IR (neat) 3400, 2924, 1720, 1558, 1515, 1483, 1447, 1414, 1227, 1157, 1013, 935, 
750 cm -1 
HRMS (ES) for C38H41 N202 (M): calcd 557.3 1626, found 557.3 1623 
PENT4METHINE DYES 
4- {I(E,2E)-3-methoxy-2-propenylidenel amino) phenol PS' °8 
MeO N 
1 3b 
To 4 aminophenol PS 18 (2 g, 3.34 mmol) was added a solution of 1, 1,3,3- 
tetramethoxypropane (7.4 mL, 45.1 mmol) and BF 3 OEt2 (0.46 mL, 3.71 mmol) in 
dry DCM (9 mL) and the solution stirred at room temperature for 6h. Dry DIEA 
(0.94 mL, 5.51 mmol) was added and the mixture stirred for 5 mm. The resin was 
isolated by filtration, washed several times with DCM (20 mL), and dried in vacuo 
to give the product as a dark blue-black resin. Found: N, 2.19; Calcd: N, 2.10. IR 
(neat) 3023, 2917, 2360, 2341, 1626, 1507, 1450, 1218, 1172,698, cm -1 . 
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2- I(1E,3E)-4-(4-hydroxyanilino)-1,3-butadienyll- I ,3,3-trimethyl-3H-indolium 
iodide PS 108 
0
1,10 a7N  H 
I 5c 
To 4-{[(E,2E)-3-methoxy-2-propenylidene]amino}phenol PS 13b (1 g, 1.56 mmol) 
and 1,2,3,3-tetramethyl-3H-indolium iodide (2.3 g, 7.6 mmol) was added DMF (8 
mL) and the mixture stirred at 120 °C for 15 min under microwave irradiation. 
After cooling, the resin was isolated by filtration, washed with DMF (3 x  10 mL) 
and DCM (3 x  10 mL), and dried in vacuo to give the product (0.96 mmolg', 87 % 
by N analysis) as a blue-black resin. Found: N, 1.87; Calcd: N, 2.14. IR (neat) 
3023, 2917, 1588, 1506, 1451, 1220, 1171, 1014, 822, 757, 733, 698 cm' The 
signal at 1626 (C=N) disappeared. 
2- I(1E,3E)-4-(4-hydroxyanilino)-1 ,3-butadienylJ-1 , 1 ,3-trimethyl-1H- 
benzolejindolium iodide PS 
z*11 
I  H." 	I N N Ja 
To 4- { [(E,2E)-3 -methoxy-2-propenylidene]amino } phenol PS 13b (1 g, 1.56 mmol) 
and 1,2,3,3-tetramethyl-3H-indolium iodide (2.7 g, 7.8 mmol) was added DMF (8 
mL) and the mixture stirred at 120 °C for 15 min under microwave irradiation. 
Aftcr cooling, the resin was isolated by filtration, washed with DMF (3 x  10 mL) 
and DCM (3 x  10 mL), and dried in vacuo to give the product as a blue-black 
resin. IR (neat) 3023, 2917, 2360, 1506, 1455, 1168, 1012, 939, 824, 752, 698 cm 
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2-{( 1 E,3E,5E)-S-t 1-(5-carboxypentyl)-3,3-dimethyl-1 ,3-dihydro-2H-indol-2- 
ylideneJ-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolium Inner 	'° 
3a 	 3a' 	5 1 
6 	7a N" 
7 	1 	3 	5 	 7' 
-o 
20c 
To PS-bound hemicyanine 15c (1.1 g, 1.1 mmol) were added dry pyridine (7 mL), 
DIEA (1.9 mL, 11 mmol), Ac 20 (1.0 mL, 11 mmol) and 1-(5-carboxypentyl)-
2,3,3-trimethyl-3H-indolium bromide (50 mg, 0.14 mmol). The mixture was stirred 
at room temperature for 1-2 h. Afterwards, the resin was removed by filtration and 
washed with DCM (4 x  10 mL). The filtrates were combined and evaporated and 
the resulting solid was dissolved in DCM (15 mL) and washed several times with 
water (10 mL). After removal of the solvent in vacuo, the crude product was 
precipitated in Et20, washed with Et20 and then purified by chromatography 
(DCM - DCM/MeOH 1:1) to give 20c as a blue solid (57 mg, 84%). 
Rf 0.32 (DCMIMeOH 9:1) 
JR (neat) 2929, 2359, 1684, 1478, 1436, 1346, 1092, 919, 897, 786, 728, 708 cm' 
HPLC 'R = 6.25 mm, 100% (ELSD, X = 650 nm) 
purity of crude product: 97% (ELSD), 90 % (A. = 650 nm) 
MS (ES): m/z (%) 483.3 [M i, 100], 484.3 [(M+l), 36], 485.3 [(M+2), 7]. 
'H NMR (360 MHz, MeOD) oH 8.25 (t (dd), 2H, 11,2 J2.3 13,4 = 45 = 13.1 Hz, 
CH-H2 + CH-H4), 7.49 (bd, 2H, I = 7.4 Hz, Ar-H4, Ar-114'), 7.44 (td (ddd), 214, 
J5,6 J6,7 z 7.7, J4,6 = 1.1 Hz, Ar-H6, Ar-H6'), 7.31-7.23 (m, 4H, Ar-H5, Ar-H5', 
Ar-H7, Ar-H7'), 6.64 (t (dd), 1H, J2,3 Z J3,4 = 12.4 Hz, CH-H3), 6.30 (d, 1H, J = 
13.7, Hz, CH-H1 or I-IS), 6.27 (d, IH, 1= 13.7, Hz, CH-Hl or H5), 4.10 (t, 2H, 1= 
7.5 Hz, CH2-0, 3.62 (s, 3H, NCH3), 2.19 (t, 2H,J= 7.4 Hz, CH 2-a), 1.87-1.79 (m, 
2H, CH2-8), 1.72-1.65 (s + m, 1411, CH 2-0 + CH3), 1.54-1.44 (m, 2H, CH2-y). 
13C NMR (90.5 MHz, MeOD) Oc  182.2 (C00, salt form), 180.3 (COOH), 174.7 
(CN), 174.3 (CN), 155.2 (CH), 155.0 (CH), 143.9 (C-Ar), 143.1 (C-Ar), 142.3 (C- 
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Ar), 142.0 (C-Ar), 129.4 (CH-Ar), 129.3 (CH-Ar), 126.3 (CH), 125.8 (CH-Ar), 
125.7 (CH-Ar), 122.9 (CH-Ar), 122.8 (CH-Ar), 111.7 (CH-Ar), 111.3 (CH-Ar), 
103.9 (CH), 103.5 (CH), 50.1 (C), 50.0 (C), 44.5 (CH2), 38.2 (CH2), 31.0 (CH 3 ), 
27.9 (CH2), 27.5 (CH3), 27.4 (CH3), 26.8 (CH2), 23.6 (CH 3 ). 
UV/vis (MeOH) 	640 rim, c = 1.77 x10 5 M'cm', A.em= 660 nm 
HRMS for C 32H39N202 (M): calcd 483.30061, found 483.30063 
2-{(IE,3E,5E)-S-13-(5-carboxypentyl)- 1,1 -dimethyl- 1 ,3-dihydro-2H- 
benzolej indol-2-ylidenel-1 ,3-pentadienyl}-1 , 1,3-trimethyl-1H- 
benzotelindolium Inner Salt 
8 	 8 
9 	 6 6 	 9
3 N 
4 	




To PS-bound Hemicyanine 15d (1.5 g, 1.56 mmol) were added dry pyridine (11 
mL), DIEA (2.6 mL, 15 mmol), Ac 20 (1.4 mL, 15 mmol) and 1-(5-
carboxypentyl)-2,3,3-trimethyl-3H-indolium bromide (80 mg, 0.20 mmol). The 
mixture was stirred at room temperature for 1-2 h. Afterwards, the resin was 
isolated by filtration and washed several times with DCM (15 mL). The filtrates 
were combined and evaporated and the resulting solid was redissolved in DCM (20 
mL) and washed several times with water (10 mL). After removal of the solvent in 
vacuo, the crude product was precipitated in Et20, washed with Et 20 and then 
purified by chromatography (DCM -* DCM/MeOH I :1) to give 20d as a dark 
blue-green solid (107 mg, 92%). 
HPLC tR = 11.5 mm, 100% (ELSD, X = 675 nm) 
MS (ES): m/z (%) 583.5 [M t , 100], 584.5 [(M+1), 45], 585.5 [(M+2), 101. 
'H NMR (360 MHz, MeOD) 8 8.33 (t, (dd) 214, Jj, 	 = J3,4 = 45 12.9 Hz, 
CH-H2 + CH-H4), 8.24 (d, 2H, J = 8.5 Hz, Ar-119, Ar-H9'), 8.00 (d, 1H, J = 8.8 
Hz, Ar-H6 or Ar-H6'), 7.99 (d, 1 H, J = 8.8 Hz, Ar-H6 or Ar-H6'), 7.97 (d, 2H, J = 
8.2 Hz, Ar-H4, Ar-H4'), 7.59-7.67 (m, 4H, Ar-H5, Ar-H5', Ar-H8, Ar-H8'), 7.47 
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(bt, (dd) 2H, J67 = Z J7, 8 = 7.6 Hz, Ar-117, Ar-H 7'), 6.68 (t, (dd) I H, J23 Z J3,4 = 
12.4 Hz, CH-H3), 6.35 (d, 2H, J = 13.7 Hz, CH-H1 or H5), 6.34 (d, 2H, J = 13.8 
Hz, CH-H1 or H5), 4.23 (t, 2H, J= 7.3 Hz, CH2-0, 3.76 (s, 3H, NCH 3), 2.33 (t, 
2H,J= 7.2 Hz, CH2-a), 1.98 (s, 12H, NCH3), 1.86-1.92 (m, 2H, CH 2-6), 1.71-1.79 
(m, 2H, CH2-13), 1.53-1.61 (m, 2H, CH2-7). 
' 3C NMR (90.5 MHz, MeOD) 8 179.4 (COOH), 176.4 (C=N), 175.8 (C=N), 154.3 
(CH), 141.6 (C), 140.9 (C), 135.1 (C), 134.9 (C), 133.4 (C), 131.7 (CH), 131.1 
(CH), 129.4 (CH), 129.4 (CH), 128.7 (CH), 126.6 (CH), 126.1 (CH), 126.0 (CH), 
123.3 (CH), 112.1 (CH), 111.9 (CH), 104.1 (CH), 103.9 (CH), 52.4 (C), 52.3 (C), 
45.0 (CH2), 36.5 (CH2), 31.9 (CH 3), 28.5 (CH 2), 27.6 (CH2), 27.5 (CH3), 26.4 
(CH2). 
UV/vis (MeOH) ?, b,= 678 mn ,F, = 1.42 x105 M'cm1 , Xm=  704 nm 
R1 0.35 (DCM/MeOH 9:1) 
IR (neat) 2931, 1684, 1479, 1454, 1436, 1349, 1092, 1006, 920, 787, 728, 704 cm 
HRMS for C40H.43N202 (M): calcd 583.33 191, found 583.33202 
HEP TAME THINE DYES 




A suspension of glutaconaldehyde dianil monohydrochlonde (2.85 g, 10 mmol) 
and BF3 Et2O (0.9 mL. 7.5 mmol) in DCM (20 mL) was stirred at room 
temperature for 15 min and then added to PS-Bound aniline 18 (2.8 g, 5 mmol). 
The reaction mixture was stirred at room temperature for 6h and then filtered. The 
resin was washed extensively with DMF, then with DCM and dried in vacuo to 
give the product as a dark red resin (0.6 mmolg', 45 % by N analysis). Found: N, 
1.66; Calcd: N, 3.71. IR (neat) 3023, 2918, 2360, 1552, 1501, 1450, 1159, 1012, 
828, 755 cm-1 . 
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Method 2 
A solution of Ac20 (0.9 mL, 9.6 mmol) in DCM (4.1 mL) was added dropwise to a 
stirring suspension of glutaconaldehyde dianilide monohydrochioride (2.5 g, 8.7 
mmol) and DIEA (2.8 mL, 17.4 mmol) in DCM (20 mL). The resulting clear 
solution was stirred for lh and evaporated. The residue was dissolved in DMF (20 
mL) and added to PS-Bound aniline 18 (2.5 g, 4.5 mmol). The mixture was stirred 
at room temperature for 4h and then filtered. The resin was washed extensively 
with DMF, then with DCM and dried in vacuo to give the product as a dark red 
resin (0.6 mmolg', 49% by N analysis). Found: N, 1.73; Calcd: N, 3.51. IR (neat) 
3023, 2918, 2360, 1552, 1501, 1450, 1159, 1012, 828, 755 cm - . 
2-I (1E,3E,5E)-6-(acetylanilino)-1 ,3,5-hexatrienylj-1 ,3,3-trimethyl-3H-indolium 
iodide' 
C~+ N 	 N'O 
19e 
A suspension of 1,2,3,3-tetramethyl-3H-indolium iodide (2.5 g, 8.3 mmol) and N-
[(E,2E,4E)-5-anilino-2,4-pentadienylidene]aniline hydrochloride (2 g, 7 mmol) in a 
(1:1) mixture of acetic acid and acetic anhydride (30 mL) was heated at 120 °C for 
2.5 h. 20° The completion of the reaction was carefully monitored by UV-visible 
spectrometry: hemicyanine intermediate and symmetrical cyanine dye have an 
absorption maximum around 489 and 750 nm, respectively. After cooling, the 
reaction mixture was evaporated and the resulting solid was dissolved in DCM (20 
mL) and repeatedly washed with water (15 mL). After removal of the solvent in 
vacuo, the crude product was precipitated in Et20, collected by filtration and dried 
to give the compound 19e as a dark red solid. 
R1: 0.36 (DCM/MeOH 9:1) 
IR (neat) 3318, 3050, 1684, 1593, 1547, 1259, 1156, 1106, 995, 917, 760 cm'. 
HPLC tR = 8.5 mm 
MS (ES): m/z (%) 371.1 [Mi , 100], 372.1 [(M--1), 25], 373.1 [(M+2), 3]. 
'H NMR (360 MHz, CDC1 3 ) 8.17 (d, J = 14.0, Hz, LH, CH), 8.15-8.12 (m, IH, 
CH), 7.92 (dd, J = 14.9, 11.4 Hz, 1H, CH), 7.64-7.12 (m, 9H, Ar), 7.00-6.96 (m, 
2H, CH), 6.61 (dd, J = 14.2, 11.4 Hz, 1H, CH), 3.78 (s, 3H, CH3), 1.74 (s, 3H, 
CH3), 1.48 (s, 6H, CH3) 
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UV = (MeOH) ?= 489 nm 
2-I(IE,3E,5E)-6-(acetvl-4-hydroxyanhlino)-I,3,5-hexatrienylj-1 ,3,3-trimethyl-
3H-indolium iodide PS 
O+N 	 N'ja o 
I - 
I 5e 
Method 1-HEMICYANINE 1 
To the resin 13c (2.9 g, 1.7 mmol) were added Ac20 (1.6 mL, 17 mmol), DIEA 
(3.0 mL, 17 mmol), pyridine (5 mL) and 1,2,3,3-tetramethyl-3H-indolium iodide 
(0.6 g, 2 mmol) and the mixture was stirred at room temperature for 1 .5h. The resin 
was isolated by filtration, washed with DMF and DCM and dried in vacuo to give 
the product as a dark resin. IR (neat) 3025, 2919, 2359, 1717, 1507, 1490, 1225, 
1017, 821, 756, 724 cm- 1 
Method 2-HEMJCYANINE 2 
To 4-aminophenol PS 18 (0.5 g, 0.8 mmol) was added a solution of compound 19e 
(0.9 g, 1.8 mmol) in DCM (5 mL) and the mixture stirred at room temperature for 
1 h. Afterwards, the resin was isolated by filtration, washed extensively with DMF, 
MeOH, DCM to remove the symmetrycal dye and dried in vacuo to give the 
product as a dark resin (0.77 mmolg', 83 % by N analysis). Found: N, 2.17; Calcd: 
N, 2.60. IR (neat) 3025, 2919, 2359, 1717, 1507, 1490, 1225, 1017, 821, 756, 724 
cm 
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A suspension of 1,2,3,3-tetramethyl-3H-indolium iodide (3.0 g, 8.4 mmol) and 
glutaconaldehyde dianil hydrochloride (2 g, 7 mmol) in a (1:1) mixture of acetic 
acid and acetic anhydride (30 mL) was heated at 120 °C for 2.5 h. The completion 
of the reaction was carefully monitored by UV-visible spectrometry: hemicyanine 
intermediate and symmetrical dicarboxylic acid cyanine dye have an absorption 
maximum around 493 and 780 rim. respectively. After cooling, the reaction 
mixture was evaporated and the resulting solid was dissolved in DCM (20 mL) and 
repeatedly washed with water (15 mL). After removal of the solvent in vacuo, the 
crude product was precipitated in Et 20, collected by filtration and dried to give the 
compound 19f as a dark red-purple solid. 
R1 : 0.36 (DCM/MeOH 9:1) 
IR (neat) 3315, 2930, 1705, 1666, 1242, 1091, 923, 756 cm-1 
HPLCIR=6.9l mm 
MS (ES): m/z (%) 421.1 [Mi, 100], 422.1 [(M+1), 30], 423.1 1 [(M+2), 6] 
'H NMR (500 MHz, CDC13) ö 8.18-8.14 (m, 2H, Ar + CH), 8.06-8.00 (m, 3H, 
Ar), 7.72-7.52 (m, 611, Ar + CH), 7.40 (d, 1H, J = 15.1 Hz, CH), 7.29 (t, 1H, J = 
9.0 Hz, CH), 7.17 (d, 2H,J= 7.0 Hz, Ar), 6.83 (t, IH, J= 12.7 Hz, CH), 5.38 (t, 
IH,J= 12.6 Hz, CH), 1.98 (s, 61-1, CH3), 1.96 (s, 3H, CH3), 1.88 (s, 3H, CH3). 
UV = (MeOH) kb,= 492 nm 
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2- I(1E,3E,5E)-6-(acetyl-4-hydroxyanilino)-1 ,3 ,5-hexatrienylj -1 , 1 ,3-trimethyl- 
IH-benzotelindolium iodide 
	
+ N 	 N'ja 
1 5f 
To 4-aminophenol PS 18 (1 g, 1.7 mmol) was added a solution of compound 19f (2 
g, 3.6 mmol) in DCM (10 mL) and the mixture stirred at room temperature for I h. 
Afterwards, the resin was isolated by filtration, washed extensively with DMF, 
MeOH, DCM to remove the symmetrycal dye and dried in vacuo to give the 
product as a dark blue-black resin. JR (neat) 3024, 2915, 1555, 1494, 1157, 994, 
941, 827, 745, 704 cm' 
2- {(1E,3E,5E,7E) -7- 11 -(5-carboxypentyl)-3,3-dimethyl-1 ,3-dihydro-2H-indol- 
2-ylidenej-1 ,3,5-heptatrienyl}- 1 ,3,3-trimethyl-3H-indoliu m Inner Salt 
6 Cf)a~N 	N 7a" 







To PS-bound Hemicyanme 15e-1 (0.4 g, 0.2 mmo1) were added dry pyridine (2.5 
mL), and 1 -(5-carboxypentyl)-2,3,3-trimethyl-3H-indolium bromide (71 mg, 0.2 
mmol). The mixture was stirred at room temperature for 2 h. Afterwards, the resin 
was isolated by filtration and washed with DCM. The filtrates were combined and 
evaporated and the resulting solid was dissolved in DCM and washed several times 
with water. The product was precipitated in Et20, washed with Et 20 and then 
purified by chromatography (DCM - DCM/MeOH 1:1) to give 20e as a green 
solid (14 mg, 12%). 
HPLC tR = 5.9 mm, 100% (ELSD, ?.= 760 run) Method! 
*based on theoretical loading of resin 15e-1 
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Method 2-20e 
To PS-bound Hemicyanine 15e-2 (0.84 g, 0.64 mmol) were added dry pyridine (4 
mL), Ac20 (0.6 mL, 6.3 mmol) and 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-
indolium bromide (40 mg, 0.11 mmol). The mixture was stirred at room 
temperature for 2 h, until completion. Afterwards, the resin was isolated by 
filtration and washed (2 x  10 mL) with DCM. The reaction was then repeated in 
the same conditions described above. The filtrates were then combined and 
evaporated and the resulting solid was dissolved in DCM (10 mL) and washed 
several times with water (8 mL). The product was precipitated in Et20, washed 
with Et20 and dried in vacuo giving 8c as a green solid (96 mg, 86%). 
Rf: 0.32 (DCMIMeOH 9:1) 
IR (neat) 2931, 2362, 1719, 1436, 1399, 1352, 1060, 1006, 915, 897, 724, 704 cm 
HPLC tR = 5.89 mm, 96 % (ELSD) 
MS (ES): m/z (%) 509.5 [M, 100], 510.5 [(M+l), 37], 511.5 [(M+2), 8] 
'H NMR (500 MHz, MeOD) ö 7.93 (t, (dd) 2H, .11,2 J2,3 = J5, 6 Z J6, 7 = 13.1 Hz, 
CH-H6 + CH-H2), 7.60 (t, (dd) 111, .13,4 = J,5 = 12.0 Hz, CH-H4), 7.49 (d, 1H, J = 
7.5 Hz, Ar-H4 or Ar-H4'), 7.48 (d, 1H, J = 7.5 Hz, Ar-H4 or Ar-H4'), 7.39 (td 
(ddd), 2H, J5, 6  = J6, 7 = 7.7, J,6 = 1.1 Hz, Ar-H6, Ar-H6'), 7.27-7.22 (m, 4H, Ar-
H5, Ar-H5',Ar-H7, Ar-H7'), 6.61 (t, (dd), 1H, .1= 12.6 Hz, CH-H3 or H5), 6.58 (t, 
(dd) 1H, .1 = 12.5 Hz, CH-H3 or H5), 6.30 (d, 1H, J = 13.7 Hz, CH-H1 or CH-
H7),6.27 (d, 1H, J = 13.7 Hz, CH-H1 or CH-H7), 4.07 (t, 2H, J = 7.5 Hz, CH2-c), 
3.59 (s, 3H, NCH3), 2.29 (t, 2H, .1= 7.3 Hz, CH2-(I), 1.82 (quintet, 2H, J= 7.7 Hz, 
CH2-8), 1.70-1.67 (m + s, 14H, CH2-0+ CH,), 152-1.46 (m, 2H, CH2-'y). 
'H NMR (360 MHz, MeOD) 8 7.93 (t, 2H, J= 13.1 Hz, CH), 7.60 (t, 111, J = 12.0 
Hz, CH), 7.51-7.39 (m, 4H, Ar), 7.34-7.23 (m, 4H, Ar), 6.61 (t, 1H, J = 12.4 Hz, 
CH), 6.58 (t, 1H, .1= 12.4 Hz, CH), 6.35 (d, 1H, J= 13.7 Hz, CH), 6.26 (d, 1H, J= 
13.6 Hz, CH), 4.12 (t, 2H, .1=7.6 Hz, CH2), 3.61 (s, 3H, NCH3), 2.21 (t, 2H, J 
7.3 Hz, CH2), 1.89-1.67 (m + s, 16H, 2x CH2+ CH3), 158-1.49 (m, 2H, CH2). 
'3C NMR (90.5 MHz, MeOD) ö 178.6 (COOH), 173.8 (CN), 173.2 (CN), 153.0 
(CH), 144.4 (C), 143.7 (C), 143.3 (C), 142.5 (C), 142.3 (C), 141.8 (C), 129.8 (CH), 
129.7 (CH), 127.0 (CH), 126.0 (CH-Ar), 124.7 (CH-Ar), 123.4 (CH-Ar), 123.3 
(CH-Ar), 111.9 (CH-Ar), 111.6 (CH-Ar), 104.8 (CH), 50.4 (C), 50.2 (C), 44.9 
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(CH2), 35.7 (CH2), 31.5 (CH3), 28.2 (CH2), 28.1 (CH3), 27.9 (CH3), 27.4 (CH 2), 
26.1 (CH2). 
UV/vis (MeOH) A= 743 urn, £ = 1.40 x 10 M'cm', Xm= 765 llIfl 
HRMS for C34H4 1 N202 (M): calcd 509.31626, found 509.3 1634 
2-{(1E,3E,5E, 7E)-7- 13-(5_carboxypentyl)-1 ,1-dimethyl-1,3-dihydro-2H- 
benzo(ejindol-2-ylidene]-1,3,5-heptatrienyl}-1,1,3-trimethyl-1H- 
benzole]indolium Inner Salt 
8 	 8 
3a N 
1 	3 	5 	7 j 4' 
E 
20f 
To PS-bound Hemicyanine 15f (0.7 g, 0.7 mmol)*  were added dry pyridine (3.2 
mL), Ac20 (0.8 mL, 8.4 mmol) and 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-
indolium bromide (34 mg, 0.08 mmol). The mixture was stirred at room 
temperature for 2 h, until completion. Afterwards, the resin was isolated by 
filtration and washed with DCM (2 x  10 mL). The reaction was then repeated in 
the same conditions described above. The filtrates were combined and evaporated, 
the resulting solid was dissolved in DCM (15 mL) and washed several times with 
water (10 mL). The product was then precipitated in Et 20, washed with Et20 and 
dried in vacuo giving 20f as a green solid (50 mg, 51 
*based on theoretical loading of the resin 15f 
Rf: 0.39 (DCM/MeOH 9:1) 
IR (neat) 2924, 2457, 1725, 1410, 1087, 1008, 920, 897, 729 cm -1 
HPLC tR = 4.20 mm, 86% (A.g, s= 800 nrn) 
MS (ES): m/z (%) 609.2 [M, 100], 610.2 [(M+1)+, 40], 611.2 [(M+2), 10] 
'H NMR (500 MHz, MeOD) 8 8.18 (d, 2H, J= 8.6 Hz, Ar-H9, Ar-H9'), 8.03-8.00 
(m, 2H, CH-H2 + CH-H6), overlapping with 8.00 (d, 1H, J = 8.8 Hz, Ar-H6 or Ar-
H6'), 7.99 (d, 1H, J = 8.8 Hz, Ar-H6 or Ar-H6'), 7.95 (d, 2H, J = 8.30 Hz, Ar-H4, 
Ar-H4'), 7.65-7.62 (m, IH, CH-H4) overlapping with 7.59 (td, (ddd) 2H, J = 8.3, 
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1.1 Hz, Ar-H8, Ar-H8'), 7.58 (d, 1H,J 8.9 Hz, Ar-H5), 7.56 (d, 1H,J 9.0 Hz, 
Ar-H5'), 7.42 (bt (dd), 2H, .16,7 Z  J7,8 = 7.5 Hz, Ar-H7, Ar-H7'), 6.56 (t (dd), 1H, J 
= 12.4 Hz, CH-H3 or H5), 6.55 (t (dd), 1H, .1 = 12.4 Hz, CH-H3 or H5), 6.27 (d, 
1H, J= 13.7 Hz, CH-H1 or H7), 6.26 (d, 1H, J= 13.7 Hz, CH-H1 or H7), 4.19 (t, 
2H, J= 7.5 Hz, CH2-6), 3.72 (s, 3H, CH3), 2.33 (t, 2H, J= 7.3 Hz, CH2-a), 1.92 (s, 
3H, NCH3), 1.85 (quintet, 2H, J = 7.7 Hz, CH2-8), 1.70 (quintet, 2H, J = 7.3 Hz, 
CH2-0), 1.52 (quintet, 2H,J= 7.8 Hz, CH2-'y). 
' 3C NMR (126 MHz, MeOD) ö 182.4 (C00), 177.9 (C=N), 177.4 (C=N), 150.8 
(CH), 141.7 (C), 140.9 (C), 135.0 (C), 134.8 (C), 133.7 (C), 132.1 (C), 131.9 (CH-
Ar), 131.3 (CH-Ar), 131.2 (CH-Ar), 129.4 (CH), 129.3 (CH), 128.9 (CH), 126.4 
(CH-Ar), 126.3 (CH-Ar), 123.4 (CH-Ar), 112.4 (CH-Ar), 112.2 (CH-Ar), 103.4 
(CH), 103.3 (CH), 52.5 (C), 52.4 (C), 45.4 (CH 2), 36.7 (CH2), 33.2 (CH3), 29.8 
(CH2), 28.9 (CH3), 28.8 (CH3), 28.7 (CH2), 27.3 (CH2). 
UV/vis (MeOH) ),abs=  781, c = 1.3 x  105 M 1 cm 1, ,= 808 nm 




A mixture of 26b (500 mg, 1.41 mmol) and N,N'-diphenylformamidine (306 mg, 
1.56 mmol) was heated at 100 °C in a solution (1:1) of acetic acid and acetic 
anhydride (3 mL) for 20 min until an orange-red colour was noticed. The reaction 
was carefully monitored by UV-visible spectrometry to avoid the formation of the 
symmetrical dye: hemicyanine intermediate 28a and symmetrical dicarboxylic acid 
have an absorption maximum at 380 and 550 nm, respectively. After cooling the 
reaction mixture, the solvent was evaporated and the solid washed with ethyl 
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acetate to remove the excess of N,N'-diphenylformamidine. After drying in vacuo, 
the intermediate 28a, isolated as an orange-red solid, was directly used for the next 
step. 
UV = (MeOH) A.abs 380 flfl 
'H NMR (360 MHz, D20) ö: 9.12 (d, 1H, J= 13.7 Hz, CH), 7.98 (s, 111, Ar), 7.86 
(d, IH, J = 8.5 Hz, Ar), 7.64 (d, 2H, J = 7.1 Hz, Ar), 7.57 (d, 1H, J= 8.5 Hz, Ar), 
7.39 (d, 2H, J = 7.0 Hz, Ar), 7.19-7.15 (m, IH, Ar), 5.43 (d, 111, J = 13.4 Hz, 
CH2), 3.97 (t, 2H, J = 7.6 Hz, CH2), 2.22 (t, 2H, J = 7.6 Hz, CH2), 1.99 (s, 3H, 
Cl3), 1.71-1.57 (m, 8H, CH2 + (CH3)2), 1.36-1.28 (m, 2H, CH2), 1.03 (quintet, 2H, 
J= 7.0 Hz, CH2). 
MS (ES): m/z (%) 455.0 [(M-1), 100], 456.0 [M, 25], 457.0 [(M+1), 5], 497.0 
[(M+COCH3), 50], 498.0 [(M+COCH3), 14], 
HPLC = 2.4 mm 







The intermediate 28a (654 mg, 1.06 mmol) was dissolved in Ac20/pyridine (1:1) 
(2-3 mL). Indolenine salt 26a (444 mg, 1.06 mmol) was added and the mixture 
heated at 80 °C for lh. After cooling the reaction mixture and removing the solvent 
in vacuo, the residue was washed with diethyl ether, dried, and then purified by 
silica gel chromatography eluting with a DCM: MeOH gradient (100% DCM to 
50% DCM/MeOH). Product 25a was obtained as a red solid. 
Yield: 248 mg (0.38 mmol, 36 %) 
'H NMR (360 MHz, CD30D) & 8.57 (t (dd), 1H, .Jj2 Z  .12,3 = 13.5 Hz, CH-H2), 
7.95 (d, 2H, .1= 1.5 Hz, H-16, Ar-H4), 7.94 (dd, 11, J= 8.0, 1.3 Hz, Ar -H6 or Ar- 
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H6'),7.93 (dd, 1H, J= 8.0, 1.6 Hz, Ar -H6, Ar-H6'), 7.43 (ci, 111, J= 8.3 Hz, Ar - 
H7 or Ar-H7'), 7.40 (d, IH, J = 8.3 Hz, Ar -H7 or Ar-H7'), 6.57 (d, 1H, J = 13.4 
Hz, CH-H1 or H3), 6.55 (d, 1H, J = 13.4 Hz, CH-H1 or H3), 4.17 (t, 2H, J = 7.5 
Hz, CH2-0, 3.72 (s, 3H, NCH3), 2.20 (t, 2H, J= 7.3 Hz, CH2-a), 1.87-1.79 (quintet 
+ s, 14H, J = 7.3 Hz, 2 x  CH3 + CH2-8), 1.70 (quintet, 2H, J = 7.5 Hz, CH2-0), 
1.56-1.47 (m, 2H, CH2-7). 
' 3C NMR (90.5 MHz, MeOD): 8 181.7 (COO), 177.1 (C=N), 176.4 (C=N), 152.4 
(CH), 145.0 (C-Ar), 144.3 (C-Ar), 143.6 (C-Ar), 141.8 (C-Ar), 141.7 (C-Ar), 
127.9 (CH-Ar), 127.8 (CH-Ar), 121.1 (CH-Ar), 120.1 (CH-Ar), 111.8 (CH-Ar), 
111.6 (CH-Ar), 104.5 (CH), 104.3 (CH), 50.4 (C), 50.3 (C), 45.1 (CH 2), 38.0 
(CH2), 31.7 (CH3), 27.8 (CH 3), 27.7 (CH3), 27.3 (CH2), 26.5 (CH2). 
MS ES: 307.0 ((M12) 2, 100 %), 615.1 (M', 20%) 
HPLC tR = 7.14 mm. 
FTIR 3446 (m), 2970 (w), 2360 (w), 1738 (s), 1556 (s), 1445 (s), 1365 (s), 1216 
(s), 1107 (s), 1018 (s), 871 (m) cm' 
R: 0.38 (DCM: MeOH 1:1) 
Mp>300°C 
UV/vis (H2O) Aex 548 nm, Aem 561 nm 








A mixture of 1,2,3,3-tetramethyl-3H-indolium-5-sulfonate (1.0 g, 2.4 mmol) and 
N-[( 1E,3E)-3-(phenylimino)- 1 -propenyl]aniline hydrochloride (0.7 g, 2.7 mmol) 
was heated at 120 °C in a solution (1:1) of acetic acid and acetic anhydride (4 mL) 
for 2 h until an orange colour was noticed. The reaction was carefully monitored 
by UV-visible spectrometry: hemicyanine intermediate 3c and symmetrical 
dicarboxylic acid have an absorption maximum at 445 and 650 nm, respectively. 
After cooling, the solvent was evaporated and the solid precipitated with diethyl 
ether, filtered and washed several times with ethyl acetate. After drying in vacuo, 
the intermediate, isolated as an orange solid, was directly used for the next step. 
Rf : 0.63 (DCMIMeOH 4:1) 
IR (neat) 3475, 3069, 2978, 2358, 1694, 1574, 1512, 1468, 1167, 1111, 1027, 995 
cm 1 
HPLC tR = 4.74 min 
MS (ES): m/z (%) 423.0 [(M-l), 100], 424.1 [M, 23], 847 [(2M-1), 7] 
'H NMR (360 MHz, D20) ö 8.55 (d, 1H, J = 12.8 Hz, CH), 8.00-7.90 (m, 2H, 
CH), 7.78-7.53 (m, 5H, Ar), 7.38-7.30 (m, 3H, Ar), 6.42 (d, 1H, J = 15.1 Hz, CH), 
5.55 (t, 1H,J= 12.8 Hz, CH), 1.66-1.64 (m, 12H). 
UV = (MeOH) kab,' 445 nm 
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To 4-aminophenol PS 18 (0.35 g, 0.6 mmol) was added a solution of 28b (0.50 g, 
1.2 mmol) in DCM/DMF (3:1) (4 mL) and the mixture stirred at room temperature 
for 1 h. Afterwards, the resin was isolated by filtration, washed extensively with 
DMF, MeOH, DCM and dried in vacuo to give the product as a dark resin (0.75 
mmolg', 75% by nitrogen elemental analysis). Found: N, 2.10; Calcd: N, 2.80. 





3a 	 3a' 
7a 	
1 	3 	5 ' 	7' 
: ~ cT 
25b 	 OH 
Classical Method 
A solution of compound 28b (225 mg, 0.53 mmol) and compound 26b (187 mg, 
0.53 mmol) in Ac20/pyridine (1:1) (2-3 mL) was stirred at 80 °C lh. After cooling 
and removing the solvent in vacuo, the residue was washed with diethyl ether, 
dried, and then purified by chromatography (DCM - DCMIMeOH 1:1) to give 
the product 25b as a blue solid (142 mg, 40  
Solid Phase Method 
To PS-bound Hemicyanine 30b (0.35 g, 0.26 mmol) were added dry pyridine (1.6 
mL), Ac20 (0.4 mL, 4.2 mmol) and 1-(5-carboxypentyl)-2,3,3-trimethyl-3H- 
indolium-5-sulfonate 26b (20 mg, 0.06 mmol). The mixture was stirred at room 
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temperature for 2 h, until completion. Afterwards, the resin was isolated by 
filtration, washed with a solution 9:1 DCMIDMF (2 x  5 mL) and the reaction 
repeated in the same conditions described above. The resin was isolated by 
filtration and then washed with a mixture 9:1 DCM/DMF (3 x  5 mL). The filtrates 
were combined and evaporated. Afterwards, the resulting solid was washed and 
precipitated with Et20 and centrifuged. The supernatant was removed and the 
precipitate dried in vacuo to give 25b as a blue solid (77 mg, 94 
Rf : 0.40 (DCM/MeOH 3:2) 
IR (neat) 3413, 2929, 1716, 1494, 1459, 1368, 1330, 1153, 1099, 1016, 926, 817 
cm-1 
HPLC tR = 3.6 mm, 94% (Xabs= 650 nm) 
MS (ES): m/z (%) 320.0 [(M/2) 2, 100], 641.0 [(M-2), 40], 642.0 [(M-1), 21], 
643.0 [M, 8] 
'H NMR (360 MHz, MeOD) & 8.31 (t (dd), 2H, .11,2 Z J2,3Z .13,4 Z  .14,5 = 13.4 Hz, 
CH-H2 + CH-H4), 7.90-7.85 (m, 4H, Ar-H4, Ar-H4', Ar-H6, Ar-H6'), 7.36 (d, 1H, 
J = 8.2 Hz, Ar-H7 or Ar-H7'), 7.33 (d, 1H, J = 8.8 Hz, Ar-H7 or Ar-H7'), 6.70 (t 
(dd), 1H, .12,3 J3,4 = 12.2 Hz, CH-H3), 6.36 (d, 1H, J = 13.1 Hz, CH-H1 or CH-
H5), 6.32 (d, 1H, J= 13.2 Hz, CH-H1 or CH-H5), 4.12 (t, 2H, J = 7.3 Hz, CH2-6), 
3.64 (s, 3H, NCH3), 2.20 (t, 2H, .1 = 7.4 Hz, CH 2-a), 1.87-1.65(m, 16H, CH2-8 + 
CH2- + 2 x  CH3), 1.56-1.47 (m, 2H, CH2-7). 
' 3C NMR (90.5 MHz, MeOD): ö 182.4 (C00), 175.9 (C=N), 175.4 (C=N), 156.2 
(CH), 145.7 (C-Ar), 144.9 (C-Ar), 143.4 (C-Ar), 143.3 (C-Ar), 142.7 (C-Ar), 
142.5 (C-Ar), 128.1 (CH-Ar), 128.0 (CH-Ar), 127.8 (CH), 121.4 (CH-Ar), 121.3 
(CH-Ar), 111.7 (CH-Ar), 111.4 (CH-Ar), 104.4 (CH), 105.3 (CH), 50.6 (C), 50.5 
(C), 45.2 (CH2), 38.8 (CH2), 31.8 (CH3), 30.7 (CH2), 28.3 (CH2), 27.9 (CH3), 27.8 
(CH3), 27.7 (CH2), 27.2 (CH2). 
UV/vis (MeOH) Xabs  647, ?,,= 667 nm 
HRMS for C32H37N202S2 (M): calcd 641.19858, found 641.19658 
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6.2 	Experimental for Chapter 3 
High performance liquid chromatography was carried out on an Agilent 
Technologies HPI 100 Chemstation system coupled to a Polymer Lab 100 ES 
evaporative light scattering detector, eluting with (A) 0.1% TFAJH20, (B) 0.04% 
TFAI MeCN. 
HPLC System III 
Column: Phenomenex Luna, C 18(2), 150 mm x  4.6 mm, 100 A. Flow rate: 1.0 ml, 
min- '. Eluents A and B. Gradient: 95% A to 5% A over 8 mm, then 5% A for 6 
mm, then 5% to 95% A over 1 mm. Detection: UV and or ELS detection. 
Preparative RP-HPLC was performed on a Hewlett Packard HP 1100 Chemstation 
eluting with (A) 0.1 M TEAB in H20, (B) MeCN. The fractions were collected 
using a Gilson G2250A robot. 
HPLC System IV 
Column: Waters (Xterra) RP 18 OBD preparative column, 19 mm x  150 mm i.d. 5 
p.m at a flow rate of 10 mL min'. Gradient: 100 % A to 80 % A over 4 mm, 80 % 
A to 50 % A over 12 mm, 50 % A to 0 % A over 2 mm, 0% A for 1 min, 0% to 
100% A over 1 min. Detection by UV at 230, 254, 260 and 282 nm. 
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Preparation of TEAB buffer 
TEAB buffer was prepared by bubbling CO2 through a solution of deionised water 
(650 mL) and TEA (278 mL) over an ice-bath until pH 8.5. The solution was 
diluted to 1 L to give a 2 M TEAB buffer and was stored at 4°C. 
Preparation of Solid Phase Bound Peptide 32. 
H2N( N 
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Attachment of the f' amino acid to the Wang resin 
Wang resin (ig, 0.93 mmol) was placed in a disposable peptide vessel and left to 
swell in 10 mL of DMF for 30 mm. In another flask, a solution of Fmoc-Ala-OH 
(869 mg, 2.79 mmol, 3 eq.) and DIC (352 mg, 2.79 mmol, 3 eq.) in DCMJDMF 
(2:1) was left under agitation for 10 mm. DMAP (34 mg, 0.28 mmol, 0.1 eq.) was 
added to the solution and the mixture was then added to the resin and left under 
agitation for lh. The progress of the coupling was monitored by a qualitative 
ninhydrin test' 68 and the coupling procedure was repeated to push the reaction to 
completion. The resin was washed with DMF (3 x  10 mL), CH202 (3 x  10 mL), 
MeOH (3 x  10 mL), CH202 (3 xl 0 mL), Et20 (3 x  10 mL). Afterwards, he resin 
was dried in vacuo and the loading of Fmoc-Alanine, was measured by a standard 
Fmoc test, 211  0.91 nimol/g (98%). The resin was swollen in CH0 and the 
solution drained off, 20% piperidine in DMF was added, the resin was agitated for 
30 minutes (twice) and washed with DMF (3 x  10 mL), CH202 (3 x  10 mL), MeOH 
(3 x  10 mL), CH202 (3 xl 0 mL) Et20 (3 x  10 mL) and dried under reduced 
pressure. 
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Solid Phase Peptide Synthesis 
To a solution of Fmoc-Ala-OH (3 eq.) and HOBt (3 eq.) in DCM/DMF (2:1) was 
added DIC (3 eq.). After 10 mm, the reaction mixture was added to the preloaded 
resin and stirred for 2 h. The progress of the coupling was monitored by a 
qualitative ninhydrin test and the coupling procedure was repeated if necessary. 
The resin was washed with DMF (3 x 20 mL), CH202 (3 x 20 mL), MeOH (3 x 20 
ML), CH202 (3 x 20 ML), and dried under reduced pressure. A solution of 20 % 
piperidine in DMF was added, the resin was stirred for 30 minutes (twice) and 
washed with DMF (3 x 10 mL), MeOH (3 x 10 mL), CH 202 (3 x 10 mL), CH202 
(2 x 10 mL), MeOH (2 x 10 mL), DMF (2 x 10 mL) and dried under reduced 
pressure. The procedure was repeated for each aminoacid in the sequence. 
Cleavage Procedure (for HPLC and MS analysis) 
95% TFA in DCM (2 mL) was added to the resin (- 10 mg) and left to stand for 10 
minutes. The resin was washed with DCM (3 x  3mL). After combining the 
filtrates, the mixture TFA/DCM was removed by evaporation under reduced 
pressure and cold diethyl ether was added to achieve a good precipitation. 
ES m/z (%) 232.3((M+H), 100), 254.3 ((M+Na), 30), 463.5 ((2M+H),10), 
485.5 ((2M+Na), 25). 
HPLC(?.22O)tR 11.1 min 
'H NMR (360 MHz, D20) : 4.26 (q, 1H, J = 7.3 Hz, CH-Ala), 4.25 (q, 1H, J = 
7.2 Hz, CH-Ala), 3.99 (q, 1H, J= 7.1 Hz, CH-Ala), 1.44 (d, 3H, J = 7.1 Hz, CH3-
Ala), 1.35 (d, 3H,J=7.3 Hz, CH3-Ala), 1.32 (d, 3H, , J = 7.2 Hz, CH3-Ala). 
183 
Succinimidyl ester of pyridinium 2-{(1E,3Z)-3-1-(5-carboxypenty1)-3,3-
dimethyl-5-sulfonato-1,3-dihydro-2H-indol-2-ylidenej-1-propenyl}-1,3,3-
trimethyl-3H-indolium-5-sulfonate 
Dye 25a (117 mg, 0.17 mmol) was dissolved in a mixture of dry DMF (2 mL) and 
dry pyridine (2 mL). Disuccinimidyl carbonate (DSC) (56 mg, 0.21 mmol) was 
added, and the mixture was stirred at 60 °C for lh, under a nitrogen atmosphere. 
The reaction was monitored by TLC (DCM:MeOH 3:2). 20 mg (0.08 mmol) of 
DSC were added to the reaction mixture to push the reaction to completion. After 
dilution of the mixture with dry ethyl acetate, the suspension was centrifuged and 
the supernatant decanted. The product, obtained as pyridinium salt, was washed 
repeatedly with dry ethyl acetate (2 mL) and dried in vacuo. Nearly quantitative 
yields of active esters were obtained. The active ester 33 was used without further 
purification. 
MS ES: 355.5 ((M-2H12) 2, 7 %), 367.1 ((M-H+Na12) 2, 100 %), 368.1 ((M+Na12) 
2, 23 %), 712.0 ((M-2H) 1 , 25 %), 713.0 ((M-H) 1 , 12 %), 714.0 (M', 5 %). 
Rf: 0.80 (DCM: MeOH 4:1) 
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Synthesis of a Cy3 Labelled Peptide: Cy3-(Ala)3-OH 
5 4 	 4• 5• 










34 	 HN 
0 
k-OH 
The active ester 33 (106 mg, 0.14 mmol) was dissolved in DMF (2 mL) and 
allowed to react with the solid-phase bound peptide Ala-Ala-Ala-H (100 mg, 0.051 
mmol), under agitation, for 3 h. The reaction was monitored by qualitative 
ninhydrin test and repeated if required. After completion of the labelling reaction, 
the resin was washed several times with water (4 mL), DMF (4 mL) and DCM (4 
mL) to remove the excess of the unbound dye. The labelled peptide was then 
cleaved from the resin with (95:5) TFA/water (8 mL) for 30 mm; the cleavage was 
repeated twice. The labelled peptide was precipitated with cold diethyl ether, 
centrifuged and dried in vacuo to give a red solid. No further purification was 
required for use in the next step. 
Yield: 32 mg (0.034 mmol, 67 %) 
HPLCIR=5.67min 
ES mlz (%): 413.8 ((M-3H/2) 2 , 100), 567.2 ((M/2+CF3C0O+K)2 , 15), 568.1 
((M/2+H+ CF3COO+K) 2 10), 829.3 ((M-H), 80) 
'H NMR (360 MHz, D20) & 8.30 (t (dd), 1H, JI,2 Z J2,3= 13.5 Hz, CH-H2), 7.74 (s, 
2H, Ar-H4, Ar-H4',), 7.66 (d, 2H, J= 8.2 Hz, Ar-H6, Ar-H6'), 7.15 (d, 1H, J = 8.2 
Hz, Ar-H7 orAr-H7'), 7.12 (d, 1H,J= 8.3 Hz, Ar-H7 orAr-H7'), 6.20 (d, 1H,J= 
12.7 Hz, CH-Hl or CH-H3), 6.17 (d, 1H, J= 13.4 Hz, CH-Hl or CH-H3), 4.16 (q, 
1H, J= 7.2 Hz, CH-Ala), 4.15 (q, IH, J= 7.1 Hz, CH-Ala), 4.04 (q, 1H, J= 7.2 Hz, 
CH-Ala), 3.88 (m, 2H, H-23, CH2-E), 3.40 (s, 3H, NCH3), 2.12 (t, 2H, J = 6.6 Hz, 
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CH2-a), 1.68-1.45 (m, 18H, CH2- + CH2- + 2 x  CH3.CH2-y), 1.25 (d, 3H,J= 7.3 
Hz, CH3.AIa), 1.23 (d, 3H,J= 7.1 Hz, CH3-Ala), 1.18-1.12 (m, 3H, CH3-Ala). 
13C NMR (90 MHz, D20): 8  177.4 (C = N), 177.2 (COOH), 176.6 (CONH), 175.7 
(CONH), 175.5 (CONH), 152.7 (CH, C-2), 145.6 (C-Ar), 145.1 (C-Ar), 142.4 (C-
Ar), 142.3 (C-Ar), 140.6 (C-Ar), 127.7 (CH, Ar-H6, Ar-H6'), 120.8 (CH, Ar-H4 or 
Ar-H4'), 120.6 (CH, Ar-H4 or Ar-H4'), 112.4 (CH, Ar-H7 or Ar-H7'), 112.2 (CH, 
Ar-H7 or Ar-H7'), 105.6, 104.6 (CH, C-i and C-3), 50.5 (C) 50.2 (C) 50.1 (CH-
Ala), 49.6 (CH-Ala), 47.7 (CH-Ala), 45.0 (CH2-E), 35.9 (CH2-a), 32.2 (CH3, 
NCH3), 28.1 (CH3), 27.9 (CH3), 27.6 (CH2-), 26.4 (Cl-12-), 25.8 (CH2-y), 17.7 
(CH3-Ala), 17.6 (CH3-Ala), 17.1 (CH3-Ala). 
FTIR 3295 (m), 2980 (m), 1652 (s), 1552 (s), 1447 (s), 1412 (s), 1176 (s), 1114 (s), 
1066 (s) cm' 
Mp at 248 °C (change of colour and bubbling) 
R1: 0.39 (DCM: MeOH 13:7) 
UV/vis (H20) X= 548 nm, ,= 561 nm 
HRMS for C 39H50N50 11 S2 (M-H): calcd 828.2943, found 828.2948. 
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N, N-disuccinimidyl carbonate (1.7 mg, 6.6 1.tmol)  was added to a solution of 34 
(4.0 mg, 4.2 p.mol) in a mixture of dry DMF (95 .tL) and dry pyridine (5 JAL). The 
reaction mixture was stirred under nitrogen at 50-60 °C for 1.5 h and then diluted 
with dry ethyl acetate (2 mL). After centrifugation, the supernatant was decanted 
and the precipitate washed repeatedly with dry ethyl acetate. To the resulting red 
solid, dissolved in 100 iL of 0.1M TEAB buffer (pH 8.5) were added 100 .tL of 5- 
186 
(3-aminopropargyl)-2'-deoxyuridine 5'-triphosphate (2.0 mg, 2.2 p.mol) in the same 
buffer solution. The reaction mixture was stirred at room temperature for 30 mm-i 
h and then purified by reverse-phase HPLC to afford the nucleotide 35 dUTP-
(Ala)3-Cy3 in 2.1% yield (50 nmol). The purified fraction was freeze-dried and the 
lyophilised red solid obtained characterised by MALDI-TOF analysis and stored at 
—20 °C. 
MALDI-TOF m/z: anal.calcd, 1333; found 1333 (M), 1356 (M+Na). 
HPLC 01565 ) tR = 16.5 mm 
UV/vis (1 x  TE buffer) X= 550 nm 
Succinimidyl ester of pyridinium 2-{(1E,3E,5Z)-5-11-(5-carboxypentyl)-3,3-




Dye 25b (70 mg, 0.10 mmol) was dissolved in a mixture of dry DMF (1 mL) and 
dry pyridine (1 mL). Disuccinimidyl carbonate (DSC) (33 mg, 0.13 mmol) was 
added, and the mixture was stirred at 60 °C for 1 h, under a nitrogen atmosphere. 10 
mg (0.04 mmol) of DSC were added to the reaction mixture to push the reaction to 
completion. After dilution of the mixture with dry ethyl acetate, the suspension was 
centrifuged and the supernatant decanted. The product was washed repeatedly with 
dry ethyl acetate (2 mL) and dried in vacuo. Nearly quantitative yields of active 
esters were obtained. 
HPLC IR = 7.26 mm 
ES - m/z 738.2 (M-2H), 739.1 (M-1H), 740.1 (M). 
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37 	 OH 
The active ester 36 (70 mg, 0.090 mmol) was dissolved in DMF (2 mL) and 
allowed to react with the solid-phase bound peptide PS-Ala-Ala-Ala-H (80 mg, 
0.045 mmol), under agitation, for 3 h. The reaction was monitored by qualitative 
ninhydrin test and repeated if required. After completion of the labelling reaction, 
the resin was washed several times with water (4 mL), DMF (4 mL) and DCM (4 
mL) to remove the excess of the unbound dye. The labelled peptide was then 
cleaved from the resin with (95:5) TFA/water (8 mL) for 30 mm; the cleavage was 
repeated twice. The labelled peptide was precipitated with cold diethyl ether, 
centrifuged and dried in vacuo to give 38 mg (98%) of a blue solid which was 
purified by reverse-phase HPLC. 
Yield: 26 mg (0.027 mmol, 60 %) 
HPLC IR = 5.7 min 
ESmIz 426.7 (M-3H12) 2, 854.1 (M-2H. 
'H NMR ( 360 MHz, D20) ö: 7.97 (t (dd), 2H, Ji,2 	J3,4 45 = 13.0 Hz, CH- 
H2+ CH-H4), 7.83 (d, 2H, I = 1.5 Hz, Ar-H4, Ar-H4'), 7.79 (dd, 2H, I = 8.4, 1.5 
Hz, Ar-H6, Ar-l-16'), 7.29 (d, 2H, J = 8.1 Hz, Ar-H7, Ar-FIT), 6.46 (t (dd), lH, J23 
J,4 =12.5 Hz, CH-H3), 6.16 (d, 11-1,1 = 13.4 Hz, CH-HI or CH-H5), 6.14 (d, 1H, 
J = 13.4 Hz, CH-HI or CH-H5), 4.30 (q, 1,1 = 7.0 Hz, CH-Ala), 4.28 (q, 1H, .1 
= 7.1 Hz, CH-Ala), 4.18 (q, 1H, J = 7.1 Hz, CH-Ala), 4.03 (t, 2H, .1 = 5.7 Hz, 
CH2-s), 3.56 (s. 3H, NCH3), 2.26 (t, lH, I = 6.7 Hz, CH2-a), 2.25 (t, 2H, I = 6.4 
Hz, CH2-8), 1.81-1.76 (m, 2H, C1-h-3), 1.65-1.60 (m, 14H, 2 x  CH3, CH2-y), 1.38 
(d, 6H, J = 7.2 Hz, 2 x  CH3-Ala), 1.29 (d, 3H, J = 7.1 Hz, CH3-Ala). 
' 3C NMR (90 MHz, D20): 6  177.7 (C = N), 177.4 (COOH), 175.8 (CONH), 175.4 
(CONH), 174.7 (CONH), 152.8, 152.6 (CH, C-2, C-4),145.9 (C-Ar), 145.4 (C-Ar), 
142.7 (C-Ar), 140.1 (C-Ar), 140.0 (C-Ar), 127.5 (CH, Ar-H6, Ar-H6'), 126.9 (CH-
3),120.7 (CH, Ar-H4 or Ar-H4'), 120.6 (CH, Ar-H4 or Ar-H4'), 112.0 (CH, Ar-H7 
or Ar-H7'), 111.9 (CH, Ar-H7 or Ar-H7'), 105.4, 104.9 (CH-1, CH-5), 50.5 (C), 
50.3 (C), 50.1 (CH-Ala), 50.0 (CH-Ala), 49.9 (CH-Ala), 44.9 (C1-h-), 36.0 (CH2-
a), 32.1 (NCH3), 27.9 (CH2-5), 27.8 (CH3), 27.7 (CH3), 27.6 (C1-2-0), 25.9 (CH2-7), 
17.7 (CH3-Ala), 17.6 (CH 3-Ala) 17.3 (CH 3-Ala). 
FTIR 3276 (w), 2933 (w), 2362 (w), 1652 (m), 1497 (s), 1462 (s), 1367 (m), 1316 
(m), 1192 (s), 1154(s), 1098 (s), 1015 (s), 920 (s), 817 (s), 738 (s) cm' 
Mp at 240 °C (change of colour and bubbling) 
Rf: 0.46 (DCM: MeOH 13:7) 
UV/vis (H20) A,= 647, em  661 nm 
HRMS for C41 H53N 50 11 S2 (M-H): calcd 854.3099, found 854.3100. 
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N, N-disuccinimidyl carbonate (2.0 mg, 7.4 tmol) was added to a solution of 37 
(6.0 mg, 6.2 imol) in a mixture of dry DMF (95 .tL) and dry pyridine (5 tL). The 
reaction mixture was stirred under nitrogen at 50-60 °C for 1.5 h and then diluted 
with dry ethyl acetate (2 mL). After centrifugation, the supernatant was decanted 
and the precipitate washed repeatedly with dry ethyl acetate. To the resulting blue 
solid, dissolved in 100 tL of 0.1M TEAB buffer (pH 8.5) were added 100 PL of 5-
(3-aminopropargyl)-2'-deoxycytidine 5'-triphosphate (3.0 mg, 3.2 .imol) in the 
same buffer solution. The reaction mixture was stirred at room temperature for 30 
min-1 h and then purified by reverse-phase HPLC to afford the nucleotide 38 
dCTP-(Ala) 3-Cy5 in 1% yield (30 nmol). The purified fraction was freeze-dried and 
the lyophilised blue solid obtained characterised by MALDI-TOF analysis and 
stored at - 20 °C. 
MALDI-TOF m/z: anal.calcd, 1360; found 1358 (M-2H), 1360 (M), 1380 (M-
2H+Na). 
HPLC (?9) 1R = 17.9 mm 
UV/vis (1 x  TE buffer) X= 648 nm 
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Succinimidyl ester of 2-{( I E,3E,5Z)-5-E 1-(5-carboxypentyl)-3,3-dimethyl- 1,3-
dihydro-2H-indot-2-ylidene]-1,3-pentadienyl}-1 ,3,3-trimethyl-3H-indolium 
bromide 
Dye 20c (60 mg, 0.11 mmol) was dissolved in a mixture of dry DMF (1 mL) and 
dry pyridine (1 mL). Disuccinimidyl carbonate (DSC) (54 mg, 0.20 mmol) was 
added, and the mixture was stirred at 60 °C for 1 h, under a nitrogen atmosphere. 
After dilution of the mixture with dry diethyl ether, the suspension was centrifuged 
and the supernatant decanted. The product was washed repeatedly with diethyl 
ether (2 ml-) and dried in vacuo. The active ester 39 was used without further 
purification. 
HPLC IR = 6.85 mm. 
ESmIz (%) 580.5 (Mi, 100), 581.5 ((M+H), 40), 582.5 ((M+H)2 , 10). 
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The active ester 39 (70 mg, 0.11 mmol) was dissolved in DMF (2 mL) and allowed 
to react with the solid-phase bound peptide PS-Ala-Ala-Ala-H (100 mg, 0.056 
mmol), under agitation, for 3 h. The reaction was monitored by qualitative 
ninhydrin test and repeated if required. After completion of the labelling reaction, 
the resin was washed several times with DMF (4 mL), MeOH (4 mL) and DCM (4 
mL) to remove the excess of the unbound dye. The labelled peptide was then 
cleaved from the resin with (95:5) TFA/DCM (8 mL) for 30 mm; the cleavage was 
repeated twice. The labelled peptide was precipitated with cold diethyl ether, 
centrifuged and dried in vacuo to give 44 mg (98%) of a blue solid which was used 
for the next step without further purification. 
'H NMR (500 MHz, MeOD) 8H  8.24 (t, (dd), 2H, J,,2 J2, 3 J3,4 = J4,5 = 13.0 Hz, 
CH-H2 + CH-144), 7.49 (d, 2H, I = 7.4 Hz, Ar-H4, Ar-H4'), 7.41 (t (dd), 2H, J5, 
J6,7 = 7.5 Hz, Ar-H6, Ar-H6'), 7.29 (d, 1,1 = 7.5 Hz, Ar-H7 or Ar-H7'), 7.28 (d, 
I H, J = 7.5 Hz, Ar-H7 or Ar-H7'), 7.26 (t (dd), 2H, J4,5 Z J5.6 Z 7.5 Hz, Ar-H5, Ar-
H5'), 6.62 ((t (dd), 1H, J23 J3,4 = 12.4 Hz, CH-H3), 6.33 (d, 1H, J = 13.8 Hz, CH-
HI or H5), 6.29 (d, IH, I = 13.8 Hz, CH-Hl or H5), 4.38 (q, IH, I = 7.1 Hz, CH-
Ala), 4.35 (q, IH,J= 7.1 Hz, CH-Ala), 4.32 (q, 1H,J= 7.1 Hz, CH-Ala),.4.11 (t, 
IH, I = 7.33 Hz, CH2, CH2-E), 3.63 (s, 3H, NCH3), 2.30 (t, 1H, I = 7.4 Hz, CIE-a), 
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2.28 (t, 1H, J = 7.1 Hz, CH2-), 1.87-1.69 (m + s, 16H, CI-12-J3, CH2-y + 2 x  CH3), 
1.44-1.38 (m, 10 H, H-35, 2 x  CH3-Ala), 1.36 (d, 3H,J = 7.2 Hz, CH 3-Ala). 
' 3C NMR (126 MHz, MeOD) öc 176.0 (CN), 175.8 (CN), 175.3 (COOH), 174.8 
(CONH), 174.7 (CONH), 174.5 (CONH), 155.6 (CH-2 or CH-4), 155.5 (CH-2 or 
CH-4),144.3 (C-Ar), 143.6 (C-Ar), 142.7 (C-Ar), 142.6 (C-Ar), 129.8 (CH, Ar-H6 
or Ar-H6'), 129.7 (CH, Ar-H6 or Ar-H6'), 126.8 (CH, H-3), 125.8, 125.7 (CH, Ar-
H5, Ar-H5'), 123.4 (CH, Ar-H4 or Ar-144'), 123.3 (CH, Ar-H4 or Ar-144'), 112.1 
(CH, Ar-H7 or Ar-H7'), 111.8 (CH, Ar-H7 or Ar-147'), 104.4 (CH-1, CH-5), 51.0 
(C), 50.6 (C), 50.5 (CH-Ala), 50.4 (CH-Ala), 50.1 (CH-Ala), 44.9 (CH-c), 36.2 
(CH2-a), 31.8 (NCII 3 ), 28.2 (CH2-8), 27.9 (CII 3), 27.8 (CH3), 27.2 (C1-I2-), 26.4 
(CH2-y), 18.3 (CH 3-Ala), 18.0 (CH3-Ala), 17.7 (CH 3-Ala). 
ESmIz (%) 696.6 (M, 100), 413.4 (M 2/2, 25) 
HPLC tR = 8.71 mm 
FTIR 3267 (w), 2930 (w), 1628 (s), 1481 (s), 1449 (s), 1368 (m), 1332 (m), 1146 
(s), 1090 (s), 920 (s), 829 (s), 795 (s) cm' 
Mp 123-125 °C 
R1: 0.24 (DCM: MeOH 13:7) 
UV/vis (MeOH) A= 642, A,m= 661 flfll 
HRMS (ES) for C41 II54N 505 (M): calcd 696.41195, found 696.41173 
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A solution of N, N-disuccinimidyl carbonate (2.8 mg, 11.0 .imo1) in DMF (50 L) 
was added to a solution of 40 (6.0 mg, 7.4 tmo1) in a mixture of dry DMF (95 p.tL) 
and dry pyridine (5 iL). The reaction mixture was stirred under nitrogen at 50-60 
°C for 1-2 h and then diluted with dry ethyl acetate (2 mL). After centrifugation, the 
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supernatant was decanted and the precipitate washed repeatedly with dry ethyl 
acetate. To the resulting blue solid, dissolved in 100 tL of a solution (1:9) 
acetonitrile/0.1M TEAB buffer (pH 8.5) were added 100 pL of 5-(3-
aminopropargyl)-2'-deoxycytidine 5'-triphosphate (4.0 mg, 4.3 .imol) in the same 
buffer solution. The reaction mixture was stirred at room temperature for 30 mm-i 
h and then purified by reverse-phase HPLC to afford the nucleotide 41 dCTP-
(Ala) 3-Cy5 in 1.4% yield (60 nmol). The purified fraction was freeze-dried and the 
lyophilised blue solid obtained characterised by MALDI-TOF analysis and stored at 
—20 °C. 
MALDI-TOF m/z: anal.calcd, 1199; found 1197 (M-3H), 1199 (M). 
HPLC(A9)tR=28.8min 
UV/vis (1 x  TE buffer) A 	642 nm 
N_{6-(diethylamino)-9-[2-(1-piperazinylcarbonyl)-phenyll-3H-Xaflthefl-3-
ylidene}-N-diethyl-ammonium chloride 165 
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To a 2.0 M solution of trimethyl aluminium in toluene (2.30 mL, 4.5 mmol), a 
solution of piperazine (0.78 g, 9.1 mmol) in CH2C12 (3.5 mL) was added dropwise. 
After one hour of stirring, a white precipitate was observed. A solution of 
Rhodamine B base (1.0 g, 2.3 mmol) in 2.0 mL of C11202 was added dropwise to 
the heterogeneous solution. Gas evolution was observed during the adding period. 
After stirring at reflux for 24 h, 0.1 M aqueous solution of HC1 was added dropwise 
until gas evolution cessed. The heterogeneous solution was filtered and the solid 
was rinsed with CH2C12 and a solution 4:1 CH202: MeOH. The filtrate was 
concentrated and the residue was dissolved in CH 2C12, filtered to remove insoluble 
salts and concentrated again. The resulting glassy solid was then portioned between 
dilute aqueous NaHCO3 and EtOAc. After isolation, the aqueous layer was washed 
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with 3 additional portions of EtOAc to remove residual starting material. The 
aqueous layer was saturated with NaCl, acidified with 0.1 M HC1 and then 
extracted with 1:2 CH202: iPrOH. The organic layer was dried over anhydrous 
Na2SO4, filtered and the solvent was removed in vacuo. The glassy purple solid was 
then precipitated in Et20 and dried under high vacuum. The product 42 was 
obtained as a dark purple solid 0.76 g (67%). 
'H NMR (360 MHz, CD30D): ö 7.81-7.78 (2H, m, Ar-H3', Ar-H5'), 7.70 (1H, m, 
Ar-H6'), 7.54 (1H, m, Ar-H4'), 7.32 (2H, d, .1= 9.5 Hz, Ar-ill, Ar-H8), 7.07 (2H, 
dd, J= 9.6 Hz, J= 2.5 Hz, Ar-H2, Ar-H7), 7.02 (2H, d, J= 2.4 Hz, Ar-H4, Ar-H5), 
3.73 (8H, q, J= 7.1 Hz, CH2-Et), 3.37 (4H, hr s, CH2-2, CH2-6), 2.38 (4H, br s, 
CH2-3, CH2-5), 1.33 (12H, t, J= 7.1 Hz, CH3-Et). 
'3C NMR (90 MHz, CD30D): 8 169.1 (C=O), 158.9 (C-Ar), 156.8, 156.6 (C-Ar), 
136.4 (C-Ar), 132.9 (Ar-HI, Ar-H8), 131.7 (Ar-H4'), 131.4 (Ar-H3', Ar-H5'), 
131.0 (C-Ar), 130.8 (Ar-H6'), 128.5 (C-Ar), 115.1 (Ar-H2, Ar-H7), 114.5 (C-Ar), 
97.0 (Ar-H4, Ar-H5), 46.6 (CH2-Et), 46.2 (CH 2-2, CH2-6), 45.6 (CH2-3, CH2-5), 
12.6 (CH3-Et). 
HPLC (A.565) tR 5.56 mm (method 1). 
ESm/z (%) 256.3 ((M+H)2 /2, 30), 511.6 (M, 100) 512.7 (M+H, 30). 
FTIR 3331 (w), 2979 (w), 1626 (s), 1586 (s), 1445 (s), 1412 (s), 1334 (s), 1275 (s), 
1252 (s), 1178 (s), 1132 (s), 1075 (m), 1046 (m), 977 (m), 848 (sm, 795 (m) cm' 
Mp 223-225 °C (lit. 218-220 °C)' 65 
Rf: 0.25 (iPrOH:H20:NH40H 11:2:7) 
HRMS (ES) for C32H39N402 (M): calcd 511.30675, found 511.30728 
UV/vis (MeOH) X,,,= 561, A.,I= 581 flm 
195 
(9-{2-14-(3-carboxy-propionyl)-piperazine-1-carbonyll-phenyl}-6-
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To a stirred solution of 42 (450 mg, 0.88 mmol), succinic anhydride (90 mg, 0.88 
mmol) and DMAP (110 mg, 0.88 mmol) in CH 202, triethylamine was added. After 
stirring at room temperature for 24 h, the reaction mixture was portioned between 
AcOEt and 1 M aqueous K2CO3. The aqueous layer was washed with additional 
portions of AcOEt. NaCl was added to the isolated aqueous layer until saturation 
was achieved and the solution was extracted with 'PrOH: CH 202 2:1 .The organic 
layer was dried over Na 2SO4 and concentrated under reduced pressure. The 
resulting solid was dissolved in CH 3C13 and filtered to remove insoluble salts. Upon 
concentration, the product 43 was obtained as a dark-red solid, 526 mg (98%). 
'H NMR (360 MHz, CD30D): 6 7.78-7.76 (2H, m, Ar-H3', Ar-H5'), 7.71-7.69 
(ill, m, Ar-H6'), 7.53-7.50 (1H, m, Ar-114'), 7.28 (2H, d, J= 9.5 Hz, Ar-Hi, Ar-
118), 7.08 (2H, d, J= 9.6, Ar-H2, Ar-117), 7.00 (2H, d, J= 2.5 Hz, Ar-H4, Ar-H5), 
3.69 (8H, q, J= 7.2 Hz, CH2-Et), 3.44 (411, br s, C11 2-2, CH2-6), 3.38 (4H, br s, 
CHI-3, CH2-5), 2.56 (2H, t, J= 7.3 Hz, CH2-a), 2.40 (211, t, J= 7.1 Hz, CH2-0), 1.30 
(12H, t, J= 7.1 Hz, CH3-Et). 
'3C NMR (90 MHz, CD30D): 8 180.2 (COOH), 173.5 (C0), 169.2 (C0), 158.9 
(C-Ar), 158.8 (C-Ar), 136.2 (C-Ar), 132.9 (Ar-Hi, Ar-H8), 131.9 (Ar-114'), 131.4 
(Ar-113', Ar-H5'), 130.9 (Ar-116'), 128.6 (C-Ar), 115.1 (Ar-H2, Ar-H7), 114.5 (C-
Ar), 97.0 (Ar-H4, Ar-115), 46.6 (CH 2-Et), 42.8 (CH2-2, CH2-6), 42.5 (CH2-3, C112- 
5), 33.4 (CH2, C112-a), 30.2 (CH2-3), 12.6 (CH 3 -Et). 
IIPLC 0565) tR 6.76 mm (method 1). 
ESm/z (%) 611.7 (M, 100). 
FTIR 2977 (w), 1631 (s), 1588 (s), 1446 (s), 1411 (s), 1336 (s), 1274 (s), 1246 (s), 
1222 (s), 1178 (s), 1131(s), 1075 (m), 1005 (m), 976 (m), 820 (m), 750 (m) cm -1 
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Mp 167-169 °C (lit. 166-168 'C) 165 
Rf : 0.52 (DCM:MeOH 9:1) 
HRMS (ES) for C36H43N405 (M): calcd 611.32280, found 611.32208 
UV/vis (MeOH) A,= 560, Aem= 580 nm 
Succinimidyle ester of (9-12-[4-(3-carboxy-propionyl)-piperazine-1-carbonyl]-
phenyl}-6-diethylamino-xanthen-3-ylidene)-diethyl-ammonium; chloride 
CI- 
))Lf  3 
NEt2 
44 
Dye 43 (116 mg, 0.18 mmol) was dissolved in a mixture of dry DMF (1 ML) and 
dry pyridine (1 mL). Disuccinimidyl carbonate (DSC) (69 mg, 0.27 mmol) was 
added, and the mixture was stirred at 60 °C for lh, under a nitrogen atmosphere. 
After dilution of the mixture with dry diethyl ether, the suspension was centrifuged 
and the supernatant decanted. The product was washed repeatedly with diethyl 
ether, dried in vacuo and used for the enxt step without further purification. 
HPLC (),550) IR  5.07 mm 
MS (ES): m/z (%) 708.3 [M, 100], 709.3 [(M+1), 40], 709.3 [(M+2), 10] 
R1: 0.68 (DCM:MeOH 9:1) 
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Synthesis of a Rho B Labelled Peptide: Rho -(Ala) 3-OH 
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The active ester 44 (134 mg, 0.18 mmol) was dissolved in DMF (2 mL) and 
allowed to react with the solid-phase bound peptide PS-Ala-Ala-Ala-H (100 mg, 
0.056 mmol), under agitation, for 3 h. The reaction was monitored by qualitative 
ninhydrin test and repeated if required. After completion of the labelling reaction, 
the resin was washed several times with DMF and DCM to remove the excess of 
the unbound dye. The labelled peptide was then cleaved from the resin with 
TFAlwater (95:5) for 30 mm; the cleavage was repeated twice. The labelled peptide 
was precipitated with cold diethyl ether, centrifuged and dried in vacuo to give 43 
mg (93%) of a blue solid which was used for the next step without further 
purification. 
'H NMR (360 MHz, D20): 6 7.83-7.72 (m, 2H, Ar-H3', Ar-H5'), 7.58 (d, 1H, J 
7.7 Hz, Ar-H6'), 7.56-7.50 (m, 1H, Ar-H4'), 7.09-7.04 (m, 2H, Ar-Hi, Ar-H8), 
6.87-6.80 (m, 2H, Ar-H2, Ar-H7), 6.65-6.64 (m, 2H, Ar-H4, Ar-H5), 4.25 (q, 1H, J 
= 7.3 Hz, CH-Ala), 4.20 (q, 1H,J= 7.1 Hz, CH-Ala), 4.12 (q, 1H, J= 7.1 Hz, CH-
Ala ), 3.44-3.55 (m, 8H, CH2-Et), 3.23 (br s, 2H, CH2-2, CH2-6), 3.23 (br s, 211, 
CH2-3, CH2-5), 2.57-2.40 (m, 411, CH2-a), 1.28 (m, 9H, CH 3-Ala), 1.14 (t, 1211, J 
6.9 Hz, CH3-Et). 
' 3C NMR (90 MHz, D20): 6 176.0 (COOH), 175.3 (C0), 173.7, 173.6, 173.4 
(CONH), 170.8 (C=O), 157.9 (C-Ar), 156.2 (C-Ar), 154.3 (C-Ar), 135.0 (C-Ar), 
133.3 (Ar-HI, Ar-H8), 132.3 (Ar-H4'), 131.6 (Ar-H3', Ar-H5'), 131.1 (Ar-H6'), 
128.9 (C-Ar), 115.0 (Ar-H2, Ar-H7), 113.4 (C-Ar), 97.2 (Ar-H4, Ar-H5), 50.9, 
50.0, 49.4 (3 x  CH-Ala), 46.8 (CH 2-Et), 42.8, 42.6, 42.4, 41.5 (CH2-2, CH2-3, CH2-
5, CH2-6), 30.8 (CH2, CH2-a), 28.9 (CH 2-3), 17.3, 17.2, 17.1 (3 x  CH3-Ala), 12.9 
(CH3-Et). 
Im 
HPLC 01565) tR 7.54 mm 
ESm/z (%) 824.9 (M i, 100), 413.4 (M/2, 47) 
FTIR 3291 (w), 2977 (w), 1644 (s), 1587 (s), 1465 (s), 1411(s), 1336 (s), 1274 (s), 
1246 (s), 1177(s), 1128 (s), 1072 (m), 1006 (m), 921 (m), 822 (m), 796 (m) cm -1 
Mp 113-115°C. 
R1: 0.30 (DCM:MeOH 9:1) 
UV/vis (MeOH) Aex= 560, ?= 581 nm 
HRMS (ES) for C 45 H5 8N708 (M): calcd 824.434 14, found 824.43470 
Synthesis of dUTP-(Ala) 3-Rho 
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A solution of N, N-disuccinimidyl carbonate (3.6 mg, 11.0 p.mol) in DMF (50 1.tL) 
was added to a solution of 45 (8.0 mg, 9.3 1.tmol) in a mixture of dry DMF (95 L) 
and dry pyridine (5 tL). The reaction mixture was stirred under nitrogen at 50-60 
°C for 1-2 h and then diluted with dry ethyl acetate (2 mL). After centrifugation, the 
supernatant was decanted and the precipitate washed repeatedly with dry ethyl 
acetate. To the resulting blue solid, dissolved in 100 .tL of 0.1 M TEAB buffer (pH 
8.5) were added 100 i.L of 5-(3-aminopropargyl)-2'-deoxyuridine 5'-triphosphate 
(3.0 mg, 3.2 tmol) in the same buffer solution. The reaction mixture was stirred at 
room temperature for 30 mm- 1 h and then purified by reverse-phase HPLC to 
afford the nucleotide 46 dUTP-(Ala) 3-Rho in 1.5% yield (50 nmol). The purified 
fraction was freeze-dried and the lyophilised red solid obtained characterised by 
MALDI-TOF analysis and stored at - 20 °C. 
MALDI-TOF m/z: anal.calcd, 1327; found 1326 (M-H). 
HPLC (A.565) 1R = 23.9 mm 
UV/vis (1 x  TE buffer) A.max = 567 nm 
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(4)5-{ I(5-carboxypentyl)aminol carbonyl}-2-(3,6-dihydroxy-9H-xanthen-9-
yl)benzoic acid' 64  
OH 
47 
5(6)-Carboxyfluorescein (100 mg, 0.27 mmol) in DMF (3 mL) was treated with 
PyBOP (211 mg, 0.41 mmol) for 2 mm, then 6-aminohexanoic acid methyl ester 
hydrochloride (95 mg, 0.52 mmol) and DIEA (185 j.tL, 1.08 mmol) were added and 
the reaction mixture heated at 60 °C for 20 min under microwave irradiation. The 
reaction mixture was evaporated under reduced pressure, dissolved in CH 202 (3 
mL) and treated with 2M HC1 (3 mL). The brown precipitate was dissolved in (2:1) 
'PrOH/CH2C12 (3 mL) and washed with brine (3 mL x  3). The organic layer was 
dried over Na2SO4, and concentrated under reduced pressure. The resulting solid 
was dissolved in water/THF (2 mL) and stirred with 2M LiOH (2 mL) for 2h. The 
reaction mixture was evaporated under reduced pressure, dissolved in H20 (2 mL) 
and treated with 2 M HC1. The precipitate was then washed with water, filtered and 
freeze-dried. Product 47 was obtained as orange-brown solid 114 mg (85%). 
'H NMR (360 MHz, CD30D): oH 8.41 (s, 1H, H-7, isomer 6), 8.19 (dd, 1H, J = 
8.0, 1.3 Hz, H-5, isomer 6), 8.12 (dd, 1H, J = 8.1, 0.9 Hz, H-6, isomer 5), 8.07 (d, 
IH, J = 8.2 Hz, H-7, isomer 5), 7.60 (s, 1H, H-4, isomer 5), 7.29 (d, 1H, J = 7.9 
Hz, H-4, isomer 6), 6.69 (d, 2H, J = 1.8 Hz, H-o, isomer 5 & 6), 6.61 (d, IH, .1 = 
8.7 Hz, H-m, isomer 5), 6.60 (d, 1H, J = 8.7 Hz, H-m, isomer 6), 6.54 (td, 2H, J = 
8.7, 2.7 Hz, H-p, isomer 5 & 6), 3.44 (t, 2H, J = 7.1 Hz, CH2-E, isomer 6), 3.33 (t, 
2H, J = 6.9 Hz, CH2-c, signal partially obscured by CD 30D peak, isomer 5), 2.33 
(t, 2H, J = 7.3 Hz, CH2-a, isomer 6), 2.26 (t, 2H, J = 7.3 Hz, CH2-a, isomer 5), 
1.68 (quintet, 411 J = 7.0 Hz, CH2-, CH2-8, isomer 6), 1.58 (quintet, 4H .J = 7.7 
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Hz, CH2-3, CH2-, isomer 5), 1.46 (quintet, 2H, J = 6.9 Hz, CH2-y, isomer 6), 1.35 
(quintet, 2H J = 7.2 Hz, CH2-y, isomer 5). 
' 3C NMR (90 MHz, DMSO): öc 176.0 (COOH), 169.7 (C=O), 169.6 (C0), 166.0 
(CO), 165.8 (C=O), 161.2 (C-Ar), 156.0 (C-Ar), 154.0 (C-Ar), 153.3 (C-Ar), 
142.2 (C-Ar), 137.9 (C-Ar), 136.1 (CH, C-5, isomer 6),130.7 (CH, C-6, isomer 5), 
130.6 (CH, m), 129.7 (C-Ar), 128.0 (C-Ar), 126.4 (CH, C-7, isomer 5),125.7 (CH, 
C-4, isomer 6), 124.7 (CH, C-7, isomer 6), 123.8 (CH, C-4, isomer 5), 114.3 (CH, 
p), 114.2 (CH, p), 110.7 (C-Ar), 110.6 (C-Ar), 103.8 (CH, o), 83.4 (C), 40.7 (CH2 -
c), 35.2 (CH2-a), 35.1 (CH2-a), 30.2 (CH2-8), 30.1 (CH2-8), 27.5 (CH2-3), 25.8 
(CH2-y), 25.7 (CH2- y). 
FTIR 2930 (w), 1710 (m), 1585 (s), 1537 (s), 1454 (m),1265 (s), 1239 (s), 1208 (s), 
1112 (s), 849 (s). 
HPLC (? o) tR 5.05 mm 
ES- m/z (%) 488.2 (M-1) 
Mp 180-185 °C 
HRMS (ES) for C27H24N 1 08 (M): calcd 490.14964, found 490.14961 
Rf: 0.20 (DCM:MeOH 4:1) 
UV/vis (MeOH) A,,= 492, A,,= 517 nm 
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Dye 47 (118 mg, 0.24 mmol) was dissolved in a mixture of dry DMF (1 mL) and 
dry pyridine (1 mL), 200 j.tL of DMSO were added to aid the solubilisation of 47. 
Disuccinimidyl carbonate (DSC) (123 mg, 0.48 mmol) was added, and the mixture 
was stirred at 60 °C for lh, under a nitrogen atmosphere. After dilution of the 
mixture with dry diethyl ether, the suspension was centrifuged and the supernatant 
decanted. The product was washed repeatedly with diethyl ether and dried in vacuo 
to afford a yellow solid. 
MS (ES): m/z (%) 585.1 [(M-l), 100], 586.1 [M, 35]. 
Rf: 0.73 (DCM:MeOH4:l) 
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The active ester 48 (106 mg, 0.18 mmol) was dissolved in DMF (2 mL) and 
allowed to react with the solid-phase bound peptide PS-Ala-Ala-Ala-H (100 mg, 
0.056 mmol), under agitation, for 3 h. The reaction was monitored by qualitative 
ninhydrin test and repeated if required. After completion of the labelling reaction, 
the resin was washed several times with DMF (4 mL), 20 % piperidine in DMF (4 
mL), DMF (4 mL), and DCM (4 mL) to remove the excess of the unbound dye. The 
labelled peptide was then cleaved from the resin with (95:5) TFAlwater (8 mL) for 
30 mm; the cleavage was repeated twice. The labelled peptide was precipitated with 
cold diethyl ether, centrifuged and dried in vacuo to give 43 mg (93%) of a yellow 
solid which was used for the next step without further purification. 
'H NMR (500 MHz, CD30D): oH 8.82 (t, 1H, J = 5.6 Hz, NH, isomer 6), 8.69 (t, 
1H, J = 5.5 Hz, NH, isomer 5), 8.45 (s, 1H, H-7, isomer 6), 8.22 (dd, 1H, J = 8.0, 
1.6 Hz, H-5, isomer 6), 8.16 (dd, 1H, J = 8.1, 1.4 Hz, H-6, isomer 5), 8.11 (d, lH, J 
= 7.9 Hz, H-7, isomer 5), 7.63 (s, 1H, H-4, isomer 5), 7.33 (d, 1H, J = 8.0 Hz, H-4, 
isomer 6), 6.73 (d, 2H, J = 1.7 Hz, H-o, isomer 5 & 6), 6.65 (d, 1H, J = 8.2 Hz, H-
m, isomer 5), 6.64 (d, 1H, J = 8.1 Hz, H-m, isomer 6), 6.60-6.57 (m, 2H, H-p, 
isomer S & 6), 4.38 (q, 1H, J = 7.1 Hz, CH-Ala), 4.35 (q, 1H, J = 7.2 Hz, CH-Ala), 
4.31 (q, 1H, J = 7.2 Hz, CH-Ala), 3.47 (t, 2H, J = 7.0 Hz, CH2-E, isomer 6), 3.33 (t, 
2H, J = 6.9 Hz, CH2-E, isomer 5, signal obscured by CD 30D peak), 2.30 (t, 2H, J = 
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7.3 Hz, CH2-a, isomer 6), 2.23 (t, 2H, J = 7.6 Hz, CH2-a, isomer 5), 1.75-1.67 (m, 
4H, CH2-, CH2-6, isomer 6), 1.60 (ddd, 4H .1 = 7.2 Hz, CH2-0, CH2-, isomer 5), 
1.47 (quintet, 2H, J = 7.6 Hz, CH2-'y, isomer 6), 1.42-1.32 (m, 1 IH, CH2-y, isomer 
5, 3 x  CH-Ala). 
' 3C NMR (126 MHz, CD30D): öc 175.7 (COOH), 175.3 (CO), 174.5 (CO), 
174.1 (C=O), 170.1 (C=O), 167.9 (C=O), 167.7 (C=O), 161.4 (C-Ar), 153.9 (C-Ar), 
142.0 (C-Ar), 137.7 (C-Ar), 135.0 (CH, C-5, isomer 6),130.0 (CH, m), 129.9 (CH, 
C-6, isomer 5), 128.4 (C-Ar), 126.0 (CH, C-7, isomer 5), 125.5 (CH, C-4, isomer 
6), 124.6 (CH, C-7, isomer 6), 123.8 (CH, C-4, isomer 5), 113.6 (CH, p), 110.7 (C-
Ar), 103.2 (CH, o), 50.0, 49.9, 49.7 (3 x  CH-Ala), 40.7 (CH2-E), signals partially 
obscured by CD30D peak, 45.5 (C), 45.4 (C), 36.2, 36.1 (CH2-a, isomer 5 and 6), 
29.7, 29.6 (CH2-8, isomer Sand 6), 27.2, 27.1 (CH2-0, isomer 5 and 6), 26.4, 26.0 
(CH2-y, isomer  and 6), 17.8, 17.6, 17.5, 17.2, 17.1 (3 x  CH3-Ala, isomer S and 6). 
HPLC (Ao) tR 7.07 
ES m/z (%) 701.4 ((M-1H), 100), 723.4 ((M-2H+ Na), 47), 350.8 ((M-1H) 2/2, 
37), 
Rf: 0.77 (DCM:MeOH 4:1) 
UV/vis (MeOH) X= 492, Aem= 517 flm 
IR (neat) 3467, 2928, 2861, 2361, 2342, 1737, 1655, 1407, 1254, 1062, 864, 819 
cm 1 . 
HRMS (ES) for C36H39N4011 (M): calcd 703.26098, found 703.25936 
204 





H2N 	 H 
 
O 	0 	0 I 	 - o / OH 11 11 11 
_O-P --O -p-O -P 0 
I 
O_ O 	OIj 	
0 
OH 	 50 
A solution of N, N-disuccinimidyl carbonate (3.6 mg, 11.0 .tmol) in DMF (50 tL) 
was added to a solution of 49 (8.0 mg, 9.3 imol) in a mixture of dry DMF (95 gL) 
and dry pyridine (5 l.LL). The reaction mixture was stirred under nitrogen at 50-60 
°C for 1-2 h and then diluted with dry ethyl acetate (2 mL). After centrifugation, the 
supernatant was decanted and the precipitate washed repeatedly with dry ethyl 
acetate. To the resulting yellow solid, dissolved in 100 tL of 0.1 M TEAB buffer 
(pH 8.5) were added 100 p1 of 8-(3-aminopropargyl)-2'-deoxyguanosine 5'-
triphosphate (4.0 mg, 4.1 tmol) in the same buffer solution. The reaction mixture 
was stirred at room temperature for 30 mm- I h and then purified by reverse-phase 
HPLC to afford the nucleotide 50 dGTP-(Ala) 3 -FAM. The purified fraction was 
freeze-dried and the lyophilised yellow solid obtained characterised by MALDI-
TOF analysis and stored at —20 °C. 
MALDI-TOF m/z: anal.calcd, 1244; found, 1258 (M-4H+N1-L1) 
HPLC (A491 ) 1R = 24.3 and 25.5 mm 
UV/vis (1 x  TE buffer) A= 498 nm 
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Synthesis of dCTP-(Ala) 3-FAM 
o o 0 
II 	II 	II 
- o--o-I,-o1,-o 
o_ o o 
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A solution of N, N-disuccinimidyl carbonate (3.6 mg, 11.0 l.lmol) in DMF (50 iL) 
was added to a solution of 50 (5.0 mg, 5.8 tmol) in a mixture of dry DMF (95 .tL) 
and dry pyridine (5 .tL). The reaction mixture was stirred under nitrogen at 50-60 
°C for 1-2 h and then diluted with dry ethyl acetate (2 mL). After centrifugation, the 
supernatant was decanted and the precipitate washed repeatedly with dry ethyl 
acetate. To the resulting yellow solid, dissolved in 100 p1 of 0.1 M TEAB buffer 
(pH 8.5) were added 100 p1 of 5-(3-aminopropargyl)-2'-deoxycytidine 5'-
triphosphate (2.0 mg, 2.2 imol) in the same buffer solution. The reaction mixture 
was stirred at room temperature for 30 mm- 1 h and then purified by reverse-phase 
HPLC to afford the nucleotide 51 dCTP-(Ala)3-FAM. The purified fraction was 
freeze-dried and the lyophilised yellow solid obtained characterised by MALDI-
TOF analysis and stored at —20 °C. 
MALDI-TOF m/z: anal.calcd, 1204; found 1202 (M-2H), 1204 (M), 1224 (M-
3H+Na). 
HPLC (A49 1 ) IR = 22.7 and 25.4 mm 
UV/vis (1 x  TE buffer) X,ax=  498 nm 
6.3 Experimental for Chapter 4 
Materials and Methods 
RP (reverse phase) purified synthetic oligonucleotides were purchased from Sigma 
Genosys Ltd. (UK). The lyophilised DNA samples (50 nmol) were reconstituted 
using I xTE buffer (10 mM Iris, pH7.5-8.0, 1mM EDTA) and stored at -20 °C. 
Fluorescently labelled ddNTPs were obtained from Perkin-Elmer Life Science 
(Boston, MA). Thermo Sequenase DNA polymerase supplied with lOx reaction 
buffer was purchased from GE Healthcare (Chalfont St. Giles, UK). Subtilisin 
Carlsberg was obtained from Sigma Aldrich, UK. Ziplipsc 18  were purchased from 
Millipore (Bedford, USA). All other chemicals were purchased from Sigma 
Aldrich. Primer extensions and protease cleavages were performed on a Eppendorf 
MasterCycler Personal thermal cycler with a heated lid. 
HPLC Analysis 
RP-HPLC was performed on a Hewlett Packard HPI 100 Chemstation eluting with 
(A) 50 % Acetonitrile in 0.1 M TEAB, (B) 0.1 M TEAB and (C) Acetonitrile on a 
Luna (Phenomenex) C18 ODS (2) analytical column, 100 mm x  4.60 mm, i.d. 5 
jim, flow rate 1.0 mL min- , using the method described below. The fractions were 
collected using a Gilson G2250A. 
Method: gradient: 100 % (A) to 0 % (A) over 15 mm, 50 % (C) to 100 % (C) over 
1 mm, constant at 100 % (B) for 6.5 mm, injection volume 100 j.tL, detection by 
UV at 565, 260, 254, 220 rim, 641 nu-n. 
MALDI-TOF Analysis 
Oligonucleotide MS spectra were obtained by matrix-assisted laser desorption 
ionization time-of-flight (MALDI) on an Applied Biosystems Voyager DE STR 
MALDI-TOF mass spectrometer (MS) equipped with a pulsed nitrogen laser (20 
Hz, 337 nm). A total of 400 shots were summed for each spectrum with an 
acceleration voltage of 20 W. 
Preparation of the matrix 
9 parts of 5 mg/100 p.L of 3-hydropicolinic acid in 50% acetonitrile/water were 
mixed with 1 part 5 mg/ 100 j.tL of ammonium citrate in water. 
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MALDI Plate Spotting 
Oligonucleotides were desalted using ZipTipsc18 according to the manufacturer's 
protocol and dissolved in 10 pL of a solution of 10% acetonitrile/0. I M TEAA 
buffer. 1 iL of the oligonucleotide solution was mixed with 1 p1. of the matrix 
solution directly on the stainless steel MALDI sample target plate. 
Primer extension using dUTP-(A1a)3-Rbo 46 
The polymerase extension reaction mixture consisted of 200 pmol of primer 1, 320 
pmol of p53-exon7 template 1, 640 pmol of dUTP-(Ala) 3-Rho 46, 16 units of 
Thermo Sequenase DNA Polymerase and 1 x  Thermo Sequenase reaction buffer in 
a total volume of 50 tL. The reaction consisted of 25 cycles at 94 °C for 20 s, 46 
°C for 40 s and 60 °C for 90 s. After reaction, the extension product II was purified 
by RP-HPLC and freeze-dried. A portion of the desired DNA product was desalted 
by using ZipTipsc 1 8 and analized by MALDI-TOF MS. The rest of the product was 
used for the cleavage step. 
MALDI-TOF MS (linear, negative) m/z: anal.calcd, 6674; found, 6673 (M-l). 
HPLC (X 565 , 260) tR 7.21 mm 
Primer I sequence: 
5' - AGAGGATCCAACCGAGAC-3' 
p53-exon7 Template I sequence: 
5 ' -GTGTACATCAACATCACCTACCACCATGTCAGTCTCGGTTGGATCCTCTATTGTGTCCGG- 3 
Primer extension using dCTP-(Ala)3-Cy5 41 
The polymerase extension reaction mixture consisted of 200 pmol of primer 1, 320 
pmol of p53-exon7 template 11, 640 pmol of dCTP-(Ala)3-Cy5 41, 16 units of 
Thermo Sequenase DNA Polymerase and I x  Thermo Sequenase reaction buffer in 
a total volume of 50 jiL. The reaction consisted of 25 cycles at 94 °C for 20 s, 46 
°C for 40 s and 60 °C for 90 s. After reaction, the extension product IV was 
purified by RP-HPLC and freeze-dried. 
HPLC (X 1 , 260) tR 9.29 mm 
Primer I sequence: 
5'- AGAGGATCCAACCGAGAC-3' 
p53-exon7 Template II sequence: 
5 '-GTGTACATCAACATCACCTACCACCATGTCGGTCTCGGTTGGATCCTCTATTGTGTCCGG- 3' 
Primer extension using dUTP-(AIa)3-Rho on a homopolymeric sequence 
The polymerase extension reaction mixture consisted of 200 pmol of primer 1, 320 
pmol of p53-exon7 template IV, 640 pmol of dUTP-(Ala) 3-Rho 46, 16 units of 
Thermo Sequenase DNA Polyrnerase and 1 x  Thermo Sequenase reaction buffer in 
a total volume of 50 ILL. The reaction consisted of 25 cycles at 94 °C for 20 s, 46 
°C for 40 s and 60 °C for 90 s. After reaction, the extension product was purified 
by RP-HPLC and freeze-dried. 
HPLC (A, 260) tR 7.21 mm 
Primer sequence 1: 
5'- AGAGGATCCAACCGAGAC-3' 
ST p53-exon7 Template IV sequence: 
5' -GTGTACATCAACATCACCTACCACCATCAAAGTCTCGGTTGGATCCTCTATTGTGTCCGG- 3' 
Primer extension using dUTP-(Ala)3-Rho and dCTP-(Ala)3-Cy5 
The polymerase extension reaction mixture consisted of 200 pmol of primer 1, 320 
pmol of p53-exon7 template V, 640 pmol of dCTP-(Ala) 3-Cy5 41, 640 pmol of 
dUTP-(AIa) 3 -Rho 46, 16 units of Thermo Sequenase DNA Polymerase and 1 x 
Thermo Sequenase reaction buffer in a total volume of 50 1iL. The reaction 
consisted of 25 cycles at 94 °C for 20 s, 46 °C for 40 s and 60 °C for 90 s. After 
reaction, the extension product was purified by RP-HPLC and freeze-dried. 
HPLC major peak Q1565 , 260) tR 6.70 mm 
HPLC small peak (4 1 , 260) tR 7.40 mm 
Note: all the peaks (template and product extensions) were shifted of 0.5 mm. 
Primer sequence I: 
5'- P.GAGGATCCPJCCGAGAC-3' 
p53-exon7 Template (AG) V sequence: 
5 '-GTGTACATCAACATCACCTGAGAGAGAGGTCTCGGTTGGATCCTCTATTGTGTCCGG-3' 
Cleavage by protease of the extension product 
The extended primer II was dissolved in 7 AL of a solution (2:5) of 0.1 M TEAB 
buffer! H 20. 15 units of Subtilisin A were dissolved in 10 ILL of Subtilisin A buffer 
(10 mM Sodium Acetate buffer with 5 mM Calcium Acetate, pH 7.5), added to the 
solution of the extended primer and left in incubation at 37 °C for 10 mm. The 
resulting DNA product 111 was purified by RP-HPLC and freeze-dried. A portion 
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of the desired DNA product was desalted using ZipTips and analized by MALDI-
TOF MS. 
MALDI-TOF MS (linear, negative) m/z: anal.calcd, 5866; found, 5865 (M-l), 
5936 (M+71),6007 (M+142). 
I-IPLC (A.565, 260)  tR 6.3 mm 
Primer after cleavage (III): 
3'- CAGAGCCAACCTAGGAGA-5' 
6.4 Experimental for Chapter 5 
Materials and instruments 
RP (reverse phase) purified synthetic oligonucleotides, 50 nmol scale, were 
purchased from Sigma Genosys Ltd. (UK). The 5' end of DNA primers was amino 
modified. The lyophilised DNA samples were reconstituted using 1 xTE buffer (10 
mM Tris, pH7.5-8.0, 1mM EDTA) and stored at -20 °C. Fluorescently labelled 
ddNTPs were obtained from Perkin-Elmer Life Science (Boston, MA). GenHyb 
hybridisation buffer and aldehyde slides were purchased from Genetix Ltd. (New 
Milton, UK). CodeLinkTM  glass slides (25 mm x  75 mm x  1mm) and Thermo 
Sequenase DNA polymerase supplied with I Ox  reaction buffer were purchased 
from GE Healthcare (Chalfont St. Giles, UK). Subtilisin Carlsberg was obtained 
from Sigma Aldrich, UK. 20x Standard saline citrate (SSC) buffer was obtained 
from Fisher Scientific UK (Loughborough,UK). Other buffers and solutions for 
microarray experiments were prepared following standard recipes 177  using DNA 
grade water (Fisher Scientific UK). Hybridisation and primer extension reactions 
were performed on a Hyb4 hybridisation station from Genomic Solutions 
(Huntingdon, UK). DNA printing was performed using a Robot Microarrayer 
(Genetix QMini, U.K.). 
Design of Primers & Templates 
DNA primers and templates were designed with the Oligo Analyzer v. 3.1 
program. 
Signal Detection and Data Analysis 
All slides were scanned using a LaVision BioTech Bioanalyzer 4F/4S Scanner 
featuring a white-light source, four color filters and a CCD camera. The following 
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filters were used (excitation wavelength ± bandwidth of transmission/emission 
wavelength ± bandwidth of transmission): FITC: (480 ±40 / 535 ± 50); Cy3: (546 
±12 / 585 ± 40); Texas Red: (560 ± 55 / 645 ± 75); Cy 5: (640 ± 20 / 680 ± 30). 
The filters were from Chroma Technology Corporation (Rockingham, USA). 
The intensity of the fluorescence signals was determined with the FIPS 2.0 
analysis software supplied with the chip reader and data files were imported in 
Microsoft Excel for further analysis. 
6.4.1 Preparation of DNA Microarrays 
Printing on CodeLinkTM  slides 
5'-amino modified DNA primers were diluted to a final concentration of 20 jiM in 
lx printing buffer (50 mM sodium phosphate, pH 8.5). A 5'-amino modified DNA 
primer labelled in 3' position with fluorescein was used as control. 
The oligonucleotides were printed onto CodeLinkTM  slides at 25 °C and 35-40% 
relative humidity by contact printing. Solid pins (150 pm diameter, K2783, 
Genetix) were used for printing with the following conditions: 1 stamp per spot, 10 
ms stamping time and 10 ms inking time. The same pattern was reproduced twice: 
a lOxlO subarray for a 3'-amino modified and 5' fluorescein labelled 
oligonucleotide and three lOx 10 subarrays for 3'-amino modified DNA 
oligonucleotides. The slides were kept overnight in a chamber containing a 3M 
NaCl solution. Residual NHS ester groups on the surface were blocked using pre-
warmed blocking solution (0.1 M Tris, 50 mM ethanolamine, pH 9.0, 20 mL) at 50 
°C for 30 min. Afterwards, the slides were rinsed with deionised water (2 x  20 
mL), then with 4 x  SSC, 0.1 % SDS (20 mL, pre-warmed to 50 °C) for 30 min and 
with deionised water (2 x  20 mL). The slides were spin-dried at 3000 rpm for 6 
min and scanned using a FITC filter. DNA sequences of primers and their 
fluorescence intensities (average) are shown in Table 6.1. 
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Primers Pattern 1 Pattern 2 
5'-H2N-TTT TTT TAT GAC ACC GTC ATC AGC AG--3' 728795 654663 
5'-H2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-3 1917 1869 
5'-H2N-TTT TTT CAG GAC CTA GAA CGG GCA GC-3' 2526 1959 
5' -H2N-TTT TTT CCT TCT TGC TGG CAC CCA AT-3' 2120 1859 
Table 6.1 DNA sequences and correspondent fluorescence intensities (A,= 480 rim). Exposure 
time: 100 ms. 
Hybridisation on CodeLinkTM  slides 
To 50 j.tL of a 2 jiM solution of oligonucleotide templates in 1 x  TE buffer, were 
added 50 1iL of 2x GenHyb buffer (50% formamidine, 2mg/mL herring sperm 
DNA, 0.4 % SDS, 8.4 x  SSC). Prior to hybridisation the solution was heated to 85 
°C for 3 minutes to denaturise the oligonucleotides. The solution was then added to 
the slide surface and incubated for 3 h at 55 °C in an automated hybridisation 
system (GenHyb4). The slide was rinsed briefly with 4 x  SSC (20 mL), then with 
2x SSC, 0.1 % SDS at 55 °C for 5 mm (2x20 mL), with 0.2 x  SSC (20 mL) at room 
temperature for 1 min and finally with 0.1 SSC (20 mL) at room temperature for 1 
mm. The slide was spin-dried at 3000 rpm for 6 min and scanned using a FITC 
filter. An oligonucleotide labelled in the 5' position with fluorescein was used as 
hybridisation control. DNA sequences of primers and templates and their 
fluorescence intensities (average) are shown in Table 6.2. 
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Pattern 1 Pattern 2 DNA sequences 
rAT GAC ACC GTC ATC AGC AG-F-3' 574700 601924 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-Fi-5' 
5 • -H2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-3 606584 574326 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5 
5' -H2N-TTT TTT CAG GAC CTA GAA CGG GCA GC-3' 1877 2044 
GTC CTG GAT CTT GCC CGT CGA TCA G-5 
5'-R2N-TTT TTT CCT TCT TGC TGG CAC CCA AT 3' 1834 1815 
GGA AGA ACG ACC GTG GGT ThA TCA G-5' 
Table 6.2 DNA sequences and correspondent fluorescence intensities (A,,,,= 480 nm). Exposure 
time: 100 ms. 
6.4.2 Four Color Primer Extension with dideoxynucleotides on CodeLinkTM  slides 
CodeLinkTM slides were spotted with four identical arrays of 102 amino 3' amino-
modified DNA primers and then treated with a solution of complementary DNA 
templates. Printing and hybridisation were performed as described in the previous 
sections 6.4.1. A reaction mix of 100 tL was prepared with a final concentration of 
0.8 U/1iL of Thermo Sequenase DNA Polymerase and 2 1iM of labelled ddNTPs 
(Texas Red-ddATP, Fluorescein-ddCTP, Cy5-ddUTP and TAMRA-ddGTP) in I x 
Thermo Sequenase reaction buffer (26 mM TrisHCl, pH 9.5 and 6.5 MM  MgCl2). 
The solution was added to the slide and incubated at 55 °C for 1 h in an automated 
hybridisation chamber (GenHyb4). After incubation, the slide was rinsed briefly 
with 4xSSC (20 mL), then with 2x SSC, 0.1 % SDS (2x20 mL) at 55 °C for 5 mm, 
with 0.2xSSC (20 mL) at room temperature for 1 min and finally with 0.1 SSC (20 
mL) at r.t for 1 mm. The slide was spin-dried at 3000 rpm for 6 min and then 
scanned. Fluorescence intensities were measured for all DNA duplexes at four 
different wavelengths (Table 6.3). 
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Table 6.3 DNA sequences and correspondent fluorescence intensities. 
Fl = fluorescein, S = -2HN-TTT T'IT- 
Positi Texas 
FITC Cy3 Cy5 Primer/Template 
on  Red 
390870250 22451000 24480751 2028250 
'-S-TAT GAC ACC GTC ATC AGC AG-F1-3' 
Al 3 -ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
106500000 19690750 5077500 44873250 
'-S-TAT GAC ACC GTC ATC AGC AG-3' 
Bi 3' -ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
'-S-CAG CCC CGA TGG TCT CAT TC 3' 
16662000 88496252 34140000 1239500 3' -GTC GGG GCT ACC AGA GTA AGT CTA CGA GTC 
Cl I 
'-S-GCA NAG TGA TCC CCC AAA TAA C 3' 
24860500 45806249 15531750 15036000 3' -CGT TTC ACT AGG GGG TTT ATT GAC TCG TCC AC 
Di  
'-S-CTG TCC CCA GAG GAT ATG GT 3' 
217899746 20929500 15652000 1289750 3' -GAC AGG GGT CTC CTA TAC CAG TAC GAC TCG 
El  
'-S-ACA TGG GGA AGA GAC GCG GG 3' 
21172500 23974499 8767750 31596000 3' -TGT ACC CCT TCT CTG CGC CCA TGC TGC TGA 
Fl  
12820999 59803750 28417750 1407750 '-S-TTG TGG AAG TCA GTG TGG CGA T 3' 
GI  3 1 -AAC ACC TTC AGT CAC ACC GCT ATC GCT CAC AGT 
'-S-AGG CCG ACT TTG TCT GCA ACA CCC 3' 
18051250 86653748 31872000 2068000 3' -TCC GGC TGA AAC AGA CGT TGT GGG TAT CAC GAG C 
Hi  
'-S-AAT TCT CCT GCC TCA GCC TCC 3' 
18799500 105816498 37190000 1850500 3' -TTA AGA GGA CGG AGT CGG AGG TCG CTC AGA T 
'-S-ATT ACA GGC ATG AGC CAC CA 3' 
35333000 17473750 3842500 42502750 3' -TAA TGT CCG TAC TCG GTG GTA TCA GTC TGT 
JI  
'-S-CAG GCA TGA GCC ACC ACG CC 3' 
14108250 69390000 25918500 1229250 3' -GTC CGT ACT CGG TGG TGC GGT GCG ACT CGT 
Ki 
'-S-AGG AGA TTG ACA TTC TGC GC 3' 
14287500 65266000 26318750 1496500 3' -TCC TCT AAC TGT AAG ACG CGT GCT CTC ACT 
LI  
'-S-CGT TAT GTT GCC TAG GCT GG 3' 
23849250 21955501 5781750 40306749 3' -GCA ATA CAA CGG ATC CGA CCA TGC ATA GCA 
Ml  
'-S-GCC TGG AAA GCG AGC TCG GG 3' 
28501500 35119251 6227500 42579750 3'-CGG ACC TTT CGC TCG AGC CCA TAC AGT GCT 
Ni 
'-S-AGA CCC CAC CTC TGT GAA CT 3' 
18531000 85151752 41517750 1776750 3'-TCT GGG GTG GAG ACA CTT GAT CTG TAC GTC 
01  
27632750 29480250 6079000 51081751 
'-S-CTA TCT CTG TTT TTG CTT TCT TTA TG 3' 
P1  3'-GAT AGA GAC AAA AAC GAA AGA AAT ACA TGC GCT AT 
19969250 97416250 37450751 1683500 
'-S-AGC TCA CTG CAA CCT CTG CC 3' 
3'-TCG AGT GAC GTT GGA GAC GGT GAC AGT GAC 
'-S-TTT CTG CTC TGA CAA CCT CCC A 3' 
36502500 36669750 5506500 78877000 3'-AAA GAC GAG ACT GTT GGA GGG TAT GCT GTC TC 
B2  
13579500 14836250 9486250 13736250 '-S-ACT CCT CCT GGG GGA ATC 3' C2  3 1 -TGA GGA GGA CCC CCT TAG ATG TGA CTG T 
'-S-CTG AAA ACC CAT GTA AAG AGT G 3' 
16945000 20889000 5577750 38997750 3' -GAC TTT TGG GTA CAT TTC TCA CAT AGC TCG AG 
02 
'-S-TCA ACA TGG AAA TGA TCC TGA 3' 
14520249.75 47499500 27374501 1125500 3'-AGT TGT ACC TTT ACT AGG ACT TGC ACT GTC A 
E2  
21224500 23524000 4963500 47880999 
'-S-TTC CCA TTC CTC CTA CTG TGT G 3' 
F2  3' -AAG GGT AAG GAG GAT GAC ACA CAC TGC TGC AC 
'-S-CTC ATA TAA ATA GGC CAT ACC CA 3' 
16675000 13202250 2988500 52255500 3 1 -GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 
(32  _ 
'-S-TCT GGA TGA ATA CTG CAG CTG 3' 
297693750 36987750 0 4658500 3'-AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 
H2 _ 
'-S-GGG TCC AGT TCA CTG TGA AG 3' 




'-S-GGT TTT TGA TTT GCA TCA GAC T 3' 
31152750.5 131363998 0 5245000 3'-CCA AAA ACT AAA CGT AGT CTG ATA GCA GTG TC 
J2 __ 
22215250 27158999 50680000 
'-S-GAG GTC AGA GGA GTA ATA TTA TTG G 3' 
K2 _  3' -CTC CAG TCT CCT CAT TAT AAT AAC CAT CAT GCT CA 
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'-S-AGG GGG GCT GGG GAG GGA GA 3' 
6181500 5148000 3666000 5067250 3' -TCC CCC CGA CCC CTC CCT CTA CTA GAT AGC 
L2  
'-S-TGT GGC GTC ATT CTC CAA AG 3' 
15341750 54776999 34896500 1079500 3 1 -ACA CCG CAG TAA GAG GTT TCT CGA CGA CGA 
M2  
'-S-CAC TGA GTT GCT GGA ACG AGG 3' 
16992749.75 59556750 34112500 1976750 3'-GTG ACT CAA CGA CCT TGC TCC TGC ATC TGC G 
N2  
34616999 32997500 5797250 50640749 
'-S-TGC CCT CTT 3' CGA TGC TCA GG 
02  3' -ACG GGA GAA GCT ACG AGT CCA TGA TGA TGA 
23716750 17671250 4908250 38462000 '-S-CGC CGG CGG 
GAT TCC TAC CC 3' 
P2  3' -GCG GCC GCC CTA AGG ATG GGA ATG CTA CGG 
'-S-AAG GCC AAG GCT CAC AAG GCA 3' 
231953500 65218499 48747250 2042250 3' -TTC CGG TTC CGA GTG TTC CGT GTG CGA TCG T 
A3  
'-S-GGA GAA GGC ACC CAG CCA TC 3' 
18139250 85915500 30253250 1275500 3 1 -CCT CTT CCG TGG GTC GGT AGT GTC TGC GTC 
B3  
'-S-CTG ACC CTG GGA GGA AGC 3' 
18909750 20466500 5831750 33052250 3' -GAC TGG GAC CCT CCT TCG ATC TGC CTG A 
C3  
'-S-AGA AGG AAG AGT TCT GGG GG 3' 
17311000 20128250 9976000 23255250 3'-TCT TCC TTC TCA AGA CCC CCA TCA GTC AGC 
03  
43289000 44087501 11514750 61041500 '-S-ATA CGA CTG AGG CGC CTA CCT 3'  E3 3'-TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 
'-S-TTC TTT GCT GCT TTC ACT GAA 3' 
22136500 68121750 57733249 1547250 3' -AAG AAA CGA CGA AAG TGA CTT CTC GAC CTC A 
F3 
'-S-CTG CTG CAG GCC CCA GAT GA 3' 
26517000 26649250 5569500 51154251 3' -GAC GAC GTC CGG GGT CTA CTA CTC GCA GTC 
03  
'-S-TGG CTG GCA AGG GCT TCT CCT 3' 
228819758 70838750 39019250 2001500 3'-ACC GAC CGT TCC CGA AGA GGA GCG ACG ACG T 
H3  
'-S-AAT GTG AGT GAT TTC AGG GAA G 3' 
27930500.5 22380000 6569500 41308500 3' -TTA CAC TCA CTA AAG TCC CTT CAG TAG CTA GA 
3 
'-S-CGG ACC ACG ACG TCA CGC AG 3' 
33107999 36109251 8223000 43924750 3' -GCC TGG TGC TGC AGT GCG TCA CGA CGA TCG 
J3 
'-S-GGA TGT ACT TTT TCA CAA GGT C 	3' 
23765000 26105750 5065750 37795000 3' -CCT ACA TGA AAA AGT GTT CCA GAC GAG CAT AG 
K3  
'-S-TCC TAG ACC AAC TCC ACA CTG 3' 
17142250 71175250 36450999 1432000 3'-AGG ATC TGG TTG AGG TGT GAC TGT ATC ATG C 
L3  
'-S-CTG ACG TCT TGA CTG TGA ACC 3' 
19456499.5 90233250 30242500 2506750 3' -GAC TGC AGA ACT GAC ACT TGG TCG ATG CGT A 
M3 
'-S-GTG GTC CGG CGC ATG GCT TC 3' 
16065750 32052251 35985751 1109250 3'-CAC CAG GCC GCG TAC CGA AGT CAG TAT CAG 
N3  
'-S-CAG GAC CTA GAA CGG GCA GC 3' 
46776250 43478751 7975000 66123249 3' -GTC CTG GAT CTT GCC CGT CGA TCA G 
03  
213602746 42600000 22619251 3461750 
'-S-GTG AAA TAA ATT GGG CCA GG 3'  
P3 3'-CAC TTT ATT TAA CCC GGT CCG CAC TGT CAC 
21522000 101761004 46820750 2587000 '-S-CTT CGT TCC AAA GGG CCA GGA T 3' A4  3' -GAA GCA AGG TTT CCC GGT CCT ATC TCG TCG TA 
'-S-CCT TCT TGC TGG CAC CCA AT 3' 
25615000 150258250 48539748 1520000 3' -GGA AGA ACG ACC GTG GGT TAT CAG CAC TAC 
B4  
21001000.5 68233500 37943500 2044500 '-S-CCT CCG 
CAG ACC CAC TCC TTG 3' 
C4  3' -GGA GGC GTC TGG GTG AGG AAC TGA GTC GTC C 
42635500 38452250 8213500 52793000 
'-S-ATC GAC AGT GAG TGT GGC CC 3' 
04  3'-TAG CTG TCA CTC ACA CCG GGA GAT GAT TAG 
19256250 62805750 38416750 2060750 '-S-CAT 
GGA TGC TAC CAA TAT CCT G 3' 
E4  3' -GTA CCT ACG ATG GTT ATA GGA CT  CTA CTA GC 
18136500 64302250 36208000 1327500 
'-S-CCC AAG GAG GAG GCA TTC GG 3' 
F4  3' -GGG TTC CTC CTC CGT AAG CCT GTG TAT GTG 
'-S-ACC TGC CGA TGT CCC CCC GC 3' 
13113499.75 48272250 22559750 1087500 3' -TGG ACG GCT ACA GGG GGG CGT GCT TAT GCT 
04  
163342250 61997249 26483750 1668750 
'-S-GGT GGA GGA GAA CTG CCA GCT 3' 
H4  3'-CCA CCT CCT CTT GAC GGT CGA GAC TCG GAC G 
'-S-AAA TAC TCA CCA AAC TGC CCT C 3' 
29797499.5 33414251 8488000 43638750 3' -TTT ATG AGT GGT TTG ACG GGA GAC TAC TAC GA 
14  
'-S-TTT TTC TCG CTT GGT GGT GGA 3' 
232949262 78999752 43221999 1360000 3'-AAA AAG AGC GAA CCA CCA CCT GCA GCA TCG T 
J4  
21561000 102668000 46263500 1731000 
'-S-CTG GGA CCA AGT GGC CGA GGT 3' 
K4  3 1 -GAC CCT GGT TCA CCG GCT CCA TGT AGA TCT G 
215 
'-S-GGC TCC ACA CGG CGA CTC TCA T 3' 
238359504 61460500 28364750 3018500 3' -CCG AGG TGT GCC GCT GAG AGT AGT CGT GCT C 
L4 
'-S-ACG CTG CAG ACG ATC CTG GGG G 3' 
37405750 46328750 17386000 41425250 3' -TGC GAC GTC TGC TAG GAC CCC CAT ACT ACT GA 
M4  
'-S-TTT TTC AGC AGG AGT TAC ACT GG 3' 
22006750 23997750 4763250 44996749 3' -AAA AAG TCG TCC TCA ATG TGA CCA TCT ATC T 
N4  
'-S-CCT TCT TGC TGG CAC CCA AT 3' 
56167500 71732500 14838500 43676250 3' -GGA AGA ACG ACC GTG GGT TAA TCA G 
04 
50505000 52089749 10924000 50949251 
-S-CTG GTC AAG ATC GGG GAC TTT 3' 
P4  3 1 -GAC CAG TTC TAG CCC CTG AAA ATG CGT ATC A 
'-S-GGA AAA ACT CTT CAG GTG TAG AAG 3' 
28194750 36470750 6341000 54150749 3' -CCT TTT TGA GAA GTC CAC ATC TTC ATC GTC ATC G 
A5  
53955749 42452250 5682750 69574250 '-S-GTG GAG TGT TTG TTC ACA CCC CC 3' B5  3'-CAC CTC ACA AAC AAG TGT GGG GGA TAC GAC TAC 
43441249 44417751 9265000 67103998 '-S-CAG GGA CAT CG 3' 
TTG TCG GGC 
C5  3' -GTC CCT GTA AAC AGC CCG GCA TGC TCG ATG 
21649750 95563502 49242999 1469500 '-S-CAA CCT CCA CCT CCT GTT TTC AAG 3' 05 3' -GTT GGA GGT GGA GGA CAA AAG TTC TGA TGA TGA C 
19319750 75660750 37256000 1752500 '-S-GTG CCC TCC 
TTC CCA ATC TT 3' 
E5  3'-CAC GGG AGG AAG GGT TAG AAT CTG TAC GAC 
28747250 76027250 54824500 1917250 
'-S-CCC TAG TGC TCG TCG CCG TGG 3' 
F5  3 1 -GGG ATC ACG AGC AGC GGC ACC TAG CAG TAG C 
22661249.5 21984751 4316000 56000000 
'-S-AAG CAA TTG AAA CCG ATA AGG 3' 
G5  3' -TTC GTT AAC TTT GGC TAT TCC ACT GTC GTA T 
22303749.5 102772500 36494000 3878000 
'-S-GCT GCG GAC AAC ACC CAT GG 3' 
H5  3 1 -CGA CGC CTG TTG TGG GTA CCT ACA TGT ATG 
'-S-TGG TTG GAA TTC CCA GCA TTT 3' 
25767500 32709751 8664000 32278751 3'-ACC AAC CTT AAG GGT CGT AAA ACT GAT ACT G 
15  
'-S-CCG TCG GGG GCC TGG ATG TC 3' 
17922500 52020250 28398750 3490750 3' -GGC AGC CCC CGG ACC TAC AGT ATG TAG TA 
J5  
'-S-GTT GCT GTG GAC TCA GTG CT 3' 
165318000 67529250 26187250 2297750 3'-CAA CGA CAC CTG AGT CAC GAG CAG TGC AGC 
K5 
'-S-CCG GGA AGA GTG GAA CAA TTT TTC 3' 
17538750 52403500 44153500 1024750 3' -GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 
L5  
'-S-TGG GTG AGG TTG TGG AAG AG 3' 
26088249.5 33001750 6542000 49407251 3'-ACC CAC TCC AAC ACC TTC TCA TGT CAC TGC 
M5  
38988000 35170750 9368000 50896752 
'-S-CAT GAT CCC AGA GTC CGC CC 3' 
3'-GTA CTA GGG TCT CAG GCG GGA TCG GTC ATA 
N5 
'-S-GCA AAG TGA TCC CCC AAA TAA CG 3' 
17964750 99644248 43451750 1315750 3' -CGT TTC ACT AGG GGG TTT ATT GCT GCT GCT GCT 
05  
19504000 73179250 51270499 1579250 
'-S-TTC TCC TAC TGG GTC TGG CT 3' 
P5  3 1 -AAG AGG ATG ACC CAG ACC GAC TCG TCG CGT 
40139750 41025250 9255750 47643000 '-S-ATG TTG GCC AGG CTG GTC TC 3' A6  3 1 -TAC AAC CGG TCC GAC CAG AGA TCG ATA CTG 
31626250.5 35672250 8828750 51404500 '-S-TTG GGC CAG GGT GGG AGC AG 3' B6  3 1 -AAC CCG GTC CCA CCC TCG TCA TCG ATA CTA 
'-S-CCA TGT CAC ATC CTG TCT CCT 3' 
33597250 31244250 6892250 47432000 3' -GGT ACA GTG TAG GAC AGA GGA ATC GTC ATC G 
C6  
40026750 47369250 11604250 52372249 
'-S-TGT TTG AGC TCA GGA GTT TCA GAC TG 3' 
D6  3 1 -ACA AAC TCG AGT CCT CAA AGT CTG ACA AGT TGC TG 
'-S-TCT GCA TCA TGT CTA CCA GG 3' 
38573500 30915500 6454250 60892752 3' -AGA CGT AGT ACA GAT GGT CCA TGT CGT AGA 
E6  
33101750 31479250 5916250 49168000 
'-S-ACC CTG AGA TGA CAA TGC CT 3' 
F6  3'-TGG GAC TCT ACT GTT ACG GAA CCT CCT CCT 
'-S-CTC TTC ATG CAC CGG AAA AG 3' 
28800000 82719000 63124499 3554750 3'-GAG AAG TAC GTG GCC TTT TCC TCA TCA TCA 
G6  
'-S-AGG TCT CGG TGG ATG TAG TG 3' 
30992500 29056250 5757500 51243501 3' -TCC AGA GCC ACC TAC ATC ACA TGC AGT ACT 
'-S-AAA AAG GAA ACC TTG CAA GTG 3' 
273252500 30756751 24379750 3934750 3' -TTT TTC CTT TGG AAC GTT CAC GCT GCT GCT A 
16 
'-S-GCT TCC CAA TGG AGC TGC GG 3' 
213637750 64717001 29129750 2726500 3' -CGA AGG GTT ACC TCG ACG CCG CTA CTA CTA 
'-S-ATC ACT GTG GGA GCT GTC GAC 3' 
22783750 80535000 44697500 3253250 3' -TAG TGA CAC CCT CGA CAG CTG CAG TAT TAT C 
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-S-CAC CCA CAC CTC GTC CCT TT 3' 
24402000 97497752 46266250 2611250 3' -GTG GGT GTG GAG CAG GGA AAT CAG TGC CAG 
L6  
-S-CAG CTG GAA CAG ATG CTC ACT G 3' 
20400500 59219503 44161999 2426000 3'-GTC GAC CTT GTC TAC GAG TGA CCA CAT CAT CA 
M6  
-S-CCC CTT TGT AGG AAA CTT TTT G 3' 
19829000 47488499 37185500 3225000 3' -GGG GAA ACA TCC TTT GAA AAA CCA TGA GAC GA 
N6  
-S-TGA GCC AGA ATG CCT TCA TC 3' 
22194749 101373004 28259252 3646750 3'-ACT CGG TCT TAC GGA AGT AGT AGC TGC GTC 
06 
-S-GTG GTC CGG CGC ATG GCT TC 3' 
45846502 65066250 14116500 39862000 3'-CAC CAG GCC GCG TAC CGA AGT CAG TAT CAG 
P6  
-S-AAG AGA CTC CCC TGA TGA ATG 3' 
33211500 54905501 40828000 2927000 3' -TTC TCT GAG GGG ACT ACT TAC GTC TCG AGC A 
A7  
-S-AGG TGA TTC AGC AGA CCT TCA A 3' 
44414000 41914250 6747250 73306250 3' -TCC ACT AAG TCG TCT GGA AGT TAG CTG GTC AC 
B7  
-S-CCG GCC GAT GCT GGA GGA GAG 3' 
49002498 47955001 8383000 71968000 3 1 -GGC CGG CTA CGA CCT CCT CTC ACA CGA CGA C 
C7 
-S-ACA GCA AAA GAT TGG TGG CT 3' 
41461500 46508502 8669500 60959751 3' -TGT CGT TTT CTA ACC ACC GAA CTA TGT TGT 
D7  
-S-GGC TTC CTG GTG GGT GGC CC 3' 
42744250 38630250 6328750 48001001 3' -CCG AAG GAC CAC CCA CCG GGA TGC ATC GCC 
E7  
-S-CCG TTG CTG GAG TAG CCA TT 3' 
22023750 99455000 39093000 2283250 3' -GGC AAC GAC CTC ATC GGT AAT GTC CTG GAC 
F7 
6.4.3 Primer Extension using Enzymatically Cleavable Nucleotides on CodeLinkTM 
slides 
Primer Extension with dUTP-(A) 3-Rho 
CodeLinkTM slides with immobilised DNA duplexes were prepared as described in 
the sections 6.4.1. Four 3'-amino modified DNA primers were printed in four 6x6 
subarrays. 100 iL of a solution consisting dUTP-(A) 3-Rho (2.5.tM), and Thermo 
Sequenase DNA polymerase (1 U/iiL)  in 1 x  Thermo Sequenase reaction buffer 
were added to the surface of a CodeLinkTM  slide. After incubation at 55 °C for 1 h, 
the slide was rinsed briefly with 4xSSC (20 mL), then with 2x SSC, 0.1 % SDS 
(2x20 mL) at 55 °C for 5 mm, with 0.2xSSC (20 mL) at room temperature for 1 
min and finally with 0.1 SSC (20 mL) at room temperature for 1 min. The slide was 
spin-dried at 3000 rpm for 6 min and scanned using a Cy3 filter. DNA sequences of 
primers and templates and their fluorescence intensities (average) are shown in 
Table 6.4. 
Initial primer extension experiments were performed on an automated hybridisation 
chamber at 55 °C for lh. An incubation time of 15 min proved to be adequate for a 
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successful incorporation of enzymatically cleavable nucleotides in growing DNA 
primers. 
Fluorescence 
DNA sequences Intensity 
5HNTTT TTT TAT GAC ACC G'rc ATC AGC AG-_ 	-3' 17,005 
3-AlA CTG TGG CAG TAG TCG TCA TCA G-E-5' 
5'-HN-TTT TTT TAT GAC ACC GTC ATC AGC AG-3 690,911 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
5' -H 2N--TTT TTT CAG GAC CTA GAA CGG GCA GC-3' 605621 
3'-GTC CTG GAT CIT GCC CGT CGA TCA G-5' 
5' -H2N-TTT TTT CCT TCT TGC TGG CAC CCA AT 3' 713,966 
3'-GGA AGA ACG ACC GIG GGI TAA ICA G-5' 
Table 6.4 DNA sequences and correspondent fluorescence intensities (A,,,= 585 nm). Exposure 
time: 100 ms. 
6.4.4 Two steps in one: annealing and primer extension 
Primer Extension with dUTP-(A)3-Rho. 
5'-amino modified DNA primers were printed as described in the section 6.4.1. 100 
iL of a solution containing three DNA templates (2 1iM), Thermo Sequenase 
polymerase (1 U/jiL) and dUTP-(A) 3-Rho (2.5 jIM) in 1 x  Thermo Sequenase 
reaction buffer, were heated to 85 °C for 3 min and added to CodeLink slidesTM 
The slide was incubated at 55 °C for lh and then cooled down to 35 °C over lh. 
Then the slide was rinsed briefly with 4xSSC (20 mL), with 2x SSC, 0.1 % SDS 
(2x20 mL) at 55 °C for 5 mm, with 0.2xSSC (20 mL) at room temperature for 1 
min and finally with 0.1 SSC (20 mL) at room temperature for 1 mm. The slide was 
spin-dried at 3000 rpm for 6 min and scanned using a Cy3 filter. DNA sequences of 






TOT TAT GAO ACC GTC ATC AGC AG--3' 200382 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
5'-H2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-3' 1086064 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F]-5 
5'-H2N-TTT TTT CAG GAC CTA GAA CGG GCA GC-3' 1375772 
3'-GTC CTG GAT CTT GCC CGT CGA TCA G-5' 
5'-H2N-TTT TTT CCT TCT TGC TGG CAC CCA AT 3' 1219389 
3'-GGA AGA ACG ACC GTG GGT TAA TCA G-5 
Table 6.5 DNA sequences and correspondent fluorescence intensities (= 585 rim). Exposure 
time: 200 ms. 
Primer Extension with dCTP-(A) 3-FAM 
Primer extension was carried out with dCTP-(A) 3-FAM as described in the section 
6.44. The slide was scanned using a FITC filter. DNA sequences of primers and 
templates and their fluorescence intensities (average) are shown in Table 6.6. 
DNA sequences Fluorescence 
Intensity 
-H2N-TTT TTT TAT GAO ACC GTC ATC AGC AG— 	3 • 5 	 - 725995 
3-ATA CTG TGG CAG TAG TCG TCA TCA G-Fl-5 
5-H2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-3 1 312804 
3-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5 
5-H2N-TTT TTT GGT GGA GAA CTG CCA GCT C-3 1 209324 
3-CCA CCT CTT GAC GGT CGA GAC TCG GAC G-5' 
5' -H 2N-TTT TTT TCT GGA TGA ATA CTG CAG CTG C-3 198786 
3'-AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G-5 
Table 6.6 DNA sequences and correspondent fluorescence intensities (A= 480 nm). Exposure 
time: 100 ms. 
Primer Extension with dCTP-(A)3-Cy5. 
Primer extension was carried out with dCTP-(A) 3-Cy5 as described in the section 
6.44. The slide was scanned using a Cy5 filter. DNA sequences of primers and 
templates and their fluorescence intensities (average) are shown in Table 6.7. 
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Fluorescence 
DNA sequences Intensity 
5'-HN-TTT TTT TAT GAC ACC GTC ATC AGC AG-F1-3' 199410 
3-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 
5-14 2N-TTT TTT TAT GAC ACC GTC ATC AGC AGC-3' 395602 
3'-ATh CTG TGG CAG TAG TCG TCG TCA G-F1-5' 
5'-H 2N--TTT TTT GGT GGA GAA CTG CCA GCT C-3' 335376 
3-CCA CCT CTT GAC GGT CGA GAC TCG GAC G-5' 
5'-H2N-TTT TTT TCT GGA TGA ATA CTG CAG CTG C-3' 322561 
3-AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G-5 
Table 6.7 DNA sequences and correspondent fluorescence intensities (A= 680 rim). Exposure 
time: 500 ms. 
6.4.5 Dual Color Primer Extension Assay 
Dual color primer extension was carried out following the procedure described in 
the section 6.4.3 using a reaction mix containing dCTP-(A) 3-Cy5 (2.5 jtM), dUTP-
(A)3-Cy3 (2.5 1iM) and Thermo Sequenase DNA polymerase (IU/j.tL) in I 
Thermo Sequenase reaction buffer for a total volume of 100 [tL. The slide was 
scanned using Cy3 and Cy5 filters. DNA sequences of primers and templates and 
their fluorescence intensities (average) are shown in Table 6.8. 
Primer/Template duplexes Cy3 Cy5 
5 1 -H2N-TTT TTT CAG GAC CTA GAA CGG OCA GC -3 267,887 144,144 
3'-GTC CTG GAT CTT CCC CGT OGA GAG AGA GAG-5' 
5'-H2N-TTT TTT CCT TCT TGC TGG CAC CCA AT -3' 107,809 87,868 
3'-GGA AGA ACG ACC GTG GGT TAA GAG AGA GAG-5' 
5 1 -H2N-TTT TTT GGT GGA GAA CTG CCA GCT C-3' 5,101 158,217 
3'-CCA CCT CTT GAC GGT CGA GAC TCG GAC G-5' 
5'-H2N-TTT TTT AAA TAC TCA CCA AAC TGC CCT C 	-3 1 503,317 13,092 
3'-TTT ATG AGT GGT TTG ACG GGA GAG ACT ACT ACG A-5' 
5'-H2N-TTT TTT TTT TTC CTT GGT GGT GGA C-3' 3,375 131,264 
3'-AAA AAG AGC GAA CCA CCT GCA CAT CGT-5' 
5' -H2N-TTT TTT TGG TTG GAA TTC CCA GCA TTT -3' 287,069 2,897 
3'-ACC AAC CTT AAG GGT CGT AAA ACT GAT ACT G-5' 
5' -HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC G-3' 3,136 3,098 
3-GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T-5'  
Table 6.8 DNA sequences and correspondent fluorescence intensities (X m= 585 nm and 680 nm). 
Exposure time: 200 ms. 
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6.4.6 SBS cycles 
Cycle 1: Extension with dUTP-(A) 3-Cy3 
Primer extension was carried out with dUTP-(A) 3-Cy3 as described in the section 
6.4.3. The slide was scanned using a Cy3 filter. DNA sequences of primers and 
templates and their fluorescence intensities (average) are shown in Table 6.9. 
Cycle 1. Removal ofthefluorophore 
0.11 .tmo1es of Subtilisin Carlsberg were dissolved in 200 gL of 10 mM Sodium 
Acetate buffer (pH7.5). The solution, pre-warmed to37 °C, was applied on the 
surface of the chip and left in incubation at 37 °C for 15 mm. The cleavage was 
repeated, if necessary. Afterwards, the slide was rinsed briefly with 4xSSC (20 
mL), then with 2x SSC, 0.1 % SDS (2x20 mL) at 55 °C for 5 mm, with 0.2xSSC 
(20 mL) at room temperature for I min and finally with 0.1 SSC (20 mL) at room 
temperature for 1 mm. The slide was spin-dried at 3000 rpm for 6 min and scanned 
using a Cy3 filter. DNA sequences of primers and templates and their fluorescence 
intensities (average) are shown in Table 6.9. 
Primer/Template duplexes Extension Cleavage 
5'-H2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-'.-3' 
3'-ATh CTG TGG CAG TAG TCG TCA TCA G- -5' 11997 26233 
5 1 -H2N-TTT TTT TAT GAC ACC GTC ATC AGC AGUA-3' 
3' -ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 745216 36803 
5' -H 2N-TTT TTT AAA TAC TCA CCA AAC TGC CCT diG 3' 
3'-TTT ATG AGT GGT TTG ACG GGA GAC TAC TAC GA-5' 660282 1346  
5'-H2N-TTT TTT GTG GAG TGT TTG TTC ACA CCC CCU A-3' 
3'-CAC CTC ACA AAC AAG TGT GGG GGA TAC GAC TAC-5' 1255773 65148 
5-H2N-TTT TTT CCT TCT TGC TGG CAC CCA ATU C-3' 
3'-GGA AGA ACG ACC GTG GGT TAA GAG AGA GAG-51 1083526 38767  
5'-HN-TTT TTT CCG GGA AGA GTG GAA CAA ITT TTC G-3' 
4981 14850  3'-GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T-5'
Table 6.9 DNA sequences and correspondent fluorescence intensities after the first cycle of extension 
and cleavage (A,,= 585 nm). Exposure time: 100 ms. 
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Cycle 2: Extension with dCTP-(A)3-Cy5 
Primer extension was carried dCTP-(A) 3-Cy5 as described in the section 6.4.3. The 
slide was scanned using a Cy5 filter. DNA sequences of primers and templates and 
their fluorescence intensities (average) are shown in Table 6.10. 
Cycle 2. Removal ofthefluorophore 
Removal of the fluorophore was carried out as described in the section 6.4.3. The 
slide was scanned using a Cy5 filter. DNA sequences of primers and templates and 
their fluorescence intensities (average) are shown in Table 6.10. 
Primer/Template duplexes Extension Cleavage 
5'-H2N-TTT TTT TAT GAC ACC GTC ATC AGC AG-N-3' 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 1032 1134 
5'-H2N-TTT TTT TAT GAC ACC GTC ATC AGO AGA-3' 
3'-ATA CTG TGG CAG TAG TCG TCA TCA G-F1-5' 1417 1205 
5'-H2N-TTT TTT AAA TAC TCA CCA AAC TGC CCT C G 3' 
3'-TTT ATG AGT GGT TTG ACG GGA GAC TAC TAC GA-5' 683 1067 
5'-H2N-TTT TTT GTG GAG TGT TTG TTC ACA CCC CC 	A-3' 
3'-CAC CTC ACA AAC AAG TGT GGG GGA TAC GAC TAC-5' 676 1036 
5'-H2N-TTT TTT CCT TCT TGC TGG CAC CCA AT 	C-3' 
3'-GGA AGA ACG ACC GTG GGT TAA GAG AGA GAG-5' 37782 2840 
5' -H2N-TTT TTT COG GGA AGA GTG GAA CAA TTT TTC G-3' 
3'-GGC OCT TOT CAC CTT GTT AAA AAG CTT CTG TGC T-5' 1656 919 
Table 6.10 DNA sequences and correspondent fluorescence intensities after the second cycle of 
extension and cleavage (A,,= 680 ran). Exposure time: 100 ms. 
6.4.7 Dual Color Primer Extension: Optimisation 
Primer Concentration 
5' amino-modified DNA primers were prepared at a final concentration of 30, 20, 
10 and 5 .tM in I x  printing buffer (50 mM sodium phosphate, pH 8.5) and printed 
on a CodeLinkTM  slide in four different subarrays. All primers were printed in three 
replicates as described in the section 6.4.1 and then hybridised to their 
complementary DNA templates. After washing and drying the slide, DNA primers 
were extended at 55 °C for 15 min using 100 j.tL of a reaction mix containing 
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Thermo Sequenase DNA polymerase (1U/tL), dCTP-(A)3-Cy5 (2.5 p.M) and 
dUTP-(A)3-Cy3 (2.5 jiM) in 1 x  reaction buffer (26 mM TrisHCl, pH 9.5 and 6.5 
MM M902). Then the slide was rinsed briefly with 4xSSC (20 mL), with 2x SSC, 
0.1 % SDS (2x20 mL) at 55 °C for 5 mm, with 0.2xSSC (20 mL) at room 
temperature for I min and finally with 0.1 SSC (20 mL) at room temperature for 1 
mm. The slide was spin-dried at 3000 rpm for 6 min and scanned using Cy3 and 
Cy5 filters. DNA sequences of primers and templates and their fluorescence 
intensities (average) are shown in Table 6.11 and 6.12. 
Primer/Template duplexes 	 5 p 	10 pM 	20 pM 	30 pM 
5' 2HNTTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 
	
1699 	1489 	2639 	1815 
5'-2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 
	
11683 	16412 	19366 	12303 
5'-2HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 	 14589 	20901 	30783 	20552 
5'-2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 	26209 	33900 	90900 	68276 
5'-2HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 	7681 	13363 	36454 	33720 
Table 6.11 DNA sequences and correspondent fluorescence intensities (A,,,,= 680 run). Exposure 
time: 100 ms. 
Primer/Template duplexes 5pM 10 pM 20 pM 30 pM 
5'-2HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 1338 1371 2173 1407 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 
5'-2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 294611 291356 642849 586908 
5'-2HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 134990 165346 324123 277849 
5'_ 2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 27777 33343 62128 60055 
5'-2HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 126823 154490 415157 280458 
Table 6.12 DNA sequences and correspondent fluorescence intensities (A,= 585 nn). Exposure 
time: 100 ms. 
Template Concentration 
5' amino-modified DNA primers were printed on a CodeLink slide at a final 
concentration of 20 jiM. Each primer was printed in three replicates and in three 
identical subarrays. Afterwards, three solutions (10 jtL each) of complementary 
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DNA templates prepared at different concentrations: 0.5, 2 and 5 1.tM were pipetted 
on each sub-array on the slide, covered by cover slips and incubated at 55 °C for 
3h. After washing, the slide was spin-dried at 3000 rpm for 6 mm, scanned and 
incubated at 55 °C for 15 min with 100 j.tL of a reaction mixture containing Thermo 
Sequenase DNA polymerase (1U/1iL), dCTP-(A) 3-Cy5 (2.5 .tM) and dUTP-(A)3-
Cy3 (2.5 .tM) in I x  reaction buffer. 
Then the slide was rinsed briefly with 4xSSC  (20 mL), with 2x SSC, 0.1 % SDS 
(2x20 mL) at 55 °C for 5 mm, with 0.2xSSC (20 mL) at room temperature for 1 
min and finally with 0.1 SSC (20 mL) at room temperature for 1 mm. The slide was 
spin-dried at 3000 rpm for 6 min and scanned using Cy3 and Cy5 filters. DNA 
sequences of primers and templates and their fluorescence intensities (average) are 
shown in Table 6.13 and 6.14. 
Primer/Template duplexes 	 0.5 PM 	2pM 	5pM 
5'-2HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 230 	1240 	4618 
5'- 2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 	4053 	34248 	65431 
5'-2HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 	10065 	57565 	89635 
5'-2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 	66073 	301994 	236441 
5'-2HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 	5530 	26197 	13749 
Table 6.13 DNA sequences and correspondent fluorescence intensities (?= 680 ran). Exposure time: 100 
MS. 
Primer/Template duplexes 0.5 pM 2 pM 5 p 
5'- 2 HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 1323 2365 2269 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 
5'-2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 473191 2159232 1424391 
5'- 2 HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 252602 54844 465582 
5'-2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 63551 111982 72616 
5'- 2 HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 49884 104373 105108 




5' amino-modified DNA primers were printed on CodeLink slides at a final 
concentration of 20 p.IVI. Each primer was printed as three replicates and in three 
identical subarrays. After hybridisation with a 2 pM solution of DNA templates, to 
each sub-array on the slide were added three different solutions (10 pL each), 
containg Thermo Sequenase DNA polymerase at a constant concentration of I U/p.L 
and the labelled nucleotides dCTP-(A)3-Cy5 and dUTP-(A)3-Cy3 at a final 
concentration of 2.5, 5 and 25 jtM. The three subarrays, each covered by a cover 
slip, were incubated at 55 °C for 15 mm. Then the slide was rinsed briefly with 
4xSSC (20 mL), with 2x SSC, 0.1 % SDS (2x20 mL) at 55 °C for 5 min, with 
0.2xSSC (20 mL) at room temperature for 1 min and finally with 0.1 SSC (20 mL) 
at room temperature for 1 mm. The slide was spin-dried at 3000 rpm for 6 min and 
scanned using Cy3 and Cy5 filters. DNA sequences of primers and templates and 
their fluorescence intensities (average) are shown in Table 6.15 and 6.16. 
Primer/Template duplexes 	 2.5 pM 	5 p 	25 pM 
5'-2HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 2132 	2089 	1949 
5'- 2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 2613 6132 3065 
5'-2HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 3377 5599 3599 
5'-2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 5794 9,933 11332 
5'-2HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 4773 6,851 5239 
Table 6.15 DNA sequences and correspondent fluorescence intensities (A,,,= 680 mu). Exposure 
time: 100 ms. 
Primer/Template duplexes 2.5 pM 5pM 25 pM 
5' -2HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 8681 10570 7633 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 
5'-2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 1084237 964024 1116387 
5'-2HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 627764 556675 607813 
5'-2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 206803 356655 167447 
5'-2HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 996853 842773 856402 
Table 6.16 DNA sequences and correspondent fluorescence intensities (A'= 585 nn). Exposure 
time: 100 ms 
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Enzyme Concentration 
Printing and hybridisation were performed as described in the section 5.10.2.1 and 
5.10.3.1. Three solutions of 10 p.L each, containing the labelled nucleotides dCTP -
(A)3-Cy5 and dUTP-(A)3-Cy3 at a final concentration of 2.5 PM and Thermo 
Sequenase DNA polymerase at different concentrations (2, 1 and 0.25 UI jiL) were 
pipetted on each sub-array and then covered by cover slips. After incubation at 55 
°C for 15 mm, the slide was rinsed briefly with 4xSSC (20 mL), with 2x SSC, 0.1 
% SDS (2x20 mL) at 55 °C for 5 mm, with 0.2xSSC (20 ML) at room temperature 
for 1 min and finally with 0.1 SSC (20 mL) at room temperature for 1 mm. The 
slide was spin-dried at 3000 rpm for 6 min and scanned using Cy3 and Cy5 filters. 
DNA sequences of primers and templates and their fluorescence intensities 
(average) are shown in Table 6.17 and 6.18. 
Primer/Template duplexes 0.25U/pL IU/pL 2U/pL 
5'-2HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 1,458 1,885 9,143 
5'-2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 4,018 8,354 23,804 
5'-2HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 6,016 12,259 23,804 
5 1 -2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 6,334 21,467 55,604 
5'-2HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 4,344 5,298 19,241 
Table 6.17 DNA sequences and correspondent fluorescence intensities (A= 680 nm). Exposure 
time: 100 ms. 
Primer/Template duplexes 0.25U/pL IU/pL 2U1pL 
5'-2HN-TTT TTT CCG GGA AGA GTG GAA CAA TTT TTC 3' 
GGC CCT TCT CAC CTT GTT AAA AAG CTT CTG TGC T 11863 8532 9682 
5'-2HN-TTT TTT ATA CGA CTG AGG CGC CTA CCT 3' 
TAT GCT GAC TCC GCG GAT GGA AGA CTC TCC T 647524 979411 840812 
5'-2HN-TTT TTT GGG TCC AGT TCA CTG TGA AG 3' 
CCC AGG TCA AGT GAC ACT TCA GCG TCT CTC 343279 563527 806383 
5'-2HN-TTT TTT TCT GGA TGA ATA CTG CAG CTG 3' 
AGA CCT ACT TAT GAC GTC GAC GAC ATC ATC G 193303 134855 337659 
5'-2HN-TTT TTT CTC ATA TAA ATA GGC CAT ACC CA 3' 
GAG TAT ATT TAT CCG GTA TGG GTA GTC GTC ACG 581772 674433 1010308 
Table 6.18 DNA sequences and correspondent fluorescence intensities Q m= 585 run). Exposure 
time: 100 ms 
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Primer Extension on aldehyde slides 
Printing 
Aldehyde slides were printed according to the manufacturer protocol.' 56  5 '-amino 
modified DNA primers were diluted to a final concentration of 20 PM in a solution 
1:1 of 1 x  TE buffer and microarray spotting solution (0.3 M NaCl, 0.2 M NaHCO3, 
pH 8.5). Printing was conducted at 75% humidity using a contact printer. Slides 
were washed twice with 0.2% SDS (20 mL) for 2 min and twice with deionised 
water for 2 mm. Schiff bases were reduced at room temperature with a sodium 
borohydride (100 mg of sodium borohydride dissolved in 30 mL of PBS buffer and 
10 mL of absolute ethanol). Slides were then washed 3 times with 0.2% SDS for 1 
mm, rinsed twice with deionised water and spin-dried at 4000 rpm for 6 min. 
Hybridisation 
Hybridisation was performed as for CodeLinkTM  slides. Slides were washed twice 
at 37 °C for 10 min with a SPSC buffer (50 mlvi sodium phosphate/i M NaCl, pH 
7.5), then at 37 °C for I min with a SPSC buffer at pH 8.5. Slides were spin-dried at 
4000 rpm for 6 min. 
Primer Extension 
Primer extension was performed as for CodeLinkTM  slides. Washing was carried out 
using SPSC (50 mM sodium phosphate/i M NaCl) buffers at pH 7.5 and 8.5. After 
incorporation of dUTP-(A) 3-Rho, slides were washed with SPSC buffer at pH 6.5. 
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Appendix: Optimisation of dual color primer extension 
Primer concentration 
Primer concentration gradient experiments were carried out to find the optimal 
primer concentration for dual color primer extension. Four subarrays of 5 DNA 
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Figure 6.1 Primer Gradient Experiment: A) Normalised Fluorescence Intensities in 
the blue channel; B) in the red channel. Solutions: A=5 jiM, B= 10 jiM, C= 20 jiM, 
D= 30 W. 
After annealing with a solution containing complementary DNA templates (2 PM), 
primer extension was performed with Thermo Sequenase (1U/PL) and a 
combination of Cy3-(A) 3 -dUTP and Cy5-(A) 3 -dCTP (2.5 jiM). Afterwards the slide 
was scanned in the blue and in the red channel. 
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Experimental data have shown that 20 and 30 jiM solutions of DNA primer 
provided good signal intensity and specificity. Decreasing of fluorescence intensity 
at 30 jiM concentration is due to dye quenching at high density of DNA primers. 
Template concentration 
A template concentration gradient experiment was run on a CodeLinkTM  slide. 20 
p.M solutions of 5 DNA primers were printed onto the slide in three subarrays. 
Afterwards, the primers were annealed to DNA templates added to different areas 
of the slide at different concentrations: 5, 2 and 0.5 p.M. The result of dual color 
primer extension has shown that a concentration of 2 p.M provided good signal 
intensity in the red and blue channel. Decreasing of fluorescence intensity at 5 PM 
concentration is due to dye quenching at higher density of labelled primers. 
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Figure 6.2 Template Gradient Experiment: Normalised Fluorescence Intensities in the red channel. 
Solutions: A=0.5 jiM, B=2 jiM, C= 5 i.tM. 
Figure 6.3 Template Gradient Experiment: Normalised Fluorescence Intensities in the blue channel. 
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Effect of enzyme & nucleotide concentration 
Six subarrays of 5 DNA primers were printed on CodeLinkTM  slides. After 
annealing, three subarrays of double stranded DNA were treated with three 
solutions containing the enzyme at different concentrations: 2, 1 and 0.25 U/tL and 
the nucleotides Cy3-(A)3-dUTP and Cy5-(A) 3 -dCTP at a constant concentration of 
5tM. 
The other four subarrays were treated with three solutions containing the 
nucleotides Cy3-(A) 3 -dUTP and Cy5-(A) 3 -dCTP at different concentrations (2.5, 5 
1iM, 25 j.tM) while the enzyme concentration was kept constant (1 U4tL). 
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Figure 6.4 Enzyme Gradient Experiment: A) Normalised Fluorescence Intensities in the red channe 
B) in the blue channel. Solutions: A=0.25 UI jiL, B=l UI j.tL, C= 2 U/ gL. 
This experiment was carried out in order to see if, higher concentrations of 
nucleotides would favorite multiple incorporations or mis-incorporation and to find 
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the minimum amount of enzyme needed to provide acceptable results, as Thermo 
Sequenase is relatively expensive. 
As expected, higher signal intensities were obtained at higher concentrations of 
nucleotides and enzyme. No substantial difference was noted in terms of specificity 
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Figure 6.5 Nucleotide Gradient Experiment: A) Normalised Fluorescence Intensities in the red 
channel; B) in the blue channel. Solutions: A=2.5 1tM, B=5 jiM, C= 25 RM. 
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Unsymmetrical functionalised cyanine dyes, covering the 
whole colour range, were readily synthesised (in 100 mg 
amounts) by a combination of microwave and solid-phase 
methodologies. 
Fluorescent probes represent a versatile tool for visualising specific 
molecular targets and events in vitro and increasingly in vivo.' -' 
Multicolour fluorescence detection has proved to be useful for 
multiplexed assays on a variety of microarray formats'-' and for 
the simultaneous investigation of multiple biological processes in 
living cells." As a consequence, an increasingly large number of 
fluorescent probes, available in different colours, with the ability 
to be straightforwardly conjugated to biomolecules, are required.' 
The cyanine dyes (Fig. 1), a class of highly fluorescent com-
pounds, have all the key requirements necessary for highly sensitive 
multicolour detection, with wavelengths which are tunable, by 
synthesis, across the visible spectrum. They also display excellent 
photophysical properties, including high extinction coefficients 
and quantum yields, while having fluorescence wavelengths remote 
from the natural autofluorescence of biomolecules.'° They are 
thus routinely used as fluorescent probes in a wide-range of 
applications such as DNA sequencing, cellular analysis," flow 
cytometry' 3 and in vivo imaging.' 4" 5 
Fig. I Structure of cyanine dye. R', R 2 = H, -(CHCH) 2 -, R 1 = SO,, 
R 2 = H; n = 1,2,3. 
Conventional synthetic methods for the preparation of un-
symmetrical cyanine dyes are based on the condensation of 
quaternised indolenine derivatives with vinylogous homologues 
of diphenyl formamidine and typically affording mixtures of 
the desired compound along with unreacted hemicyanine and 
undesired symmetrical analogues.' 6 
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To avoid time-consuming purifications and allow enhanced 
access to a broad range of cyanine dyes, solid-phase synthesis 
methods"" have been reported. In particular, Mason et al.2° 
reported a highly versatile strategy based on the attack of a 
heterocyclic carbon nucleophile onto a polyene-chain precursor 
immobilised onto a solid support to generate unsymmetrical 
trimethine and pentamethine dyes. 
However, there is still a great demand for the development of 
a facile synthetic method for the preparation of sulfonated and 
non-sulfonated cyanine dyes, available in different colours (e.g 
far-red profiles for in vivo imaging) and amenable to biomolecule 
conjugation (e.g. with an appendant carboxyl group or equivalent). 
Herein, we report a common synthetic pathway for the prepa-
ration of a wide colour-range of hydrophobic and hydrophilic 
cyanine dyes suitable for bioconjugation, using both microwave 
and solid-phase methodologies, the combination of which offers 
a practical approach to the rapid and practical preparation of 
a variety of Cy-fl uoroph ores. The general synthetic procedure 
(Schemes 2 and 3) shows the parallel synthesis of the range of 
cyanine dyes with the starting point being the N-alkylation of 
indolenines (Scheme I). 
R2 
R 
2a-c 	 3a-c 
W. R2 = H 
R 1 , R2 = -(CHCH)2- 
c:R'SO3 , R2 °'H 
Oh 
Scheme I Microwave-mediated alkylation of indolenines. (i) methyl 
iodide, acetonitrile, 150°C, 30 min to I h, microwave; (ii) 6-bromohexanoic 
acid, acetonitrile, 150 °C, Ito 3 h, microwave 
The heterocyclic quaternary ammonium salts 2 and 3 are usually 
obtained by heating the corresponding heteroaromatic base I with 
an excess of alkylating agent in an aprotic solvent' 6'2 ' over several 
days. In the first simplification of the synthesis it was possible 
to reduce the reaction time by microwave heating the reaction 
mixture at 150°C in acetonitrile (Scheme I) to give rapid access to 
a broad range of desired heterocyclic quaternary ammonium salts 
856 1 Org. Biomol. Chem., 2009,7, 856-859 	 This journal is 	The Royal Society of Chemistry 2009 
R = OEt 
R = -CHCH-OMe 
6cr R = CHCH)2W(Ac)Ph 
RR; 
2a-c 
5a: R1 , R2 = H, (n = 3) 
Sb: R 1 , R2 = -(CH=CH)r. (n = 3) 
5cr R 1 = 503, R2 = H, (n = 2) 
a:R 1 R2 =H,(n1) 
b: R 1 R2 = H, (n = 2) 
icr R 1 R2 = H. (n = 3) 
R 1 , R2 = -(CHCH)2., (n = 1) 
R 1 , R2 = -(CH=CH)2-. (n = 2) 
it: R 1 , R2 = .(CHCH)2 (n = 3) 
ig: R 1 = S03. R2 = H. (n = 2) 




H 2 N 
Scheme 2 Solid phase synthesis of the cyanine dyes: (a) triethylorthoformate for 6a, malonaldehyde bis dimethyl-acetal for 6b, BF3 Et2 0, DCM. 6 h; 
glutaconaldehyde (2-pentenedial) dianilide hydrochloride, Ac 2 0, DIEA, and pyridine for 6c; (b) DMF, 120 ° C, 15 mm, microwave, for trimethine and 
pentamethine dyes; AcO, DIEA, and pyridine, 1.5 h; (c) DCM, I h. 
R 	R 2 
01,10 
Table I Properties of dyes synthesised on solid phase 
Dye (nm) (nm) Yield' 
8a 547 561 68% 
Sb 640 660 84% 
Sc 743 765 86% 
Sd 587 603 49% 
Se 678 704 92% 
Sf 781 808 51% 
Sg 647 667 94% 
• Measured in MeOH (except for compound 8g which was dissolved in 
H : O). I Yield of isolated product in the final step (based on the amount of 
heterocycle used in the cleavage step). 
ia-g 
(0 
R 1 R2 = H, (n = 1) 
R, R2 = H, (n = 2) 
C 	 Sc: R 1 R2 = H, (n = 3) 
8d: R 1 , R2 = -(CH=CH) 2-, (n = 1) 
Be: R 1 , R2 = -(CH=CK)T, (n = 2) 
8f: R 1 , R2 = -(CHCH)2-, (n = 3) 
89: R 1 = S03 , R2 = H, (n = 2) 
Scheme 3 Cleavage of the cyanine dyes from the resin. (i) Ac 2 0, (DIEA), 
and pyridine, 2 h. 
in good yields (66-95%), including sulfonated (2c, 3c) and/or 
carboxylated (3a—c) variants. 
To synthesise cyanine dyes the alkylated indolenines (2a—c) 
were reacted with the resin bound polymethine imines (6a—c) 
(Scheme 2, route A) as originally reported by Mason el al. ,° 
although again using microwave irradiation (15 mins, 120 °C). 
Though microwave heating accelerates the attack of a second 
molecule of the indolenium salt 2 onto the polymer-bound imine 
6, the symmetrical impurity obtained is cleaved from the resin and  
it was observed that microwave heating in this step gave rise to 
higher yields and purities of the final compound. Cleavage from 
the solid support was then accomplished using the carboxylated 
indolium salt (3a—c) to give functionalised cyanine dyes suitable 
for conjugation with biomolecules (Scheme 3). The unsymmetrical 
trimethine and pentamethine cyanine dyes were obtained in good 
yield (Table I) and purity (85-1000/o by ELSD detection) and in 
preparative scale (up to 100 mg). 
Further studies were carried out to extend this protocol to the 
synthesis of heptamethine dyes, as they have attracted great interest 
as fluorescent probes for in vivo imaging. 11-12.21 
In an initial approach the monofunctionalised heptamethine 
dye Sc was obtained following the route A. Glutaconaldehyde 
dianilide hydrochloride was reacted with the supported ani-
line 4, in the presence of Ac 20, to form the polymer-bound 
polymethine 6c. 
The reaction of the indolenium salt 2a with 6c produced the 
desired supported hemicyanine 7c via loss of N-phenylacetarnide, 
This journal is 	The Royal Society of Chemistry 2009 	 Org. Biomol. Chem., 2009, 7, 856-859 1 857 
but resulted also in the release of the hemicyanine in solution 
by cleavage from the resin, with a consequent decrease in the 







Scheme 4 Formation of hemicyanine 7c. (I) 2a, Ac.O, D!EA, pyridine, 
1.5 h. 
This led to the development of an alternative catch-and-release-
strategy (Scheme 2, route B) based on the formation of the 
hemicyanine intermediates 5a,b in solution and the captive loading 
onto the solid support (4) to form 7c,f. The loading of the  
hemicyanine 5a onto the resin in this manner was carried out 
in DCM for I h, with an 86% yield as determined by nitrogen 
elemental analysis. The desired dyes were then cleaved from the 
resin by nucleophilic attack of 3a,b onto the intermediates 7c,f in 
pyridine:Ac 2 0 (10:1) to afford the unsymmetrical heptamethine 
dyes Sc and 81 in good yield (Table I) and purity (>90%), as 
determined by HPLC analysis and 'H NMR (Fig. 2). 
The catch-and-release protocol described above has proven to 
be effective also for the synthesis of sulfoindocyanine dyes. The 
presence of sulfonate groups on the ring systems improves water 
solubility, prevents aggregation in water and reduces non-specific 
binding to biomolecules and cellular constituents.' However, 
purification by chromatography of these dyes is difficult. 
To overcome this limitation, Jiang etal." recently suggested the 
use of poly(ethylene glycol) as a soluble support, which has its own 
handling problems and low loading. In addition, Mason ci al. 1 
described the synthesis of sulfonated cyanine dyes on polystyrene 
resin; however they reported that the sulfonated heterocycles did 
not react during the formation of the hemicyanine intermediate on 
solid phase but they did react in the dye formation step allowing 
the synthesis of mono-sulfonated cyanine dyes. 
Microwave heating enabled the solid-phase synthesis of the 
pentamethine sulfoindocyanine dye 8g from polystyrene resin 
(route A), although in low yield (10 1/6) and purity. 
I 	 I 	I 
5' 	4• 




1 	3 	5 
OH 
LJiiA 
Fig. 2 1 H NMR of the crude heptamethine dye 8c. 
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The catch-and-release method (route B) proved to be far 
more effective, resulting in the formation of 8g in excellent yield 
and purity (94%), without the need for further purification by 








Fig. 3 HPLC chromatogram of the crude sulfonated dye 8g. 
In conclusion, two practical approaches to the solid phase syn-
thesis of unsymmetrical cyanine dyes suitable for bioconjugation 
have been reported. The method proposed is straightforward and 
enables, in a few steps, the synthesis of cyanine dyes spanning the 
whole colour range. Through a catch-and-release strategy we have 
also been able to synthesise, on solid phase, heptamethine and 
water soluble cyanine dyes in high yield and purity without the 
need for chromatographic purification, thus providing an easy 
route to the preparation of these invaluable fluorescent probes 
in amounts sufficient to satisfy the most hungry of biological 
appetites. 
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